Characterisation of Vibrio anguillarum for the development of vaccine in cod (Gadus morhua). by Gratacap, Remi M. L.
 Characterisation of Vibrio anguillarum for the 
development of vaccine in cod (Gadus morhua). 
 
 
 
A THESIS SUBMITTED TO THE UNIVERSITY OF STIRLING FOR THE 
DEGREE OF DOCTOR OF PHILOSOPHY 
 
 
 
 
by 
 
REMI M. L. GRATACAP 
 
 
 
 
 
INSTITUTE OF AQUACULTURE, UNIVERSITY OF STIRLING, STIRLING, 
SCOTLAND 
 
DEC 2008 
 
 ii
 
 
 
 
To Sarah and my parents, 
Bénédicte and Benoît, who encouraged me in my love of science. 
 iii
DECLARATION 
 
I declare that this thesis has been compiled by myself, and is the result of my own 
investigation. It has not been submitted for any other degree and all sources of information 
have been duly acknowledged. 
 
 
 
 
Remi M. L. Gratacap 
 iv
ACKNOWLEGEMENTS 
 
I would like to thank my supervisors Dr. Kim Thompson, Professor Alexandra Adams and 
Professor Ian Bricknell for their assistance and encouragement throughout the course of this 
study. I would like also to express my gratitude to Professor Patrick Smith and Dr. William Roy, 
for their insights and practical approach in this project. 
I would like to acknowledge Mrs Gillian Dreczkowski, Dr. Margaret Crumlish, Dr. Alison 
Morgan, Mrs Hilary McEwan, Mrs Karen Snedden, Professor Hugh Ferguson, Dr. Dave Morris, 
Dr. James Bron, Dr. Charlie McGurk, Dr. Janina Costa, Dr. Saravanane Poobalane, Mr Niall 
Auchinachie, Mr Robert Aitkin, the staff of the Institute of Aquaculture and of Machrihanish fish 
farm. I am also thankful to my friends and fellow PhD students for helping me with various 
aspects of this thesis, most of all Ms Sarah Barker and Dr. Farah Manji. 
I am very grateful to the sponsors of this project, Intervet-Schering-Plough and SeaFish for the 
contribution in making this thesis a reality; I would like to thank the Fishery Society of the British 
Isles (FSBI), the Scottish International Education Trust (SIET) and the Institute of Aquaculture 
(Stirling University) for travel grants to present some of this work at international conferences. 
I finally thank all the researchers who sent me isolates of Vibrio anguillarum and allowed this 
study to take place: Dr. Dawn Austin (UK), Dr. Jeremy Carson (AUS), Dr. Ysabel Santos (ES), 
Dr. Duncan Colquhoun (NO), Dr. Nicky Buller (AUS), Dr. Christian Michel (FR), Dr. Philippe 
Roch (FR), Dr. Amedeo Manfrin (IT), Dr. Harry Birkbeck (UK), Dr. Lene Bay (DK), Dr. Luc 
Grisez (BE) and Dr. Saturo Nakano (JP). 
 v
ABBREVIATIONS 
μL: microlitre 
μg: microgram 
μm: micrometre 
A: ampere 
AFLP: amplified fragment length polymorphism 
BPI: bactericidal/permeability-increasing 
(protein) 
CD: cluster of differentiation 
cfu: colony forming units 
CRP: C-reactive protein 
CSF: colony stimulating factor 
Da: Dalton 
DGGE: denaturing gradient gel electrophoresis 
DIVA: differentiating infected and vaccinated 
animals 
DNA: deoxyribonucleic acid 
dph: days post hatch 
ECP: extracellular products 
e.g.: example 
ELISA: enzyme-linked immunosorbant assay 
et al.: et alias (and others) 
FCS: forward scatter channel 
g: gram 
X g: multiple of gravity 
h: hours 
HMW: high molecular weight 
HSW: high salt wash-buffer 
i.e. id est (that is) 
IFN: interferon 
Ig: immunoglobulin 
IL: interleukin 
IP: intraperitoneal 
ISH: in situ hybridisation 
IU: international units 
kb: kilo base 
L: litre 
LBP: lipopolysaccharide binding protein 
LD: lethal dose 
LMW: low molecular weight 
LSW: low salt wash-buffer 
LPS: lipopolysaccharides 
M: molar 
mAb: monoclonal antibody 
 
 
mg: milligram 
MHC: major histocompatibility 
min: minutes 
mL: millilitre 
mm: millimetre 
MMW: medium molecular weight 
MOMP: major outer membrane protein 
MW: molecular weight 
nm: nanometre 
NMR: nucleic magnetic resonance 
OD: optical density 
pAb: polyclonal antibody 
PAMP: pathogen associated molecular pattern 
PBS: phosphate buffer saline 
PCR: polymerase chain reaction 
PFGE: pulse field gel electrophoresis 
PRR: pattern recognition receptors 
RAG: recombinant activator gene 
RAPD: random amplified polymorphic DNA 
RNA: ribonucleic acid 
ROS: reactive oxygen species 
rpm: rounds per minutes 
RPS: relative percentage survival 
RT: room temperature (18-22°C) 
SAP: serum amyloid-P 
SDS-PAGE: sodium dodecyl sulphate-
polyacrylamide gel electrophoresis 
sec: seconds 
SH: serum haemolysis 
sp.: species 
TBS: tris buffer saline 
TGF: transforming growth factor 
TLR: toll-like receptor 
TNF: tumour necrosis factor 
TSA: tryptone soy agar 
TSB: tryptone soy broth 
TTBS: tween tris buffer saline 
T: tonne 
V: volt 
VAR: Vibrio anguillarum related (organisms) 
v/v: volume/volume 
w/v: weight/volume 
 vi
ABSTRACT 
 
Atlantic cod (Gadus morhua L.) is one of the most promising new fish species introduced to 
cold water aquaculture due to the large established market in Europe and the USA and the 
decline in wild stock. So far, the production of farmed cod has been relatively low, with the main 
hindrance due to diseases. Vibrio anguillarum has been recognised as the biggest disease 
problem of farmed cod and has slowed the development of a successful cod aquaculture 
industry. 
When the first incidences of V. anguillarum occurred in cod aquaculture, vaccines designed for 
vibriosis in Atlantic salmon (Salmo salar L.) were used in an attempt to combat the disease. 
However, these vaccines did not provide sufficient protection, possibly because they lacked 
serotype O2b, which is known to affect cod and to a lesser extent salmonids. Recently, 
vibriosis vaccines specifically designed to protect Atlantic cod have been formulated, but 
outbreaks of vibriosis in vaccinated fish are still being reported, suggesting that these 
formulations are inadequate. The aim of this project was to develop a whole cell inactivated 
vaccine formulation specifically tailored to protect Atlantic cod against Vibrio anguillarum. 
The serological classification of V. anguillarum was first investigated by producing a set of 
monoclonal antibodies (mAbs). Using lipopolysaccharides (LPS) extracted with butan-1-ol, 4 
mAbs were selected and shown to react specifically with V. anguillarum serotypes O1, O2a and 
O2b. A collection of over 150 V. anguillarum isolates were screened using these, which 
revealed that most of the isolates had been previously correctly classified. A new sub-serotype 
of V. anguillarum O2 was identified from isolates recovered from outbreaks of vibriosis in 
Norway as well as Scotland. This new sub-serotype was referred to as O2d since the sub-
serotype O2c has been recently identified in vibriosis cases from Atlantic cod. However, it was 
shown that the O2c sub-serotype might not belong to the O2 serotype, but in fact belongs to 
another serotype. To protect Atlantic cod against all the V. anguillarum serotypes (and sub-
serotypes) which they are susceptible to, it is recommended that isolates from serotypes O1, 
O2a, O2b, O2c and O2d should all be included in a bacterin vaccine for cod. 
In order to determine which isolates from each of the serotypes to include in the vaccine, a 
variety of virulence factors of V. anguillarum were investigated in vitro. The interaction of some 
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candidate isolates from O1, O2a and O2b serotypes (O2c and O2d were not identified at the 
time this part of the study took place) with cod phagocytic cells were studied using flow 
cytometry. Phagocytosis and respiratory burst of cod macrophages and neutrophils as well as 
cod serum killing of V. anguillarum were quantified. It was found that isolates within the same 
serotype displayed varying degrees of resistance to phagocytosis and the subsequent 
respiratory burst activity as well as that all the V. anguillarum strains tested were resistant to 
Atlantic cod serum killing. These in vitro assays were found to be very useful in assessing the 
virulence of V. anguillarum. The isolate within each serotype eliciting the highest percentage of 
positive phagocytic cells was selected in order to increase the antigen presentation pathway, 
thus theoretically enhancing the protection elicited by the vaccine. 
A multivalent formalin-inactivated non-adjuvanted vaccine was prepared which included all the 
serotypes previously described and was injected intraperitoneally into Atlantic cod. A bath 
challenge was performed on vaccinated and mock-vaccinated fish, 6 weeks post immunisation, 
using V. anguillarum isolates from the serotypes O2b, O2c and O2d that were not included in 
the vaccine. An excellent level of protection was obtained against O2b and O2d (relative 
percentage survival 100% and 96.4%, respectively), but the challenge with the sub-serotype 
O2c isolate did not produce any mortality in the control group and needs to be repeated. The 
vaccine formulation was very efficient at protecting Atlantic cod against vibriosis but further 
challenges need to be performed with other serotypes included in the vaccine (O1 and O2a), 
as well as with more isolates from the O2b, O2c and O2d sub-serotype. 
To conclude, Atlantic cod is a species which will certainly have a major influence in marine 
aquaculture, but many areas have to be improved. The development of an effective and broad 
range vaccine to protect cod against Vibrio anguillarum offers another advance which should 
help Atlantic cod aquaculture to reach its full potential. 
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Chapter 1. 
 
General Introduction 
 
1.1. Atlantic cod aquaculture 
Atlantic cod (Gadus morhua L.) farming started in the 1880s with attempts to release millions of 
larvae to sea in an effort to restock and enhance cod stocks in specific locations. A century 
later this strategy did not seem to be very efficient (Shelbourne, 1964), especially with Atlantic 
cod fisheries suffering declining catches since the early 1970s (Figure  1-1, A). Together these 
have prompted greater efforts in aquaculture research to help substitute for the decreasing 
supply of cod from fisheries. The production of 70,000 juvenile Atlantic cod in enclosed 
systems in the mid 1980s, by the Institute of Marine Research in Norway, was considered to be 
the first success in cod farming (Svasand et al., 2004), but more research was needed before 
the large scale development of the industry could take place. It wasn’t until advances in sea 
bass and sea bream reproduction were made in the late 1990s that the production of farmed 
cod could take place, using hatchery protocols developed for these species. The ability to delay 
maturation also represented a major milestone for the industry (Hansen et al., 2001). Intensive 
rearing soon followed with investment in integrated production systems by large companies, 
often exploiting many small production sites (Rosenlund and Skretting, 2006). The possibility of 
using equipment developed by the salmon industry for production and processing makes this 
industry more economically viable. 
The main focus of cod production nowadays is in Norway, but the actual level of production is 
still very low (Figure  1-1, B); with around 12,000 T produced in Norway in 2007 (Hellberg et al., 
2005-2006-2007). Estimates suggest that worldwide production could reach over 140,000 T by 
2010, with Norway as the major producer (50-60%), and Canada and the United States of 
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America producing the rest (Rosenlund and Skretting, 2006). The United Kingdom is not 
forecast to be a major player in the cod industry at this time. 
 
Figure  1-1 (A) Atlantic cod catches and (B) cod aquaculture production from 1950 to 
2006. Data source FAO, FishStat software. 
 
Some of the major challenges for successful development of this industry include reduction in 
production costs, increased quality and an all-year-round supply of juveniles. At the moment 
around 85 to 95% of mortalities occur in juvenile production (Magnadottir et al., 2004). Major 
efforts have also been made to improve nutrition and rearing conditions of both stock and 
brood-stock. The increased use of vegetable proteins for cod nutrition is a major advantage 
over that of salmon, which do not tolerate soybean meal. Recent research has shown that the 
inclusion of up to 25% of dietary protein derived from Soya could be used in cod diets 
(Treasurer et al., 2008). 
Aquaculture production of Atlantic cod is also hindered by several diseases. The main 
pathogens that can affect cod are reviewed in Bricknell et al. (2006) and Samuelsen et al. 
(2006), and in the yearly health reports issued by the Norwegian Veterinary Institute (Hellberg 
et al., 2005-2006-2007). These are summarised in Table  1-1. Further research is needed in 
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disease management and breeding programmes for disease resistance and should include the 
development of effective vaccines for Atlantic cod. 
Table  1-1 List of the known and potential pathogens of Atlantic cod. 
 Bacteria Virus family (Disease) 
Vibrio anguillarum 
Aeromonas salmonicida Known pathogens 
Francisella philomiragia subsp. 
noatunensis 
Birnaviridae  (IPNV) 
Nodaviridae (VNNV) 
Rhabdoviridae  (VHSV) 
Mycobacterium spp. Potential pathogens 
Vibrio ordalii, Vibrio logei 
Togaviridae  (SPDV) 
 
IPNV: Infectious Pancreatic Disease Virus; VNNV: Viral Nervous Necrosis Virus; VHSV: Viral Hemorrhagic 
Septicaemia Virus; SPDV: Salmon Pancreas Disease Virus. 
The protoctistan and metazoan parasites are not included in this table but can be found in Bricknell et al. (2006) 
and Hemmingsen and MacKenzie (2001). 
 
1.2. Vibriosis in fish 
The most economically important disease recorded in farmed cod is vibriosis, caused by Vibrio 
anguillarum, with outbreaks occurring in vaccinated fish every year. 
1.2.1. History of the disease 
The first report of a suspected vibriosis outbreak in teleost was in 1761 (in eels), and was 
published by Bonaveri (reported in Drouin de Bouville, 1907), describing this disease as “pestis 
rubra anguillarum”. Over a hundred years later (1893), the first isolation of the pathogen 
responsible for vibriosis in eels was reported by Canestrini who referred to the bacterium as 
Bacterium anguillarum (Canestrini, 1907). In 1909 and 1912, Bergman first mentioned the 
responsible agent of vibriosis as Vibrio anguillarum after he described a bacterium isolated 
from Sweden (Bergman, 1909; Bergman, 1912). In the half century that followed, many related 
organisms were described and compared to V. anguillarum including Vibrio piscum in 1927 
(David, 1927), Actinobacter ichthyodermis later reclassified as Pseudomonas ichthyodermis 
(ZoBell and Upham, 1944) and Vibrio piscum var japonicus (Hoshina, 1956). In 1971, all these 
organisms were regrouped under the name proposed by Bergman in 1912, Vibrio anguillarum 
(Hendrie et al., 1971). This reclassification was confirmed the following year with 87% 
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homology by DNA-DNA hybridization for all the strains investigated (Anderson and Ordal, 
1972). 
The first atypical Vibrio anguillarum was described in 1969 (Pacha and Kiehn, 1969), and in the 
following years additional isolates were described as being closely related to the original strains 
but not identical (Harrell et al., 1976), which prompted the discrimination of V. anguillarum into 
biotype 1 (original strains) and biotype 2 (related). In 1981 the advances in DNA methods 
highlighted more clearly the differences between biotype 1 and 2, especially regarding plasmid 
size and its cleavage, which prompted Schiewe and Crosa (1981) to reclassify Vibrio 
anguillarum biotype 2 under a new species, Vibrio ordalii. Nowadays, the distinction between 
these two species is well established (Schiewe et al., 1981; Schiewe and Crosa, 1981; Kaper 
et al., 1983; Egidius et al., 1986; Grisez et al., 1991; Pazos et al., 1993; Alsina et al., 1994; 
Alsina and Blanch, 1994a; Alsina and Blanch, 1994b; Tiainen et al., 1995). 
The classification of V. anguillarum and V. ordalii has not been straight forward and the results 
from several different studies have led to confusion. Baumann et al. (1978) reclassified both 
groups (biovar 1 and 2) as Benecka anguillarum, but 2 years later retracted this classification 
(Baumann et al., 1980). The most confusing reclassification came in 1985 from an elegant 
study using ribonucleotide sequences and which led to the total reclassification of V. 
anguillarum, V. pelagius and V. damsela into the new genus Listonella and V. fischeri and V. 
logei into Photobacterium genus (MacDonell and Colwell, 1985). However Nearhos and Fuerst 
(1987) were unable to confirm those results and the following year saw additional attempts to 
reclassify these organisms. Smith et al. (1991) put the Listonella into Photobacterium, Austin et 
al. (1995) considered them better suited as Vibrio and finally, Austin et al. (1997) could not 
support the reclassification of Vibrio into Listonella. 
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Currently, the biological classification of V. anguillarum is very clear and the relatedness of this 
organism with closely related bacteria is completely characterised but the nomenclature of this 
pathogen, Vibrio or Listonella, is still under debate and both appear in the literature. 
Interestingly, even if no official retraction has been published, Professor Rita Colwell (one of 
the authors responsible for the creation of the Listonella genus) now refers to this organism as 
Vibrio anguillarum (Colwell, 2005). In the present study, the name Vibrio anguillarum will be 
used. 
1.2.2. Susceptible species 
There are over 85 species of bacteria in the genus Vibrio (http://www.bacterio.cict.fr/, updated 
2008), of which a dozen are reported pathogenic to fish and shellfish (Toranzo and Barja, 
1990) such as V. anguillarum and V. ordalii (Schiewe et al., 1981), V. tubiashii (Hada et al., 
1984), V. damsela, now Photobacterium damselae (Love et al., 1981), V. vulnificus II (Tison et 
al., 1982), V. carchariae (Grimes et al., 1984), V. salmonicida (Egidius et al., 1986) and V. 
cholerae non-O1 (Muroga et al., 1979; Yamanoi et al., 1980). 
Most of the important economical species cultured in aquaculture are susceptible to Vibrio 
species, such as Atlantic salmon (Salmo salar), rainbow trout (Oncorhynchus mykiss), sea 
bream (Sparus aurata), sea bass (Dicentrarchus labrax), ayu (Plecoglossus altivelis), Atlantic 
cod (Gadus morhua), saithe (Pollachius virens) and turbot (Scophthalmus maximus) (Larsen et 
al., 1994; Kent and Poppe, 2003). 
1.2.3. Clinical signs 
Clinical signs of vibriosis were first described in eels in Norway by Bergman (1909) and later in 
the UK by McCarthy (1976). The disease manifested itself by the appearance of areas of 
macroscopic haemorrhaging, with swelling and boils. Destroyed epithelium is evident at the top 
of and around the lesion, while haemorrhaging can be present in the skin. The liver and 
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intestine may also have haemorrhagic (petechia) tissue and the heart lumen can be filled with 
fluid. Histopathologically, the muscle fibres are widely separated, with intermuscular connective 
tissue filling only some of the space, while the rest is filled with fluid (Roberts, 2001). An 
abundance of red blood cells and few leukocytes can be detected in the intermuscular tissues. 
Salmonids are susceptible to vibriosis to varying degrees. The most characteristic clinical signs 
are splenomegaly, gall bladder distension, petechia of the liver and severe necrotic liquefaction 
of the kidney (degeneration and necrosis of hepatocytes) with necrosis of the musculature and 
congestion and prolapse of rectal tissues. Vasodilution of glomerular capillaries, cloudy 
swelling and hyaline droplet degeneration of the epithelial tubular cells, oedematous gills and 
desquamation of interstitial mucosa may also be observed (Baumann et al., 1984; Ransom et 
al., 1984; Lamas et al., 1994). 
Atlantic cod was one of the first species of fish to be reported as being susceptible to vibriosis 
(Bergman, 1912), with the clinical signs reviewed by Egidius (1987). Briefly, the first reports of 
the gross signs of the disease described infection of the eye, affecting the cornea (Bergman, 
1912) and fin erosion and haemorrhages in the head region (Baumann et al., 1984; Egidius 
and Andersen, 1984). Bergman (1912) reported isolating the bacteria from the blood and 
artificial infecting cod, producing the same symptoms, fulfilling Koch’s postulates. Another study 
reported a slightly different pathology, characterised by ulcers and papules all over the fish 
(Bagge and Bagge, 1956), and the infection took some time to develop to the ulcerative stage, 
but vibriosis in this case was thought to be a secondary infection (Egidius, 1987). Nowadays, 
vibriosis in Atlantic cod, as well as other gadoids such as saithe, presents the typical signs of 
the disease observed in other species (Egidius et al., 1983). 
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1.2.4. Transmission, route and factors influencing infection 
The triggering of an outbreak of vibriosis is the result of host-pathogen-environment 
interactions (Larsen et al., 1994), with the main predisposition being the stress level of the fish. 
Rise in temperatures has a known effect on the stress level of fish and corresponds well with 
disease outbreaks (Egidius and Andersen, 1977; Buller, 2004), especially in early to mid 
summer (Hastein and Holt, 1972), which corresponds also better with the optimal growth 
temperature of V. anguillarum. Fluctuations in salinity, as well as temperature, have been 
reported as a possible trigger for V. anguillarum outbreaks (Rodgers and Burke, 1981). Other 
factors can also increase the incidence of vibriosis such as transport and transfer from 
freshwater to seawater (Hastein and Holt, 1972) or pollution (Larsen and Jensen, 1979; Larsen 
and Willeberg, 1984; Larsen, 1984) or the vaccination of Atlantic cod which is sometimes 
followed by outbreaks (Dr Colquhoun, personal communication). 
The point of entry of V. anguillarum has been debated for many years. Several different routes 
have been proposed, such as directly via the skin (Svendsen and Bogwald, 1997), through the 
gills (Baudin Laurencin and Germon, 1987) or through the gastrointestinal tracts (Olsson et al., 
1996; Grisez et al., 1996). Using bath immersion as the route of infection, the pathogen was 
first seen in the skin in ayu at 12 h post infection, followed by muscle, spleen and liver at 24 h, 
and direct contact between the fish led to the highest transmission level (Muroga and Delacruz, 
1987; Kanno et al., 1989). The rate of infection was increased if the skin was damaged, so the 
physical and chemical barrier of the mucus and epidermis play an important role in protection 
against V. anguillarum (Kanno et al., 1989). Other possible points of entry are the gills (Baudin 
Laurencin and Germon, 1987) or the digestive tract, but these might be less important than the 
skin (Funahashi et al., 1974; Kawai et al., 1981; Evelyn, 1984; Kanno et al., 1989), and some 
studies reported a very low or unsuccessful infection using the gills as a point of infection 
(Kanno et al., 1989; Olsson et al., 1996). Most of the different mucus producing tissues (skin, 
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gills, intestine) in different fish species have been shown to attract V. anguillarum (Chen and 
Hanna, 1992; Bordas et al., 1998; Knudsen et al., 1999; Larsen et al. 2001). Vibrio anguillarum 
was shown to adhere to rainbow trout gut sections (Horne and Baxendale, 1983), and a large 
number of bacteria could be observed in the peritoneal mesenteric of the gastrointestinal tract 
of rainbow trout (Nelson et al., 1985). It was later shown that the bacterium could use gut 
mucus as a sole source of carbon in turbot (Olsson et al., 1992). The hypothesis of the 
gastrointestinal tract as a point of entry is fairly well supported, for example, with the recovery 
of V. anguillarum from the spleen after anal and intragastric intubations (Olsson et al., 1996). 
Using transparent zebrafish and a fluorescent-labelled bacteria, the pathogen was observed 
entering the mouth (probably through drinking water) and then the gastrointestinal tract before 
producing septicaemia (O'Toole et al., 2004). 
1.2.5. Antibacterial agents, probiotics and immunostimulants 
Antibiotic medication is the only effective way to treat an infectious bacterial disease outbreak. 
Vibrio anguillarum has been shown to be sensitive to most antibiotics, with some differences in 
sensitivity between serotypes (Table  1-2) (Pedersen et al., 1995; Samuelsen and Bergh, 2004; 
Vik-Mo et al., 2005). The most commonly used antibiotic in treating outbreaks of V. anguillarum 
is oxolinic acid (OA) and flumequine (both quinolone), but resistant strains to OA have been 
identified recently (Colquhoun et al., 2007), which highlights the recurrent problems of antibiotic 
resistance development. This is a well known phenomenon in Vibrio anguillarum (Aoki et al., 
1985; Pedersen et al., 1995). 
Table  1-2 Sensitivity of V. anguillarum serotypes O1 and O2 to selected antibiotics 
used in aquaculture. 
Antibiotic Serotype O1 Serotype O2 
Colistin Resistant Sensitive 
Ampicilin Sensitive Resistant 
Cephalothin Sensitive Resistant 
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The introduction of vaccination drastically reduced the levels of antibiotics used in the treatment 
of vibriosis in salmon in Norway (from 50 T in 1987 to 1 T in 2002). The reduction in their use 
correlates well with the increased protection offered by vaccination (Hastein et al., 2005). 
Nevertheless certain situations require the use of antibiotics such as the outbreaks of vibriosis 
occuring just after vaccination (Dr. Colquhoun, personnal communication). 
The use of immunostimulants and probiotics are of interest to cod aquaculture since these tend 
to act on the innate immune system of cod. Cod appear to rely heavily on innate immunity to 
protect them from pathogens (Magnadottir, 2006). Immunostimulants and probiotics generally 
improve fish health and together with vaccination, have reduced the used of chemo-
therapeutants (Pedersen et al., 2004), but many of the mechanisms leading to these benefits 
are still unknown. 
A possible definition of immunostimulant is “a naturally occurring compound that modulates the 
immune system by increasing the host’s resistance against diseases that in most 
circumstances are caused by pathogens” (Bricknell and Dalmo, 2005). The use of these 
immunostimulants as vaccine adjuvants will be treated more extensively in Section  1.4.1. 
Probiotics are defined as live micro-organisms which when consumed in adequate amounts as 
part of food confer a health benefit to the host (WHO/FAO, Food and Nutrition Paper 85). They 
work possibly by competitive exclusion, alteration of the microbial metabolism or stimulation of 
the host immunity (Gatesoupe, 1999; Irianto and Austin, 2002). The use of probiotics have 
shown minor improvements on survival of Atlantic cod to V. anguillarum after feeding on 
Carnobacterium dilergens (Gilberg and Mikkelsen, 1998), and probiotics have also elicited an 
increased survival in turbot after adding selected bacteria to the water at the same time as 
challenging with V. anguillarum (Hjelm et al., 2004; Planas et al., 2006). Most of the 
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mechanisms involved in probiotic benefits are unknown and offer exciting new lines for 
research. 
1.2.6. Characterisation and classification of Vibrio anguillarum 
1.2.6.1. Culture and biochemical tests 
Vibrio anguillarum, as described by Buller (2004) and in the Bergey’s manual of Systematic 
Bacteriology (Baumann et al., 1984), is a Gram-negative bacterium with short rods, curved or 
straight, round ended, occurring singly or in pairs and is pleomorphic. The size of the bacterium 
is typically 0.5 to 0.8 µm in diameter and 1.4 to 2.6 µm in length. It is a facultative anarobe, 
capable of both fermentative and respiratory metabolism. It has rapid motility and is β-
haemolysin positive. After 2 days of culture on agar, the colonies are 2mm and a glistening 
cream-colour. The bacterium is catalase and oxidase positive. Optimal growth occurs at pH 7, 
salinity of 2% and at a temperature of 25°C (Larsen, 1984). The 0/129 Vibriostatic test (2, 4-
diamino-6, 7-di-iso-propylpteridine phosphate) is the typical antibiotic test which differentiates 
Vibrionaceae from Aeromonas (Aeromonas being resistant to both concentrations) but other 
bacterial species are also sensitive to this test such as Moritella, Photobacterium and 
Flavobacterium (Buller, 2004). For this reason, the results of these tests have to be considered 
carefully and are not conclusive, especially since Pedersen et al. (1995) showed that some V. 
anguillarum isolates were resistant to this antibiotic. A clearing zone of more than 9 mm on 500 
µg discs is considered sensitive for Vibrio species (Bernardet and Grimont, 1989). 
The first biochemical classification of V. anguillarum took place in 1935 (Nybelin, 1935), based 
on sucrose and mannitol utilisation and indole production, and 2 groups of bacteria were 
identified. In the next 45 years, 3 additional groups were added (Table  1-3). Only groups A and 
C were regularly recovered from infected animals (Hastein and Holt, 1972; Egidius and 
Andersen, 1977), the other three groups represented environmental isolates. 
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Table  1-3 First biogrouping of V. anguillarum with reference to published reports. 
Group Indole Mannitol Sucrose  
A + + + (Nybelin, 1935) 
B - - - (Nybelin, 1935) 
C - + + (Smith, 1961) 
D + + - (Larsen and Jensen, 1979) 
E + - - (Larsen and Jensen, 1979) 
 
With the advances in bacteriology and biochemistry in the early 70’s, new phenotypical traits of 
the bacteria could be analysed and revealed a more complex picture. This was very clearly 
highlighted by Evelyn (1971), who proposed the first archetype of V. anguillarum regarding 
biochemical reactivity, but recommended that large scale studies should be carried out due to 
the high heterogeneity observed. Biochemically, the decarboxylase reactions were found to be 
very useful for differentiating between marine Vibrio and other bacteria (Kaper et al., 1983) 
together with arabinose (Egidius and Andersen, 1977) and could be used to distinguish 
between V. anguillarum isolates recovered from wild gadoids and salmonids (Hastein and 
Smith, 1977). 
Several large scale studies were published in the mid-1980s using the increasing power of 
computers to analyse the biochemical characteristics of bacteria, allowing more complex 
patterns to be distinguished, usually grouped in phena defined as “a phenotypically reasonably 
uniform group” (Mayr, 1969). Bryant et al. (1986b) reported 38 phenon within the Vibrio genera, 
after analysing over 1000 isolates for 81 parameters. They concluded that 30 of these tests 
could be used to classify all isolates with a 90% confidence interval, and found all V. 
anguillarum isolates to fall into one group, as in the study by West et al. (1986) and Kaper et al. 
(1983). The heterogeneity of the enzymatic capacity of V. anguillarum was a characteristic 
feature found in most studies, with fermentation of carbohydrates and glycosides more 
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heterogeneous in V. anguillarum than in V. ordalii (Larsen, 1983). The latter was generally 
found to be less reactive to many biochemical tests (Colwell and Grimes, 1984). 
In 1986, Bryant et al. (1986a) compared 5 of the major studies examining numerical 
classification of the genus Vibrio (Lee et al., 1981; West et al., 1983; Lee and Bryant, 1984; 
West et al., 1986; and Lee and Bryant, unpublished), involving 142 common characteristics and 
1091 Vibrio strains. They reported 59 clusters with 87.5% similarities and 44 unclustered 
strains. Almost all the V. anguillarum isolates grouped together, with variations in their 
response to Voges-Proskauer reaction, hydrolysis of elastin and production of acid and growth 
on L-arabinose. 
The API20E system (BioMerieux, France) was the first commercially available kit (Doucet and 
Paule, 1971) for identifying enterobacteria based on their biochemistry through 20 different 
biochemical reactions. The use of this kit to identify fish bacterial pathogens was initially 
disappointing (MacDonell et al., 1982), with varying results obtained for Pasteurella and Vibrio 
(Kent, 1982), and the possible misidentification of V. anguillarum as Aeromonas hydrophila 
(Santos et al., 1993). Nowadays an API20E reaction profile is available for V. anguillarum, but 
several tests can vary (Buller, 2004), even within serotypes such as O1 (Pedersen and Larsen, 
1995) or O3 (Tiainen et al., 1997b). Serotype O2 was found to be even more heterogeneous 
than O1 (Wiik et al., 1989) and therefore classification of V. anguillarum based purely on these 
results is not recommended (Grisez et al., 1991). 
In 1995, Austin et al. (1995) analysed 260 V. anguillarum by three different phenotypical 
methods and found 9 clusters by BIOLOG-GN (including all the strains) , 5 clusters  by the 
API20E (43% of the strains and 117 profiles in total) and 32 clusters based on carbon source, 
i.e. biotyping (41% of the strains). The authors recommended caution when using commercial 
kits for identification, and demonstrated once more the biochemical heterogeneity of V. 
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anguillarum. This heterogeneity was also reported by Pedersen et al. (1999b) using a 
PhenePlate system (Kuhn et al., 1990), the authors could weakly differentiate between V. 
anguillarum from Nordic countries and those from others countries. 
In conclusion, it is clear that no distinct pattern can be seen in biochemical profiles of V. 
anguillarum. This species of Vibrio is easy to identify and distinguish from other Vibrio species 
(Alsina and Blanch, 1994a; Alsina and Blanch, 1994b) but the biochemical intra-specific 
variations do not allow the subdivision of the species in unambiguous groups. 
1.2.6.2. Lipopolysaccharides 
Lipopolysaccharides (LPS) are integral components of the Gram-negative cell wall of bacteria. 
Three structural entities are present in LPS, Lipid-A, core-oligosaccharide (attached to the lipid 
by the 2-keto-3-deoxy-octulosonic acid molecules, KDO) and a polysaccharide known as the 
O-chain, attached to the core oligosaccharide (Orskov et al., 1977). This O-chain consists of a 
repeating oligosaccharide with a varying degree of polymerisation. Advances in chemistry have 
led to improvement of LPS analysis such as the use of silver staining for visualising LPS on 
sodium dodecyl-sulphate-poly-acrylamide gel electrophoresis (SDS-PAGE) (Tsai and Frasch, 
1982), or the purification of LPS using proteinase K (Hitchcock and Brown, 1983). 
In 1973, Chester et al. (1973) analysed the composition of LPS from several Pseudomonas 
aeruginosa isolates and showed that the composition and structure of LPS suggested the 
existence of serologically common regions in the low molecular weight (LMW) LPS and specific 
regions in the medium to high molecular weight (MMW and HMW) LPS, schematised in Figure 
 1-2. Goldman and Leive (1980) and Palva and Makela (1980) suggested that the pattern 
observed for LPS, characterised by regularly spaced bands, could be due to different numbers 
of repeating units in the O side chain of the LPS. 
 14
 
Figure  1-2 Diagrammatic representation of the typical pattern of a Gram-negative 
bacterial LPS on SDS-PAGE gel. 
 
The segregation of V. anguillarum isolates based on their LPS profile was shown to be very 
consistent and corresponded directly with their serotypes (Nomura and Aoki, 1985). Structural 
analysis showed that the chemical composition of the LPS was different between different 
serotypes, as well as between V. anguillarum and V. ordalii, and may be due to a difference in 
the relative amount of hydrocarbon structures in the core region for the latter (Salati and 
Kusuda, 1986). The characteristic LPS patterns seen on SDS-PAGE for different serotypes has 
been confirmed by many authors (Grisez and Ollevier, 1995; Austin et al., 1995; Austin et al., 
1997; Tiainen et al., 1997b; Pedersen et al., 1999a), but some reports have described 
differences in the profiles within serotypes O2 and O3 as well as between membrane bound 
and extracellular LPS (Santos et al., 1995). Using immuno-electrophoretic methods, 2 groups 
within the serotype O2 of V. anguillarum have been reported, i.e. an O2a and an O2b sub-
group (Banoub et al., 1987; Rasmussen, 1987a; Rasmussen, 1987b). These antigenic 
differences could not be distinguished on SDS-PAGE (Grisez and Ollevier, 1995; Austin et al., 
1995). In 1992, the first complete chemical composition of V. anguillarum LPS was  reported as 
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well as a molecular structure for the O-polysaccharide (Eguchi et al., 1992a; Eguchi et al., 
1992b). 
The antigenicity of the different structures found in the LPS profile of V. anguillarum (Figure 
 1-2) was studied by Mutharia et al. (1993) using rabbit antisera. The authors concluded from 
the resulting profile that O2 and V. ordalii had common antigenic epitopes localised in the LMW 
region of their LPS profile contributing to the extensive cross-reactivity obtained with the rabbit 
serum, the species-specific antigens seemed to be located in the HMW-LPS. 
1.2.6.3. Immunological characterisation 
Serological classification is another way of segregating isolates based on the interaction of 
antibodies with different bacterial antigens. One of the first reports published using polyclonal 
antibodies (pAbs), segregated 13 isolates of V. anguillarum into 3 groups which were 
geographically and host dependant (Pacha and Kiehn, 1969). Even with the low number of 
isolates, the classification based on antibody reactions seems to be more homogeneous (less 
groups) than obtained with biochemical typing. A few years later, Harrell et al. (1976) reported 
an outbreak of vibriosis in fish vaccinated with V. anguillarum isolate 775 and showed that the 
recovered isolate 1669 contained antigenic determinants not present on the vaccine strain. 
From 1981 to 1985, advances in immunology and the increasing number of available isolates 
allowed more robust classification to be carried out. However, a different nomenclature scheme 
was adopted by each research group (Table  1-4). 
Table  1-4 Summary of the different names given to serotypes O1 and O2 from different 
references until 1985. 
 Serotype Reference 
After 1986 O1 O2 (Sorensen and Larsen, 1986) 
775  (Harrell et al., 1976) 
775A 569 (Strout et al., 1978) 
Type I Type II (Gould et al., 1979) 
C A (Kitao et al., 1983) 
Before 1986 
J-O-3 J-O-1 (Ezura et al., 1980) 
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One of the Japanese classification systems, J-O-1 to J-O-3 (Ezura et al., 1980), seemed robust 
at the time, with 64% of the 195 isolates grouping in the first serogroup, 6% in the second and 
30% in J-O-3. They found that isolates within the serotype J-O-1 were almost exclusively 
recovered from freshwater outbreaks of ayu and J-O-3 was composed almost entirely of 
isolates from seawater, which was confirmed by Kitao et al. (1983). A follow-up study added J-
O-4 to J-O-8 to the existing scheme and revealed the presence of a common antigen (heat-
labile, k-1) on all the serotype strains and a second one (k-2) only found in some of the J-O-1 
isolates and J-O-4 (Tajima et al., 1985). Even though the antibody profiles of serotype J-O-1 
were homologous in appearance (Harrell et al., 1976; Chart and Trust, 1984), it consisted of 
two distinct biochemical groups; which are now known to be V. anguillarum O2 and V. ordalii. 
In a 5 year study, Sorensen and Larsen (1986) produced a complete classification scheme 
using thermostable antigens, grouping 90% of the 270 isolates from fish, 30% of the 189 
isolates from the environment and 40% of the 36 isolates from invertebrates in 10 serotypes 
(O1 to O10). Serotype O1 was composed mostly of isolates recovered from farmed salmonids 
(71% of the isolates recovered from rainbow trout). The predominant group of isolates in the 
study (O2 serotype) came from marine feral fish but was also found in salmonids. Vibrio ordalii 
isolates grouped with serotype O2. Serotypes O3 to O6 were mostly environmental strains, O7 
was isolated from plaice and corresponded to the serogroup J-O-7 (Tajima et al., 1985). 
Serotypes O8, O9 and O10 were isolated from diseased fish, but are rarely recovered from 
fish. This classification system has now been almost universally adopted and only one 
subsequent study created a different serotyping system (T-O-I to T-O-VII), where T-O-I, T-O-V 
and T-O-VI correspond to the serotypes O1, O2 and O3, respectively (Song et al., 1988). 
In one of the most complete studies on V. anguillarum, Austin et al. (1995) classified 78% of 
the 260 isolates in their collection into 15 different serotypes, 10 from Sorensen and Larsen 
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(1986) and 5 new ones (VaNT1, VaNT2, VaNT4, VaNT5 and VaNT7). They found half of all 
isolates grouping with O1 and that 60% of the isolates recovered from rotifers, artemia, 
sediments and water samples were untypable. Pedersen et al. (1999a) completed the 
serotyping scheme using pAbs, by removing two of the VaNT groups and adding 6 serotypes 
from Japanese isolates (O11 to O16, described in Kitao et al., 1983 and Kitao et al., 1984, as 
well as 4 serotypes from the study of Grisez, 1997, O17 to O23). The sub-classification of O2 
into O2a and O2b was confirmed by Bolinches et al. (1990) using pAbs. Another sub-grouping 
was revealed on analysis of the extracellular products (ECP) of strains belonging to the O3 
serotype, called O3a and O3b (Santos et al., 1995). The relationship to pathogenicity was 
clear, with O3b isolates recovered from the environment and O3a exclusively from disease 
outbreaks. The latter was very homogenous for both biochemical reactions and ribotype 
patterns (Tiainen et al., 1997b). 
Thermostable antigens on V. anguillarum are the basis of the serological classification but 
Mackie and Birkbeck (1987) showed that even after cross-absorption of the pAbs with LPS, 
they still reacted with two cell envelope proteins (most probably peptidoglycans). The 
antigenicity of major outer membrane proteins (MOMP) was investigated by Suzuki et al. 
(1996) focusing on Omp35La porin protein (first reported by Murphy, 1994) and found that even 
if commonly expressed among J-O-1 to J-O-7 serotypes, it did not participate in the antigenicity 
of this serotyping scheme. 
The use of monoclonal antibodies (mAbs) confirmed the results of the serotyping scheme 
proposed by Sorensen and Larsen (1986) and that LPS was the most antigenic molecule of V. 
anguillarum (Johnsen, 1977; Goerlich, 1987; Bolinches et al., 1990). Using mAbs, Tiainen et al. 
(1995) and Toranzo et al. (1987) showed clear immunological differences between V. ordalii 
and V. anguillarum serotype O2. They found a common heat-labile antigen (protein) between 
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both species since the pAbs they used (raised against whole bacteria) cross-reacted with both 
species, as also shown by Mutharia and Amor (1994). Fish serum has been shown to be 
unable to differentiate between V. anguillarum and V. ordalii, which prompted Mutharia et al. 
(1993) to conclude that both should be considered as the same species from a fish 
perspective. 
The possible correlation between serotypes of V. anguillarum, geographic origin and fish 
species of the recovered strains has been investigated (Toranzo et al., 1987; Larsen et al., 
1988; Myhr et al., 1991; Larsen et al., 1994). Salmonids were found to be almost exclusively 
affected by O1  and O2 serotypes (70 and 20% of the isolates recovered, respectively), the rest 
consisting of O3, O4, O5 and a few isolates that could not be typed (4%) (Larsen et al., 1994). 
Regarding non-salmonids, the majority of the isolates recovered were serotype O2 (Larsen et 
al., 1994), with O2b isolates almost entirely restricted to this group of fish (Bolinches et al., 
1990). Kitao et al. (1983) found ayu to be infected mostly by O2 isolates, whereas Song et al. 
(1988) reported half of the isolates recovered from ayu were serotype O1. Sea bass and sea 
bream seemed to be most often infected by O1, while eels are affected with isolates belonging 
to O2 as well as O3 serotype (Larsen et al., 1994). 
Atlantic cod are susceptible to most V. anguillarum serotypes, i.e. O2, O4, O5, O6, O8, O9 and 
O10 (Sorensen and Larsen, 1986), as well as VaNT5 (Austin et al., 1995). Eleven strains 
obtained from infected cod in Denmark were also reported to belong to the Vibrio anguillarum 
related organisms (VAR, Santos et al., 1996). Juvenile cod seem to be almost exclusively 
infected by serotype O2 with sub-groups O2a and O2b equally represented (Knappskog et al., 
1993), but Larsen et al. (1994) and Fouz et al. (1989) found a bias towards serotype O2a. It 
seems that the outbreaks documented more recently in farmed cod have seen a shift in the 
frequency of O2a isolates recovered towards O2b (Santos et al., 1995; Pedersen et al., 1999a; 
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Jones et al., 2000; Samuelsen et al., 2006; Bricknell et al., 2006; Hellberg et al., 2005-2006-
2007). The same phenomenon has been reported for turbot in Spain with a shift from an O1 to 
an O2a serotype (Toranzo and Barja, 1990). Due to the heterogeneity found within the O2b 
serotype affecting Atlantic cod, Larsen et al. (1994) and Espelid et al. (1991) suggested the 
existence of a third group within the O2 serotype, named O2c by Tiainen et al. (1997a), but it 
was never further characterised. Recently, Mikkelsen et al. (2007) presented good evidence to 
support this in isolates recovered from infected Atlantic cod using pAbs and mAbs, as well as 
molecular techniques. 
Several commercial kits are available for the specific identification of V. anguillarum but none 
are able to discriminate between the different serotypes. The Bionor® agglutination kit was 
shown to successfully detect O1 to O5 and O7 serotypes but failed to react with the other major 
serotypes, as well as giving false positives for V. splendidus and motile Aeromonas (Romalde 
et al., 1995). The AquaRapid-Va® and Aqua-Eia-Va® kits gave good results for O1 and O2 (a 
and b) but not O3 serotypes and a few non specific reactions were reported (Gonzalez et al., 
2004). 
1.2.6.4. Molecular characterisation 
In the late 80s and early 90s, advances in molecular tools allowed new methods to be 
developed, which allowed a faster and more accurate sequencing of the genetic code. This is 
very useful for taxonomy since sequencing can differentiate single nucleotide mutations 
between the genome of two bacterial isolates. Sequence analysis of the 16S small subunit 
ribosomal RNA led Dorsch et al. (1992) to recommend reclassification of V. anguillarum from 
the genus Listonella to the Vibrio genus. The sequence analysis of the 5S rRNA for 54 different 
strains of Vibrio confirmed this reclassification and helped to establish a clearer picture of the 
phylogeny of the family Vibrionaceae (Ruimy et al., 1994). Unfortunately this technique was not 
discriminatory enough to differentiate between V. anguillarum and V. ordalii. 
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Figure  1-3 Phylogeny of the Vibrionaceae family according to Thompson et al., 2005 
using MLSA of 16S rRNA, rpoA, pyrH and recA. 
 
The investigation of a 560 nucleotide segment of the 16S rRNA of several Vibrios spp. showed 
that V. anguillarum serotypes O1, O2a and O2b grouped closely together, with serotype O9 
further away. The sequence of this fragment in V. ordalii isolates (DF1K and DF3K) was almost 
identical to V. anguillarum isolate NCMB 6 (O2a) and V. damselae, while the V. ordalii isolate 
MSC2-75 was distantly related to these (Wiik et al., 1995). Recently, the classification of 
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Vibrionaceae has been investigated using modern molecular techniques such as MultiLocus 
Sequence Analysis (MLSA), Amplified Fragment Length Polymorphism (AFLP) and rep-PCR 
(Ben-Haim et al., 2003; Gomez-Gil et al., 2004; Thompson et al., 2004; Thompson et al., 2005; 
Mikkelsen et al., 2007; Urbanczyk et al., 2007). These molecular techniques rely on the 
sequencing of several housekeeping genes (MLSA), the restriction of the genomic DNA 
followed by amplification of the fragments (AFLP) or the amplification of repetitive extragenic 
palindromic regions of the genomic DNA (rep-PCR) all followed by the construction of 
phylogenic trees using similarity matrixes and cluster analysis. These three techniques were 
found to be more powerfull for the identification of bacteria at the species and strains levels 
compared to the sequencing of the 16S rRNA alone (Thompson et al., 2005). The application 
of AFLP to Vibrio anguillarum lead Mikkelsen et al. (2007) to highlight the possibility of the 
existance of a separate group of bacteria (possibly related to the O2 group). The distinction 
between O2a and O2b using this technique was not possible. They also found that the NCIMB 
6 reference strain (O2a) was grouped away from the O2 cluster, which was also reported by 
other groups using different techniques (Wiik and Egidius, 1986; Espelid et al., 1991; 
Knappskog et al., 1993; Wiik et al., 1995). 
Ribotyping is another method used for the identification and classification of V. anguillarum. It 
relies on the principle of cleaving ribosomal RNA with specific restriction enzymes, and 
obtaining a profile after running the fragments on an agarose gel followed by hybridisation with 
RNA probes. Many restriction enzymes are available and lead to a different restriction profiles. 
For example, Tsai et al. (1990) recommended using restriction enzymes ClaI, EcoRI, HindIII 
and ScaI for Vibrio spp. The enzymes EcoRI and HindIII produced 6 profiles for V. anguillarum 
O1 but no correlation could be found between the geographic origin of the isolates, the fish 
host or the ribotype profile obtained (Pedersen and Larsen, 1993). The results of ribotyping led 
Tiainen et al. (1997b) to question the grouping of V. anguillarum serotype O3, due to closer 
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similarities between the O3b isolates and V. aestuarianus than with V. anguillarum O3a. 
Tiainen et al. (1995) showed V. ordalii to cluster in a separate group to O2a and O2b sub-
serotypes of V. anguillarum which shared ribotypes. After cluster analysis, using Dice 
coefficient (representing the homogeneity of the groups), the authors showed that O1, O3a, O7 
and O9 were the most homogenous groups, followed by O2b, O4 and O10; and O2a, O3b, O5 
and O8 were the most heterogeneous. This technique was also used by Austin et al. (1995), 
using BglI to cleave the DNA followed by ribosomal probe labelling. They found a core group of 
V. anguillarum which they considered to represent the “true” species and suggested that the 
outliers should be questioned as to whether they belonged to this group. 
Pulse Field Gel Electrophoresis (PFGE) is another technique which allows classification of 
isolates into clusters. It relies on the digestion of DNA by restriction enzymes, and the 
fragments are then separated by three directional gel electrophoresis using variable voltage. 
This technique generated more profiles for V. anguillarum O1 than was found with ribotyping, 
and therefore has a higher power of discrimination between isolates (Pedersen et al., 1999b). 
For example, PFGE allowed the discrimination of northern and southern (European) clonal 
lineages of V. anguillarum (Skov et al., 1995), making this technique a useful tool for 
epidemiological studies. 
Polymerase chain reaction (PCR) has been used very successfully to identify V. anguillarum, 
both accurately and rapidly (Hirono et al., 1996; Gonzalez et al., 2003). The major advantages 
of this technique are the specificity of the primers which can be tailored to a particular 
requirement, the minute amounts of material required (10 pg of template DNA, Hirono et al., 
1996 or 5 bacteria per reaction, Gonzalez et al., 2003), the fact that tissue or blood can be 
used in the analysis and the possibility of carrying out the tests using non-lethal sampling (e.g. 
blood). 
 23
The random amplified polymorphic DNA (RAPD) was shown to be less powerful for the 
identification of species or strains than the AFLP, MLSA or rep-PCR (Thompson et al., 2004) 
but leads to the same type of fingerprints, and it allowed Martinez et al. (1994) to show clear 
differences between V. salmonicida, V. anguillarum and V. ordalii. They also showed the 
possibility to differentiate O1 from other serotypes. 
Another application of PCR is the generation of DNA probes which bind specifically to a target 
region in situ. Probes can be used in in situ hybridisation (ISH) where they detect the target 
region in tissue sections. This technique has been extensively used for the localisation of V. 
anguillarum in different tissues (Rehnstam et al., 1989; Aoki et al., 1989; Martinez-Picado et al., 
1994; Ito et al., 1995; Hirono et al., 1996). 
Plasmids were initially identified in V. anguillarum by Crosa et al. (1977), who found a large 
plasmid, called pJM1,in a very virulent O1 isolate. They showed later that this plasmid was 
involved in iron sequestering (Crosa, 1979; Crosa, 1980). Serotype O1 appeared to harbour 
this 67 kbp plasmid (Wiik et al., 1989; Larsen and Olsen, 1991; Myhr et al., 1991; Pedersen 
and Larsen, 1995; Pedersen et al., 1999b), but some isolates with no plasmids or more than 
one have also been reported (Olsen and Larsen, 1993). Austin et al. (1995) found the same 
plasmid in the VaNT1 group of isolates, which helped confirm their suspicions that these 2 
serotypes were closely related. Serotype O2 was first reported plasmid-less, which prompted 
the hypothesis that a chromosomal-mediated equivalent to the plasmid mediated iron-
sequestering mechanism existed (Toranzo et al., 1987; Wiik et al., 1989). Some studies later 
reported evidence that some isolates of the serotype O2 harboured a plasmid, and in some 
cases more than one (Myhr et al., 1991; Tiainen et al., 1995; Austin et al., 1995; Pedersen et 
al., 1996; Austin et al., 1997; Pedersen et al., 1999b). The other serotypes (O3, O7, O8, O9, 
VaNT4 and VaNT5) seem to lack plasmids (Austin et al., 1995; Pedersen et al., 1996) with the 
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exception a few isolates belonging to O4, O5 and VaNT7serotypes. Altogether, the power of 
plasmid analysis seems to be fairly low to segregate intra-serotypes isolates (Austin et al., 
1995). 
1.3. Immune system 
1.3.1.  Fish immune system 
The dichotomic view between the innate and adaptive immune system is being challenged by 
modern immunologists who consider the whole system as a complex multi-level, highly 
redundant network of various defence mechanisms (Whyte, 2007), also referred to as 
combinatorial system (Magnadottir, 2006). 
1.3.1.1. Innate immune system 
The innate immune system, due to its existence in animals lacking an adaptive immune 
system, is considered the provider of the “danger signals” (Matzinger, 1994) and the first line of 
defence until the adaptive response can be mounted. In fish, this system has several 
components which are more active and show more diversity than their homologues in 
mammals, such as the high activity of the alternative pathway of the complement system 
(Sunyer and Tort, 1995). If the physical barrier of the fish is breached, the innate system has a 
whole range of defences which can protect the host; both humoral (complement, transferrins, 
anti-proteases, haemolysins, lysozymes, interferon, C-reactive proteins) and cellular 
(macrophages, neutrophils, lymphocytes and scavenger endothelial cells) systems interact and 
fight the invading organism. This extremely elaborate structure is called innate because of its 
non-specificity. This means that Pattern Recognition Receptors (PRR), which can be either 
soluble (such as mannan-binding lectin or C-reactive proteins) or cellular (Mannose receptor or 
Toll-like receptors, TLRs), recognise conserved Pathogen-Associated Molecular Patterns 
(PAMPs) such as LPS, peptidoglycans and β-glucans. This interaction ultimately activates 
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relevant transcription factors, starting a wide range of responses. In fish, a least 12 different 
TLRs have been partially sequenced, compared to the 13 found in mammals, all branching 
from 6 super-families (TLR1, TLR3, TLR4, TLR5, TLR7, TLR11) (Roach et al., 2005). 
The characteristics of fish complement are similar to the ones known in higher vertebrates but 
some particular features are unique to poikilotherms (Sunyer and Lambris, 1998). Fish 
complement tends to be more heat-labile, has stronger antimicrobial action, the optimal 
temperature seems to be lower than for homeotherms and multiple forms of some of its 
components have been discovered (Sunyer et al., 1997; Nonaka, 2001; Holland and Lambris, 
2002; Lange et al., 2004). All these features make the fish complement system one of the most 
effective immune parameters to combat pathogen invasion (Sunyer and Lambris, 1998). Serum 
of fish consists of many different proteins that interact to either mark the pathogen 
(opsonisation) for cellular or humoral attack, inhibit its growth or directly destroy it by different 
biochemical pathways (mainly complement membrane attack complex but also proteases, 
lysozyme, antibacterial peptides, natural antibodies and cytokines) (Ellis, 1999; Wilson et al., 
2002; Bergsson et al., 2005; Medzhitov, 2007). 
Fish non-specific leukocytes, such as macrophages and neutrophils have been studied in many 
species. Both these types of cells can engulf particles by phagocytosis, the macrophages being 
more efficient than neutrophils, and kill pathogens primarily by the production of reactive 
oxygen species (ROS) (Ellis, 1999). Neutrophils have the additional capacity of killing bacteria 
through a myeloperoxidase driven mechanism involving halide ions (halogenetion) and H2O2 
(Ellis, 1999). This cell type is the first to respond in a localized infection due to their high 
mobility, with the macrophages shortly following, driven by chemo-attractants such as 
chemokines (Secombes et al., 2001). The peak response of the two types of cells is reached 
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within a few days of the initial infection and their numbers and activation thereafter decrease 
(Secombes, 1996). 
1.3.1.2. Adaptive immune system 
The kidney is the major lymphoid organ in fish, but the spleen, thymus and mucosa-associated 
lymphoid tissues are also important in the production of immune cells (Press and Evensen, 
1999). No bone marrow is present and the role of the lymph system is still controversial. 
Lymphoid tissues are generally composed of a framework of cells within which migratory and 
non-migratory immune cells are present. These migratory populations consist of 
immunoglobulin positive (B) and negative (T) lymphocytes, monocytes, macrophages, 
granulocytes and thrombocytes. There are also other types of non specific cells, considered 
less important in fish but nonetheless necessary, such as mast cells, non-specific cytotoxic 
cells and dendritic cells (Reite and Evensen, 2006; Bassity and Clark, 2007). 
The adaptive immune system is characterised by the emergence of combinatorial antigen 
specific receptors (Kashahara et al., 2004). This system enhances the immune resistance to 
diseases through the anamnestic response (immunological memory), focussing the innate and 
adaptive defences towards a particluar target. The fundamental components of this system are 
immunoglobulins, T-cell receptors, major histocompatibility (MHC) complexes and recombinant 
activator genes (RAG) (Watts et al., 2001). Two types of cells are heavily involved in this 
response, B and T cells, which are both divided into 2 sub-groups, B1 and B2 as well as T 
helper (expressing either the cluster of differentiation (CD) 4 and/or CD8 markers) and 
cytotoxic T-cells (also expressing the CD8 marker). There are two different types of MHC, class 
I expressed ubiquitously on all nucleated fish cells (interacting with the CD8 molecule) and 
class II, only expressed on antigen presenting cells (APC), such as B cells, 
monocytes/macrophages and on activated T cells, interacting with CD4 molecules as shown in 
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Figure  1-4 (Mannings and Nakanishi, 1996). The latter has not been detected in all studied fish 
species. 
 
Figure  1-4 Summary of the specific immune system response to a foreign antigen. 
 
Antigen presentation is a crutial part of the specific immune response. In fish, the processing 
and subsequent presentation of the antigens is believed to be similar to the processes 
described in mammals (Vallejo et al., 1992). In higher vertebrates, the pivotal messenger for 
antigen presentation promotion may be type I interferons (type I IFNs), through the up-
regulation of MHC class I genes (Samuel, 2001) and these genes have been identified in 
several fish species (reviewed in Robertsen, 2006). The MHC class II (present only on Antigen 
Presenting Cells) genes have been identified in several fish species and are present on B and 
T lymphocytes, monocytes/macrophages, epithelial cells and dendritic-like cells (Vallejo et al., 
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1992; Koppang et al., 2003), as well as on acidophilic granulocytes (neutrophils) (Cuesta et al., 
2006). 
The B cells can also respond to non-specific inducers (Figure  1-4), without the involvement of 
T-cells, especially since, contrary to what is observed in mammals, the fish B cell is able to 
phagocytose micro-organisms (Li et al., 2006). This T-independent system is based around the 
interaction of antigens with low affinity poly-binding antibodies (equivalent to natural antibodies 
in mammals, Avrameas and Ternynck, 1995), which might be produced by a B1 subset 
equivalent. A specific response requires the interaction of APC, B (2) cells and T helper cells 
(Figure  1-4). Very recently, a new pathway of T cell differentiation has been elucidated, 
possibly derived from Th1 and Th2 CD4-positive cells and named Th17, releasing interleukin 
(IL)-17 and IL-22 (Liang et al., 2006); this system appears to exist in fish (Secombes, 2008). 
This pathway could be involved in the formation of antimicrobial peptides and could act against 
extracellular bacteria and fungi. The activation of Th cells leads to the specific B cell activation 
and differentiation, resulting in the production of specific antibodies as well as both B and T 
memory cells (Figure  1-4). The anamnestic response in fish is considered poor compared to 
mammals, possibly because immunoglobulin (Ig) M is the main antibody type present, known 
to have a lower heterogeneity or genetic diversity (Pilstrom and Bengten, 1996). Although a few 
other Ig molecules and genes have been found, such as IgD (Wilson et al., 1997; Stenvik et al., 
2004), IgT (Hansen et al., 2005) and IgZ (Danilova et al., 2005), their function is still uncertain. 
The isotopic diversity of mammals might be compensated in fish by the nature of the IgM 
secreted which have been shown to be present not only in a tetrameric form but also in mono 
or dimeric configuration (Magnadottir, 1998). Fish IgM have also a high degree of flexibility 
which could increase its ability to bind epitopes (Kaattari et al., 1998). The environment in 
which the fish has evolved may have also influenced its specific immune response with sub-
optimal conditions, also called non-permissive, such as temperature, affecting the production of 
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an adequate anamnestic response, especially regarding the T-dependant response (Rijkers et 
al., 1980). 
The chemical signals which activate and regulate the specific immune response after an 
encounter with a recognised antigen are mainly composed of cytokines such as interferons 
(IFN), ILs, chemokines, colony stimulating factors (CSF) or tumor necrosis factors (TNF) 
(Secombes et al., 1996). After binding of the antigen, a cascade of these polypeptides or 
glycoproteins is released. Cytokines have been only recently studied in fish and further 
elucidation of the mechanisms involved still need to be explored. Some of the cytokines 
involved in mammalian and fish immunity are summarised in Table  1-5. 
 
Table  1-5 Various cytokines involved in different types of immune response in 
mammals and fish. 
Type of response Cytokines involved Additional information 
Inflammatory TNF-α, IL-1β, IL-6, IL-8 
Mostly produced by macrophages, 
IL-1 is the precursor of the 
inflammatory response, TNF can 
kill cells (with IFN-γ). 
Antiviral  Type I IFNs  
Cellular immune response inducers IL-2, IFN-γ, LT-α, TNF, IL-12, IL-18 
IL-2 and IFN-γ are released by Th1 
cells and act against intracellular 
bacteria and some viruses. 
Humoral immune response inducers IL-4, IL-5, IL-6, IL-9,IL-13 Released by Th2 cells. 
Regulatory (inhibitory) IL-6, IL-10, IL-13, TNF-β, IL-23, TGF-β 
IL-10 and TGF-β released by 
regulatory T cells (T reg) but TGF-β 
also stimulates the differentiation of 
Th to T reg. 
Proliferation G-CSF, M-CSF, stem cell factor Induces the proliferation of different non specific immune cells. 
TNF: Tumor necrosis factor; IL: Interleukin; IFN: Interferon; LT: Lymphotoxin; TGF: Transforming growth factor; G-
CSF: Granulocyte-colony stimulating factor; M-CSF: Macrophage-colony stimulating factor. 
 
The cytokines highlighted have not been identified in fish (Secombes, 2008).  
 
1.3.2. Cod immune system 
Atlantic cod has a poor specific immune system, but since this species has continued to thrive 
in the world’s oceans for millions of years, it would appear to have sufficient innate immune 
defences to allow it to survive infection by many pathogens (Pilstrom et al., 2005). 
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1.3.2.1. Ontogeny 
In the early stages of development, the cod immune system, as with most marine species, 
relies heavily, and for longer, on its innate immune parameters than freshwater species 
(Magnadottir, 2006). 
Post-fertilization, no maternal IgM can be detected in cod eggs (Magnadottir et al., 2004), but 
they nevertheless have an efficient  system of defences against pathogens. A small number of 
molecules associated with innate immune defences are detected before hatching, such as 
molecules of the complement system (C3) as well as apolipoprotein A-I, cathepsins, and 
lysosomal enzymes involved in cellular degradation (Magnadottir et al., 2004). 
At hatching, cod are poorly developed and undergo a long larval period before metamorphosis 
(Pedersen and Falk-Pedersen, 1992). Post-hatching, many enzymes appear around first 
feeding (gelatinase, caseinase and collagenase, 6 days post hatch, dph), followed by 
haemoglobin a few days later (Magnadottir et al., 2004). Before metamorphosis, no 
immunoglobulin producing cells are detected and immunological organs are immature; the first 
plasma cells are detected around 58 dph (Schroder et al., 1998). 
The onset of feeding, with the intake of bacteria from food and water, has been correlated with 
the start of the development of the specific immune cells in Atlantic cod (Pedersen and Falk-
Pedersen, 1992). 
1.3.2.2. Immune physiology 
In adult fish, the head kidney is bilobular and dominated by haemopoietic tissues (Sorensen et 
al., 1997). In cod, this organ has been shown to contain many immune cells, with most 
identified as granulocytes resembling neutrophils, macrophages, and lymphocytes and plasma 
cells (Heumann and Roger, 2002). The head kidney and the spleen are major organs for 
trapping and clearance of foreign particulate material, with the accumulation of melano-
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macrophages (especially in the head kidney) allowing a long retention of the antigens at these 
sites (Ronneseth et al., 2007). The spleen plays a more minor role in antibody production 
(Ronneseth et al., 2007), although some degree of organisation of antigen uptake and plasma 
cells has been observed in the spleen of cod (Arnesen et al., 2002). However, no co-
localisation of antigen and plasma cells could be observed in the head kidney or spleen, or any 
clustering of B cells in the head kidney (Stenvik et al., 2001). Sorensen et al. (1997) found the 
leukocyte population of the head kidney of cod to consist of 50% granulocytes (in accordance 
with Ronneseth et al. (2007)), 33% macrophages and 7% lymphocytes. There was also a high 
proportion of neutrophils in the blood, twice that of salmon blood (Fausa Pettersen et al., 2000); 
important in protecting the cod against bacterial infections (Sorensen et al., 1997). 
1.3.2.3. Cellular innate immunity 
Leukocytes involved in innate immunity in cod, i.e. macrophages and neutrophils, have been 
isolated and cultured from head kidney (Sorensen et al., 1997; Steiro et al., 1998) as well as 
from blood (Nikoskelainen et al., 2006). Granulocytes, resembling neutrophils, from cod appear 
to vary in size, and are predominantly granular and mono-nucleated with a cytoplasm 
containing electron-dense granules; macrophages were roughly the same size as the 
granulocytes but with a more irregular shape and the absence of electron-dense granules 
(except for a few lysosomes) (Sorensen et al., 1997). The majority of macrophages, enriched 
by adhesion, are able to survive and remain phagocytic for a week in cell culture and up to 3 
weeks with regular changes of media (Sorensen et al., 1997; Steiro et al., 1998). Unstimulated 
cells have been shown, by the same two studies to have a poor level of respiratory burst, and a 
fairly high level of variation in this response has been reported between individuals. A 
significant increase in respiratory burst (O2- and H2O2) was obtained with cod macrophages 
after incubation with LPS as well as β glucans, tuftsin, chitosan and, to a lesser extent, acid 
peptides (Sorensen et al., 1997). Acid phosphatase activity in macrophages was also 
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enhanced by culture in LPS-supplemented media (Sorensen et al., 1997). Generally, cod are 
considered to have a low response for those non-specific immune parameters (Steiro et al., 
1998). This contradicted the findings of Nikoskelainen et al. (2006), who showed the respiratory 
burst of cod blood leukocytes to be at least double that reported in trout, although this may be 
due to the relative numbers of phagocytic cells in the blood of the two species. 
1.3.2.4. Humoral innate immunity 
Magnadottir (2000) described some very peculiar aspects of cod serum, such as the optimal 
temperature for serum haemolysis (SH), using sheep red blood cells, found to be 37°C. The 
addition of EDTA, a traditional inhibitor of both the classical and alternative complement 
pathways, as well as PMSF, was found to increase the SH capacity. Nevertheless, some 
common features were found with other teleosts, such as the inhibition of the SH by high levels 
of LPS and zymosans (partial in this case) and serum of other fish, goat or ascites 
(Magnadottir, 2000). The last point is the fact that cod SH activity seems to be driven by heat 
stable molecules since heating it at 56°C for 120 min only reduced the SH activity by 45%. The 
author concluded that haemolytic factors other than complement may be involved, either 
together or independently. In recent years, the haemolytic activity of cod reared in Iceland was 
reported to be very low (or not detectable) and a shift from the data presented previously 
(Magnadottir, 2000) seems to have occurred (Magnadottir, 2006). This activity seemed to be 
more “normal”, heat sensitive and inhibited by EDTA. One of the explanations given for this 
was the possible association of apolipoprotein A-I with complement in the low SH activity cod, 
which was not found in the unusually high activity group (Magnadottir and Lange, 2004). In 
most studies the level of variation of the haemolytic activity in cod was found to be very high 
(Magnadottir et al., 2001; Magnadottir et al., 2002). The variability in SH was hypothesised to 
be due to either genetic traits or to its sensitivity to undefined external or inherent factors and 
that there might be a seasonal effect contributing to this phenomenon. 
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Lysozymes are not thought to be involved in this high haemolytic activity of cod since very low 
levels are detected in the serum and no activity has been recorded in mucus (Bergsson et al., 
2005), but a high chitinase activity was found in the plasma and various organs (Fletcher and 
White, 1973; Lindsay and Gooday, 1985). Other studies reported levels of lysozyme 
approximately half of that found in Atlantic salmon (Fagan et al., 2003; King V et al., 2006) as 
well as a high expression of a g-type lysozyme gene after vaccination (Caipang et al., 2008). 
The anti-protease activity of serum is generally high and seemed to be unaffected by 
immunisation or infection, but the seasonal effect could explain the slight variations observed 
(Magnadottir et al., 2001). Agglutinins and precipitins (lectins) are found in cod which produce 
C-reactive protein (CRP) pentraxin, but not serum Amyloid-P component (SAP). The resting 
level of CRP seems to be high (over 300 µg.mL-1) and showed a strong individual variability in 
its reduced form (1 to 4 monomeric units of the 125 kDa molecule) (Magnadottir, 2006). 
Antibodies present in the serum have been shown to very important in the early life defence 
system of fish through antiviral or antibacterial activity (Gonzalez et al., 1988; Sinyakov et al., 
2002). The total immunoglobulin concentration in the serum of cod is somewhat 5 to 10 times 
higher than that measured in Atlantic salmon or other marine fish species (Israelsson et al., 
1991; Magnadottir et al., 2001), and a positive correlation between IgM concentration and 
size/age, as well as rearing temperature of cod has been reported (Magnadattir et al., 1998). 
The total IgM can represent as much as 80% of the total protein in the serum of some cod, but 
generally, it constitutes 20% of the total protein (Stenvik et al., 2001). These results are 
reported to vary greatly between individuals (Magnadattir et al., 1998). Atlantic cod serum is 
often referred to as “sticky” and the reasons for this high level of immunoglobulins are not 
known. Samuelsen et al. (2006) hypothesised that this might be due to the uptake of bacterial 
antigens through the gut or the autonomous development of B cells to plasma cells without the 
involvement of particular antigens. The fact that different clusters of plasma cells, with separate 
 34
V-H families and no co-localisation, were found in non immunised cod, led Stenvik et al. (2001) 
to the hypothesis that immunoglobulin-producing B cells might have developed autonomously 
into plasma cells, or with the involvement of a “natural antigen” even if no evidence in any 
higher vertebrates exists for this phenomenon. This could also explain the increase in total IgM 
with the size of the fish. A similar idea is also mentioned in Solem and Stenvik (2006) regarding 
a possible weak clonal selection or an ongoing clonal expansion and differentiation of B cells in 
the particular clustered distribution of plasma cells. High levels of natural antibodies have been 
shown to possibly inhibit the production of specific antibodies in goldfish (Sinyakov et al., 2002) 
and due to the very high levels of natural antibodies in cod; this could contribute to the lack of 
detectable specific antibody response. Nevertheless, wolfish although having a high level of 
natural antibodies in the serum can still produce a high specific immune response to 
immunisation with different bacteria. In this case, the non-immunised fish natural antibodies 
showed very low cross-reaction with the different bacteria tested (Espelid et al., 2001). 
1.3.2.5. Atlantic cod adaptive immunity 
The development of the lymphoid organs in cod larvae seem to follow the “normal” ontogeny of 
these organs (head kidney, spleen and thymus) observed in other marine teleosts (Schroder et 
al., 1998), even if they seem to develop more slowly than in freshwater species (Razquin  et al., 
1990). In Atlantic cod, the head kidney and the spleen are the first organs to develop and are 
both present at the time of hatching, and the thymus is first detected 30 dph (Schroder et al., 
1998). These immune organs seem to be fully developed by 50 dph but the first plasma cells 
only appeared a week later, apparently leaving the cod larvae entirely dependant on innate 
immunity to defend itself against pathogens for almost 2 months. 
Gadoids have been described as poor or non-responders to hapten-carriers (Magnadottir et al., 
2001) or bacteria (Espelid et al., 1991; Schroder et al., 1992; Lund et al., 2006). Cod seem to 
have all the components for a normal immune response regarding gene numbers, structure, 
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organization, diversity or expression of IgM and IgD chains (Solem and Stenvik, 2006), 
although the structure of cod IgD was shown to be different from that of Atlantic salmon 
(Stenvik and Jorgensen, 2000), this cannot fully explain the very low specific immunity in 
Atlantic cod (Samuelsen et al., 2006). Pilstrom et al. (2005) reviewed the results of a decade of 
research and summarised that cod do have B cells and that these cells produce 
immunoglobulin. They found cod B cells to have the machinery to express membrane receptors 
for antigens, and described that the Ig heavy chain structure, organisation and expression (VH, 
D, JH segments) cannot explain the lack of specific antibody response, even if the number of 
V-gene families is lower in cod than rainbow trout, with 4 and 11 families respectively (Roman 
et al., 1996; Stenvik et al., 2001). Pilstrom et al. (2005) also reviewed that the Ig light chain 
structure, organisation, transcription and expression cannot explain the lack of specific antibody 
response, while the sequences for TCR and MHC class I imply that the cod is immuno-
competent against intracellular pathogens. 
The poor adaptive immune response seen in cod is also found in other gadoids, such as 
haddock (Bentley, 2002) and pollock (Magnadottir et al., 1999b), which suggests that a 
possible impairment in specific immune response to certain pathogens (i.e. V. anguillarum) is 
common to some, if not all, gadoids. 
The inflammatory response seen in Atlantic cod after vaccination is no different to that 
observed in other fish (Mutoloki et al., 2008). Cod also seem to have a normal proportion of 
plasma cells, approximately 1% of the total cell population in the head kidney, spleen and 
thymus (Schroder et al., 1998). The B cell proportion was found to be higher in the spleen than 
in the head kidney or the blood and their distribution in the spleen scattered (Ronneseth et al., 
2007). These Ig (heavy chain) mRNA positive cells (most probably blast or plasma cells) were 
found to be mostly clustered close to the connective tissues surrounding the arterioles in head 
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kidney and spleen but did not seem to be co-localised with centres of pigmented cells in the 
head kidney (Stenvik et al., 2001), as described in other fish species (Press et al., 1994). 
Positive cells were also observed in the gut and the gills but their distribution seemed to be 
more scattered (Schroder et al., 1998). 
Results from vaccination  seem to suggest that cod are able to mount an immune response 
and obtained good protection against V. anguillarum and V. salmonicida (Schroder et al., 1992; 
Stromsheim et al., 1994; Lund et al., 2006). The low levels of specific antibodies detected in the 
serum of immunised cod seems to be directed towards LPS (T cell-independent response), 
which could explain the apparent successes of vaccination against pathogenic bacteria (Lund 
et al., 2006). Levels of specific antibodies to bacteria, haptened and non-haptened molecules, 
were very poor (Magnadottir et al., 2001). The same was observed against V. salmonicida 
(Schroder et al., 1992) and V. anguillarum, but A. salmonicida was reported to elicit a stronger 
immune response, even though still poor (Lund et al., 2006). 
1.4. Vaccination 
1.4.1. Vaccine design in fish 
In 1796, Edward Jenner demonstrated that humans could be protected against smallpox virus 
by injecting a nine-year old boy with a live cowpox virus (Vaccinia); the term vaccine was then 
coined (Jenners, 1798). Almost 150 years later, Snieszko et al. (1938) showed that fish too 
were also able to mount an anamnestic response after injection of carp with heat killed 
Aeromonas punctata. A few years later, oral immunisation was successfully used to protect 
trout against Bacterium salmonicida (now known as Aeromonas salmonicida) (Duff, 1942). In 
the following two decades, the development of efficient sulfa drugs and the discovery of potent 
antibiotics diminished the interest in vaccine development for fish. However, in the late 1960’s 
and early 1970’s, the emergence of antibiotic resistant bacteria and the realisation of the 
 37
potential dangers of these treatments in fish for human health (Van Muiswinkel, 2008) 
refocused disease research towards fish vaccinology. Nowadays, vaccination is considered the 
most effective method for preventing infectious diseases in fish (Sakai, 1999). 
The definition of vaccination (or immunisation) is the administration of a substance to produce 
immunity to a disease. The modern design of a successful vaccine requires two parts, first the 
identification of an antigen on the surface of the pathogen which could be recognised by the 
fish immune system, and the induction of an optimal immune response, so that the animal 
develops a strong protective immunity (Gudding et al., 1999). There are advantages working in 
fish for testing and development of vaccines, as the possibility to obtain licences to investigate 
the effect of very diverse formulations is easier than if using mammals, the number of animals 
that can be included in the studies (often several thousands of fish vaccinated and 
subsequently challenged) or the fact that fish are now regarded as very good animal models to 
understand the mechanisms investigated in higher vertebrates (van der Sar et al., 2004; Novoa 
et al., 2006). Three main types of vaccines have been used in aquaculture: (I) whole pathogens 
(live or dead), (II) subunit and (III) DNA vaccines (which can technically be classed as a subunit 
vaccine, (Clark and Cassidy-Hanley, 2005)). 
Whole pathogen vaccines were the only type available until recently and present the immune 
system with a wide diversity of antigens present on the pathogen. This can sometimes mean 
that cross protection is acquired against closely related organisms, as between cowpox and 
smallpox viruses. However, this is not always the case, for example, different serotypes of V. 
anguillarum offer limited protection against other serotypes (Mikkelsen et al., 2007). The 
organism to be used in a vaccine can either be killed or attenuated. Inactivated vaccines are 
very safe since they are non-replicating, and are therefore non-infectious, but the majority of 
those vaccines lack the ability to induce a robust immunological response and are generally 
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considered inferior to live attenuated vaccines (Rogan and Babiuk, 2005). The killed pathogen 
may not contain important de novo proteins induced during infection, such as secreted toxins 
which could potentially be protective, for this reason, the media in which the bacteria is cultured 
is often added to the vaccine. The vast majority of bacterial vaccines used in aquaculture 
nowadays consist of inactivated pathogens (mostly multivalent formulations) and these have 
been proven extremely efficient for the prevention of many diseases (Hoel et al., 1998; Hastein 
et al., 2005). Nevertheless, the inclusion of several pathogens in a vaccine can lead to the 
inhibition of the specific response expected even if the individual pathogen induced protection, 
as seen with the combination of Tenacibaculum maritimum and Photobacterium damselae 
subsp. piscicida bacterins (Romalde et al., 2005). Several vaccines formulated with inactivated 
pathogens have failed to protect fish against bacterial and viral diseases, such as BKD 
(Piganelli et al, 1999), nevertheless, this approach should be studied first and if the results are 
not satisfactory after testing different formulations and delivery methods, other types of 
vaccines should be tried. 
Advances in genetic engineering now allow live pathogens to be attenuated for use in vaccines. 
Live attenuated vaccines induce infection but have a reduced or a complete lack of ability to 
produce the disease (Rogan and Babiuk, 2005). These offer great advantages regarding the 
cost of production, since they are injected live and little processing is necessary, but the safety 
of such products is still debated and the efforts to commercialise them has been slow (Clark 
and Cassidy-Hanley, 2005). The potential risk of reversion of the pathogen to its original form is 
a very real danger, especially since the pathogen could be potentially shed from the infected 
animal into the aquatic environment. Attenuated vaccines are still rare in aquaculture although 
a lot of research is taking place with some promising results for many pathogens such as 
Streptococcus iniae (Locke et al., 2008), Aeromonas hydrophila (Vivas et al., 2004), Yersinia 
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ruckeri (Temprano et al., 2005), Flavobacterium psychrophilum (LaFrentz et al., 2008) and 
Edwardsiella ictaluri and Flavobacterium columnare (Klesius et al., 2005). 
Subunit vaccines are based on the production of a particular antigen either purified directly 
from culture of the pathogen, expressed by a prokaryotic or eukaryotic system (Euzeby, 1997), 
or chemically synthesised, e.g. peptide vaccines. Their main advantage is that they are free of 
pathogen-derived toxins or immunosuppressive components. Any antigen can be included in 
the vaccine as long as it is accessible on the surface of the pathogen for the immune system of 
the host to recognise it (Grandi, 2001). The ease from a licensing and regulatory standpoint 
compared to attenuated or DNA vaccines makes this type of vaccine very attractive since they 
have no ability to replicate or invade the host’s genome. The main hurdle of the development of 
a subunit vaccine is first identifying and then expressing the target protein in its correct three-
dimensional structure. Bacteria and yeasts have been shown to often produce structurally 
deficient molecules from a structural point of view and the use of mammalian cells, which can 
overcome this problem, is extremely costly. Nevertheless, many new organisms are being 
investigated for protein expression, and ciliates (e.g. Tetrahymena thermophila) show great 
potential both from a cost and an expression point of view (Gaertig et al., 1999). The novel 
adjuvants and delivery method (mentioned later in this section) will also help to make subunit 
vaccines a realistic option for the future. Many of the subunit vaccines have been shown to be 
very efficient against some fish viruses and bacteria but one of the future potential uses of 
subunit vaccines is against parasites (reviewed in Clark and Cassidy-Hanley, 2005). This 
technology has already been used to produce successful vaccines against viral and bacterial 
diseases such as infectious pancreatic necrosis virus (IPNV) using the VP2 antigen (Christie, 
1997), Piscirickettsia salmonis with the OspA protein (Kuzyk et al., 2001) or the T2 fragment 
against infection by striped jack nervous necrosis virus, (SJNNV, Nodaviridae) (Husgag et al., 
2001). 
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DNA vaccines are an exciting new field in vaccinology. The principle is based on the injection 
of a plasmid coding a protective antigen, letting the host machinery transcribe and translate the 
selected gene, thus basically producing the vaccine in situ (Liu, 2003). DNA vaccines are for 
this reason, considered safe; they are also very stable and several protective antigens (as 
genes) can be theoretically injected in different plasmids (Gurunathan et al., 2000). Other 
advantages of DNA vaccines are the price of production once the design is proven protective 
and the possibility to tailor the type of response produced (Liu, 2003). The first DNA vaccine 
was approved in the US was for horse West Nile virus in July 2005 (CDC press release, 
http://www.cdc.gov), but the second was for fish (Infectious Haematopoietic Necrosis Virus 
DNA vaccine, Novartis) and the hurdle of licensing this vaccine was greater since the fish were 
farmed for human consumption. DNA vaccines, also called “vector vaccines” present similar 
problems to attenuated vaccines, e.g. the plasmid could integrate into the host’s genome, be 
released into the environment, be integrated into other organisms, including humans or mutate 
(Rogan and Babiuk, 2005). Nevertheless, this possibility has been reported to be extremely 
unlikely (Lorenzen and LaPatra, 2005). Some of the DNA vaccine constructs designed have 
been shown to be very efficient at protecting fish against diseases which have failed using 
other methods. The plasmid encoding the G protein of rhabdoviruses (VHSV and IHNV) in 
salmonids (Lorenzen et al., 2000) is the biggest success to date and has been licensed for 
vaccine use in Canada (Norvartis). But many attempts using DNA technology to prevent 
diseases caused by viruses in fish have failed so far (reviewed by Lorenzen and LaPatra, 
2005). 
Most commercial vaccines contain adjuvants, a substance used to help boost the immune 
response so that less vaccine is needed or the overall protection is increased. They are 
generally considered to (I) increase the antigen uptake and cell presentation, (II) induce a 
“danger signal” through pattern recognition receptor signalling, (III) provide a secondary signal 
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(co-stimulatory) for lymphocyte activation (Secombes, 2008), and (IV) allow prolonged delivery 
of antigens (Evensen et al., 2005). Several substances, called immunostimulants, are used to 
initiate activation of innate immune mechanisms that may result, for example, in production of 
antimicrobial peptides and hence protect the fish more efficiently against pathogens (Bricknell 
and Dalmo, 2005). Beta-glucans, bacterial products such as lipopolysaccharides (LPS), brown 
and red algae and terrestrial fungi can be used as immunostimulants (Bricknell and Dalmo, 
2005). Hormones and cytokines have also been considered as immunostimulants and can be 
used to enhance the defence system of fish (Secombes et al., 2001). As with most molecules 
having an effect on the immune system, the timing and doses of the compound have to be very 
carefully judged not to produce immuno-suppression or other non-beneficial effects (Sakai, 
1999). Many adjuvants are used in fish vaccines with the main substances comprising oil 
(which seem to produce the best results), glucans and aluminium salts (Midtlyng, 1996). Some 
vaccines against common fish diseases, such as furunculosis, require the addition of an 
adjuvant to produce satisfactory levels of protection (Hamid, 2003). In Atlantic cod, several 
compounds have been tested, immunostimulants or adjuvants, such as cod milt (histone 
antimicrobial effect), lipopolysaccharides, polymannuronic acid, levimasol, chitosan and others, 
but only the first two were shown to have a beneficial effect on cod survival (Pedersen et al., 
2004; Magnadottir et al., 2006). The LPS can have a significant effect on different cell 
populations, such as the possible maturation of monocytes into macrophages (Iliev et al., 
2005a; Belosevic et al., 2006) and to prime macrophages and consequently increase the total 
respiratory burst level of macrophages and neutrophils in Atlantic salmon (Solem et al., 1995), 
goldfish (Wang et al., 1995; Neumann et al., 1995; Neumann and Belosevic, 1996), rainbow 
trout (Novoa et al., 1996) and dab (Tahir and Secombes, 1996). Phagocytosis of glucan 
particles by Atlantic salmon macrophages was shown to increase after incubation with LPS 
(Solem et al., 1995), in trout macrophage (MacKenzie et al., 2003) as well as Mx production 
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(Acosta et al., 2004). Gene expression of many cytokines was also found to increase after 
incubation of rainbow trout monocytes and macrophages with LPS, such as TNFα, TNF2, 
Interleukin (IL)-1β1 and COX-2 (MacKenzie et al., 2003; Iliev et al., 2005a). Nevertheless, fish 
have been reported to acquire tolerance to the long term use of immunostimulants (Matsuo and 
Miyazano, 1993; Zapata et al., 1997) and more research is needed to assess the risks of these 
to fish health. 
Fish injected with oil-adjuvanted vaccines have been reported to present side effects, ranging 
from none to quite severe (Midtlyng et al., 1998). The extent of the lesions vary between fish 
species and the formulation of the oil adjuvants used, but reduced growth rate (fairly common), 
local reactions with the appearance of granulomas, and organ adhesion in the peritoneal cavity 
have been reported (Poppe and Breck, 1997; Midtlyng and Lillehaug, 1998). However, these 
draw-backs are considered to be offset by their protective effect. 
Numerous vaccine delivery methods are available to the fish farmer such as injection, 
immersion, oral, hyperosmotic immersion and spray vaccination (Smith, 1988). The method 
offering highest protection seems to be intraperitoneal (IP) injection of the vaccine, followed by 
immersion and finally oral vaccination (Palm et al., 1998). The trend in protection is reversed 
when focussing on the practicality of vaccination, oral vaccines are easier to deliver than 
immersion treatments and injection is the most time consuming and results in the highest level 
of stress for the fish (Vandenberg, 2004; Gravningen and Berntsen, 2007). New delivery 
methods for vaccinating fish have been developed in recent years, and show promising results 
such as the multipuncture/immersion, eliciting better protection than achieved by immersion 
alone and similar to the results seen with IP injection (Nakanishi et al., 2002). Renewed interest  
is also been shown in hyperosmotic immersion method of vaccination (Huising et al., 2003), 
which was developed in the 1970s (Amend and Fender, 1976). 
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1.4.2. Vaccination in Atlantic cod 
Vaccines against V. anguillarum specifically tailored for Atlantic cod have been developed in 
the last 10 years because the typical formulation used to protect Atlantic salmon against this 
pathogen did not include any isolates from the O2b sub-serotype, which is often recovered 
from outbreaks of vibriosis in farmed Atlantic cod. Homologous type vaccination-challenge 
experiments have been shown to be efficient against V. anguillarum (Espelid et al., 1991; 
Mikkelsen et al., 2004). Even in the case of heterogeneous type experiments (a different strain 
used for the challenge and the vaccine), juveniles and adult fish have shown very encouraging 
results for protection against the most common bacteria such as A. salmonicida, V. salmonicida 
and V. anguillarum (Schroder et al., 1992; Jones et al., 2000; Mikkelsen et al., 2004). 
In order to protect cod against pathogens that tend to produce very high mortality during the 
larval and juvenile stages, it is very important to determine the earliest age at which the 
vaccination can be administered efficiently (Schroder et al., 1998). So, early vaccination is 
critical for the protection of juvenile cod and since plasma cells were first detected at 0.5 g in 
Atlantic cod (Schroder et al., 1998), the onset of immuno-competence was investigated 
regarding vaccine efficiency around this size. Schroder et al. (2006a) found that the minimal 
weight for vaccinating Atlantic cod juveniles was 2 g (also shown by Gravningen and Berntsen, 
2007), but better results were obtained with 10 g fish dip-vaccinated at 28 weeks post hatch. 
So far, vaccines seem to be efficient at protecting Atlantic cod against V. anguillarum, but 
specific antibody response cannot be detected in some studies (Espelid et al., 1991; 
Gravningen et al., 2005a; Gravningen et al., 2005b), or is extremely variable between 
individuals (Lund et al., 2006), with conventional methods such as ELISA unable to detect an 
antibody response to vaccination (Bricknell et al., 2006). At this point in time, the only reliable 
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method for investigating vaccine efficacy in cod is based on relative percentage survival (RPS) 
data post-challenge (Amend, 1981). 
Other factors than the direct response to vaccination can be measured to give indications as to 
the efficacy of vaccines such as the antigen uptake or the cellular and humoral factors 
expressed and activated after vaccination. Vaccination of Atlantic cod with heat or formalin-
inactivated bacteria produces a typical inflammatory reaction around the site of injection with 
both oil and water based vaccines as well as liposome encapsulation (Mutoloki et al., 2008). 
They authors showed a normal recruitment of mononuclear cells, more pronounced in groups 
injected by oil-based vaccines. Inflammation is prolonged for longer when oil adjuvanted 
vaccines are used compared to liposome and water-based vaccines (Gravningen et al., 2005a; 
Mutoloki et al., 2008). Caipang et al. (2008) showed that a water-based vaccine (heat 
inactivated V. anguillarum) elicited an up-regulation of the cytokines IL-8 and IL-1β in cod. 
These cytokines are involved in the inflammation process and the priming of leukocytes for 
respiratory burst and phagocytosis. The response of IL-8 was maintained for 10 days post-
vaccination, possibly by the infiltration of neutrophils to sustain the elevated level of the 
cytokines. Some of the adjuvanted vaccines have also been shown to cross-protect against 
other pathogens and adjuvant-only formulations can protect Atlantic cod and other species 
against pathogens (Olivier et al., 1985; Mikkelsen et al., 2004; Gravningen et al., 2005b), which 
could be due to the recruitment of non-specific immune cells. This possibility was also raised by 
Caipang et al. (2008) after showing an up-regulation of NCCRP-1 which is a signal molecule to 
the non-specific cytotoxic cells. A possible down-fall of multivalent vaccines could be more 
severe reaction at the site of injection (Mutoloki et al., 2008), possibly due to the higher 
numbers of PAMPs presented to the immune system. 
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The antibacterial activity of cod serum seems to increase following vaccination. Caipang et al. 
(2008) identified a higher antibacterial activity against V. anguillarum after injection of an 
inactivated V. anguillarum, suggesting that innate immunity is involved in early defence against 
bacteria, and that this system can be enhanced by vaccination. Gene expression in some of 
the systems involved in antimicrobial activity were up-regulated as a result of vaccination and 
this offers an insight into the mechanisms that cod use to combat infections. Up-regulation of 
the bactericidal/permeability-increased protein and lipopolysaccharide-binding protein 
(BPI/LBP, Solstad et al., 2007; Caipang et al., 2008), goose-type lysozyme (Caipang et al., 
2008; Larsen et al., In Press), transferrin and apolipoprotein A-I genes (Caipang et al., 2008) 
were all reported as early as one day post-vaccination, which seems to suggest that cod rely 
on innate immunity immediately after infection. Transferrin up-regulation could imply an 
important reliance on the iron regulation and sequestration when bacterial infection occurs, 
however, Arnesen et al. (2002), as well as Caipang et al. (2008), were not able to detect any 
increases in transferrin after water based vaccine injection. 
Unfortunately, cell markers and molecular probes to detect mRNA of important proteins 
involved in the immune response of Atlantic cod are still not available, and the mechanisms 
involved in protecting this species for long periods after vaccination are still a mystery. Massive 
amounts of antigens of V. anguillarum were shown to be taken up in the spleen of cod 24 h 
post-vaccination, and first appeared in the spleen 1 hour after vaccination (Arnesen et al., 
2002). The head kidney was also heavily involved in the clearance of these bacteria, with the 
atrium of the heart containing fewer antigens. Both these organs showed antigen-positive cells 
for 2 weeks post vaccination, but no antigens could be detected after this time. No co-
localisation of IgM producing cells and antigen presenting cells could be detected. 
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In general, vaccines for Atlantic cod against V. anguillarum seemed to be very efficient in the 
first instance, although the mechanisms involved are still not understood. In recent years it has 
been apparent that commercial formulations used in the field do not protect this commercially 
important species against all the strains present in the environment. Several outbreaks in 
vaccinated fish have been reported (Hellberg et al., 2005-2006-2007) and more work is needed 
to investigate the variation of pathogenic strains, the immune response of cod against these 
strains and the formulation of vaccines used to provide broad protection against various 
serotypes of V. anguillarum. 
1.5. Aim and objectives 
The aim of this study was to investigate the possibility of designing a broad-range vaccine to 
protect Atlantic cod from Vibrio anguillarum. 
The specific aims of this study were addressed through the following objectives: 
To develop a set of monoclonal antibodies reacting specifically with the different pathogenic 
serotypes of V. anguillarum, and establish if any subgrouping previously unknown exists. This 
would allow inclusion of all the relevant serotypes of V. anguillarum affecting Atlantic cod in the 
vaccine formulation. 
To develop a set of in vitro assays to investigate the immune response of cod phagocytic cells 
and serum to different virulence factors of different serotypes of V. anguillarum. This would 
assist in determining which isolates should be included in the vaccine. 
To design and test a vaccine for Atlantic cod against the different V. anguillarum serotypes they 
are known to be susceptible to. 
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Chapter 2. 
 
General material and methods 
 
2.1. Bacteriology 
2.1.1. Vibrio collection 
A collection of over 150 isolates of Vibrio anguillarum was made with the help and generosity of 
a number of researchers worldwide, who very kindly provided the isolates listed in Table  2-1 
and represent isolates from different fish species collected in different geographic regions. 
Table  2-1 Vibrio anguillarum isolates used in the present study. 
Species Designation Origin of the strains Origin of isolation 
Vibrio anguillarum VA 16-RT 32 IZSV, IT Scophthalmus maximus, 1985, ES 
Vibrio anguillarum VA 12-3402/D IZSV, IT Oncorhynchus mykiss, Kidney/29/09/99 
Vibrio anguillarum VA 15-408/ittio da UI IZSV, IT Dentex dentex, 12/10/00 
Vibrio anguillarum VA 14-325/ittio ceppo IZSV, IT Oncorhynchus mykiss, 17/08/01 
Vibrio anguillarum VA 13-138/I02 ceppo IZSV, IT Solea solea, Kidney/17/04/02 
Vibrio anguillarum VA 10-76/I03 IZSV, IT Dicentrarchus labrax, Kidney/12/03/03 
Vibrio anguillarum VA 9-O2-43 F IZSV, IT Scophthalmus maximus, 14/06/99, ES 
Vibrio anguillarum VA 7-34/I04/1 IZSV, IT Dicentrarchus labrax, Kidney/13/02/04 
Vibrio anguillarum VA 8-11008 IZSV, IT Scophthalmus maximus, 14/06/99, ES 
Vibrio anguillarum VA 11-48/I02 IZSV, IT Dicentrarchus labrax, Kidney/04/03/02 
Vibrio anguillarum VA 20-07-84(1) INRA, FR Oncorhynchus mykiss, IT 
Vibrio anguillarum VA 21-NATA 98-23 INRA, FR Scophthalmus maximus, Noirmoutier, FR 
Vibrio anguillarum VA 17-15-99 INRA, FR Dicentrarchus labrax, Mediterrenea, FR 
Vibrio anguillarum VA 18-49-00 INRA, FR Dicentrarchus labrax, Antibes, FR 
Vibrio anguillarum VA 22-08-02 INRA, FR Dicentrarchus labrax, Corsica, FR 
Vibrio anguillarum VA 19-09-02 INRA, FR Dicentrarchus labrax, Corsica, FR 
Vibrio anguillarum VA 23-10-02 INRA, FR Dicentrarchus labrax, Corsica, FR 
Vibrio anguillarum VIB 64-UB A023 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 65-UB A024 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 67-UB A055 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 68-UB A056 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 87-NCMB 1873 HWU, UK Salmo salar, UK 
Vibrio anguillarum VIB 126-RVAU 840606-2/5 HWU, UK Oncorhynchus mykiss, DK 
Vibrio anguillarum VIB 134-RVAU 91-8-178 HWU, UK Scophthalmus maximus, NO 
Vibrio anguillarum VIB 135-RVAU 91-11-244 HWU, UK Scophthalmus maximus, NO 
Vibrio anguillarum VIB 195-LMG 13222 HWU, UK Artemia spp, ES 
Vibrio anguillarum VIB 227-CIP P03.82 HWU, UK Scophthalmus maximus, FR 
Vibrio anguillarum VIB 236-CIP 10283 HWU, UK Scophthalmus maximus, FR 
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Table 2-1 Vibrio anguillarum isolates used in the present study (cont.). 
Species Designation Origin of the strains Origin of isolation 
Vibrio anguillarum VIB 238-CIP 10466 HWU, UK Scophthalmus maximus, FR 
Vibrio anguillarum VIB 253-Carson 85/3954-4 HWU, UK Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VIB 266-Carson 89/3748-1 HWU, UK Rotifer, Tasmania, AU 
Vibrio anguillarum VIB 269-Evelyn, C1 HWU, UK Oncorhynchus keta, CA 
Vibrio anguillarum VIB 546-UB A0236 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 549-UB A054 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 605-PT 213 HWU, UK Plecoglossus altivelis, JP 
Vibrio anguillarum VIB 72T-LMG 4437-NCIMB6 HWU, UK Gadus morhua, NO 
Vibrio anguillarum VIB 98-RVAU 860908-3 HWU, UK Scophthalmus maximus, NO 
Vibrio anguillarum VIB 99-RVAU 89-2-62 HWU, UK Scophthalmus maximus, NO 
Vibrio anguillarum VIB 100-RVAU 91-7-175 HWU, UK Scophthalmus maximus, DK 
Vibrio anguillarum VIB 140-RVAU 910614-1/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 242-CIP 11164 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 102-RVAU 1076/2 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 103-RVAU 1089/2 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 104-RVAU 1474/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 105-RVAU 6828c HWU, UK Scophthalmus maximus, DK 
Vibrio anguillarum VIB 77-LMG 12099 HWU, UK Plecoglossus altivelis, JP 
Vibrio anguillarum VIB 604-PT 493 HWU, UK Plecoglossus altivelis, JP 
Vibrio anguillarum VIB 111-RVAU 1321/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 114-RVAU 1712/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 118-RVAU 1629 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 122-RVAU 6828g HWU, UK Scophthalmus maximus, DK 
Vibrio anguillarum VIB 606-PB 15 HWU, UK Plecoglossus altivelis, JP 
Vibrio anguillarum VIB 608-ET 1 HWU, UK Anguilla sp, JP 
Vibrio anguillarum VIB 127-RVAU 3737/1 HWU, UK Oncorhynchus mykiss, IT 
Vibrio anguillarum VIB 216-LMG 13243 HWU, UK Dicentrarchus labrax, ES 
Vibrio anguillarum VIB 129-RVAU 850617-1/3 HWU, UK Gadus morhua, FI 
Vibrio anguillarum VIB 215-LMG 13242 HWU, UK Dicentrarchus labrax, ES 
Vibrio anguillarum VIB 197-LMG 13224 HWU, UK Rotifer, GR 
Vibrio anguillarum VIB 198-LMG 13225 HWU, UK Rotifer, GR 
Vibrio anguillarum VIB 199-LMG 13226 HWU, UK Water, GR 
Vibrio anguillarum VIB 200-LMG 13227 HWU, UK Sparus aurata, GR 
Vibrio anguillarum VIB 201-LMG 13228 HWU, UK Sparus aurata, GR 
Vibrio anguillarum VIB 202-LMG 13229 HWU, UK Dicentrarchus labrax, GR 
Vibrio anguillarum VIB 82-LMG 13186 HWU, UK Dicentrarchus labrax, GR 
Vibrio anguillarum VIB 128-RVAU 850610-1/8b HWU, UK Oncorhynchus mykiss, DK 
Vibrio anguillarum VIB 141-RVAU 840523-2/4b HWU, UK Oncorhynchus mykiss, DK 
Vibrio anguillarum VIB 142-RVAU 840808-3/4a HWU, UK Oncorhynchus mykiss, DK 
Vibrio anguillarum VIB 149-RVAU V2 5/3 HWU, UK Water, DK 
Vibrio anguillarum VIB 808 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 555 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 558 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 547 HWU, UK Scophthalmus maximus, ES 
Vibrio anguillarum VIB 130-RVAU 91-7-152 HWU, UK Scophthalmus maximus, DK 
Vibrio anguillarum VIB 133 HWU, UK Scophthalmus maximus, DK 
Vibrio anguillarum VIB 66-UB A044 HWU, UK Scophthalmus maximus, Sp 
Vibrio anguillarum VIB 29-HWU VA73 HWU, UK Dicentrarchus labrax, GR 
Vibrio anguillarum VIB 30-HWU VA75 HWU, UK Sparus aurata, GR 
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Table 2-1 Vibrio anguillarum isolates used in the present study (cont.). 
Species Designation Origin of the strains Origin of isolation 
Vibrio anguillarum VIB 2-1173/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 4-1356/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 5-1384/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 6-1406/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 8-1733/2 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 9-1247/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VIB 10-1347/1 HWU, UK Gadus morhua, DK 
Vibrio anguillarum VA 33-O2α NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA 34-O2β NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA68-02.40.5355 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA-69-04.09.428 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA70-04.09.325 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA71-01.09.824 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA72-03.09.449 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA73-07.09.297 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA74-01.50.1853 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA75-04.09.412 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA76-06.09.28 NVI, NO Gadus morhua, NO 
Vibrio anguillarum VA 5-91079 UGDM, UK Scophthalmus maximus, Scotland, UK 
Vibrio anguillarum VA 6-17/99 UGDM, UK Gadus morhua, Scotland, UK 
Vibrio anguillarum VA 4-06/00 UGDM, UK Gadus morhua, Scotland, UK 
Vibrio anguillarum VIB 1-6018/1 HWU, UK Oncorhynchus mykiss, DK 
Vibrio anguillarum VIB 3-6062/A HWU, UK Oncorhynchus mykiss, DK 
Vibrio anguillarum VA 41-00/2552-1 (850) DPIWE, AU Salmo salar, Tasmania, AU 
Vibrio anguillarum VA 42-99/2107-1-AS (844) DPIWE, AU Salmo salar, Tasmania, AU 
Vibrio anguillarum VA 43-00/1147-6k (792) DPIWE, AU Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VA 44-00/1676-1 (824) DPIWE, AU Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VA 49-89/3748-2 DPIWE, AU Rotifers, Tasmania, AU 
Vibrio anguillarum VA 45-00/2354-1k (849) DPIWE, AU Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VA 46-85/3526 (778) DPIWE, AU Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VA 47-85/3954-2 DPIWE, AU Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VA 48-89/1838 DPIWE, AU Oncorhynchus mykiss, Tasmania, AU 
Vibrio anguillarum VA 50-98/2963-4 (753) DPIWE, AU Rotifers, Tasmania, AU 
Vibrio anguillarum VA 51-98/2963-1 (755) DPIWE, AU Latris forsteri, Tasmania, AU 
Vibrio ordalii V9-85/1039 (1367) DPIWE, AU Oncorhynchus tshawytscha, Marlborough Sounds NZ 
Vibrio ordalii V10-85/0679 (1366) DPIWE, AU Oncorhynchus tshawytscha, Stewart Island, NZ 
Vibrio ordalii V11-85/10739 (1365) DPIWE, AU Oncorhynchus nerka, Marlborough Sounds NZ 
Vibrio anguillarum VA 37-VIB 166 (PB 15) KVL, DK Plecoglossus altivelis, JP 
Vibrio anguillarum VA 38-VIB 167 (PB 28) KVL, DK Plecoglossus altivelis, JP 
Vibrio anguillarum VA 39-VIB 168 (ET 1) KVL, DK Anguilla anguilla, JP 
Vibrio anguillarum VA 52-AS-02-1977-1 AHL, AU Brackish water fish, AU 
Vibrio anguillarum VA 53-AS-03-2336-3 AHL, AU Cheerax destructor (freshwater crayfish), AU 
Vibrio anguillarum VIB102A (passaged) Own Gadus morhua, / passaged 17.11.06 
Vibrio anguillarum VIB2A (passaged) Own Gadus morhua / passaged 22.11.06 
Vibrio harveyi V 12 DRIM, FR Not available 
Vibrio splendidus V 13-LGP32 DRIM, FR Not available 
Vibrio vulnificus V 14 DRIM, FR IT (gulf of Taranto) 
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Table 2-1 Vibrio anguillarum isolates used in the present study (cont.). 
Species Designation Origin of the strains Origin of isolation 
Vibrio tubiashii V 15-CRL10 DRIM, FR Not available 
Vibrio anguillarum VA56 DRIM, FR Not available 
Vibrio anguillarum VA 31 LEA, BE Dicentrarchus labrax larvae, ES 
Vibrio anguillarum VA 29 LEA, BE Sparus aurata larvae, GR 
Vibrio anguillarum VA 28 LEA, BE Sparus aurata larvae, GR 
Vibrio anguillarum VA 30 LEA, BE Sparus aurata larvae, GR 
Vibrio anguillarum VA 32 LEA, BE Sparus aurata larvae, GR 
Vibrio anguillarum VA 58-V06-01 S-P, JP JP 
Vibrio anguillarum VA 60-V06-08 S-P, JP JP 
Vibrio anguillarum VA 62-V06-22 S-P, JP JP 
Vibrio anguillarum VA 59-V06-03 S-P, JP JP 
Vibrio anguillarum VA 61-V06-19 S-P, JP JP 
Vibrio anguillarum VA 40-O1 AVL (78 skid) S-P, UK Salmon salar, UK 
Vibrio anguillarum VA40(2)-V. ang 1 (O1 AVL) S-P, UK UK 
Vibrio anguillarum VA 35-220 Strain B S-P, UK UK 
Vibrio anguillarum VA 36-259 Strain A S-P, UK UK 
Vibrio ordalii V6- S-P, UK CL 
Vibrio ordalii V7- S-P, UK CL 
Vibrio ordalii V8- S-P, UK CL 
Vibrio anguillarum VA 57-NB10 VDL, UK SE 
Vibrio anguillarum VA 1-NCIMB6 VDL, UK Gadus morhua, 1956, NO 
Vibrio anguillarum VA 66-Serotype O1 VDL, UK Tasmania, AU 
Vibrio anguillarum VA 64-Serv 2b VDL, UK Machrihanish, Scotland, UK 
Vibrio anguillarum VA 67-Vib O1 VDL, UK Machrihanish, Scotland, UK 
Vibrio ordalii VA 65-MSC-275 S-P, UK Not available 
Vibrio ordalii V4-Vib O2 VDL, UK Machrihanish, Scotland, UK 
Vibrio carchariae V 1-Flounder VDL, UK  
Vibrio vulnificus I V3-ATCC27562 VDL, UK Human blood 
Vibrio vulnificus II V2-ATCC33148 VDL, UK Anguilla anguilla 
Vibrio ordalii V5 (2)-Dom F3 Kid DF3K VDL, UK Kidney, Oncorhynchus kisutch  
Vibrio anguillarum VIB 7-6192/3 DMP, ES Anguilla anguilla, DK 
Vibrio anguillarum VA 24-TM14 DMP, ES Oncorhynchus mykiss, sea water, ES 
Vibrio anguillarum VA 27-RC71 DMP, ES Scophthalmus maximus, ES 
Vibrio anguillarum VA 25-643/04 DMP, ES Solea senegalensis, ES 
 
IZSV: Istituto Zooprofilattico Sperimentale delle Venezie, Dr A. Manfrin, Padova, Italy; INRA: Institut National de la 
Recherche Agronomique,Dr C. Michel, Jouy-en-Josas, France; HWU: Heriot Watt University, Dr D. Austin, 
Edinburgh, United Kingdom; NVI: National Veterinary Institute, Section for Fish Health, Dr D. Colquhoun, Oslo, 
Norway; UG DM: University of Glasgow, Department of Microbiology , Dr H. Birkbeck, Glasgow, United Kingdom; 
DPIWE: Department of Primary Industry, Water and Environment, J. Carson, Tasmania, Australia; KVL: Royal 
Veterinary and Agricultural University, Dr L. Bay, Copenhagen, Denmark; AHL: Animal Health Laboratories, 
Department of Agriculture, Western Austrlai, Dr N. B. Buller, Perth, Australia; DRIM: Defense et Resistance chez les 
Invertebres Marins (IFREMER-CNRS), Dr P. Roch, Montpellier, France; LEA: Laboratory voor Ecologie en 
Aquacultuur, Zoologish Instituut, Dr. L. Grisez, Leuven, Belgium; S-P JP: Intervet-Schering-Plough, Dr S. Nakano, 
Hialeah, Japan; S-P UK: Intervet-Schering-Plough, Prof P. Smith, saffron Walden, United Kingdom; VDL: Veterinary 
Diagnostic Limited, University of Stirling, Prof H. Ferguson, Stirling, United Kingdom; DMP: Departamento de 
Microbiología y Parasitología, Universidad de Santiago de Compostela, Dr Y. Santos, Santiago de Compostela, 
Spain. 
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2.1.2. Growth and preparation of bacteria 
Tryptone Soya Broth+NaCl ( Appendix 1.2) was aliquoted aseptically into either 15 mL or 50 mL 
centrifuge tubes (Greiner Bio-one, Stonehouse, UK) depending on the final volume required. A 
single colony of the bacteria was collected from a plate or a loopful from a slope and inoculated 
into the broth overnight at 22°C with shaking (Adolf Kuhner AG, Basel, CH, 140 rev.min-1). 
Vibrio anguillarum is a fast growing bacterium (growing overnight) while Vibrio ordalii required 
36 h incubation to produce sufficient bacteria for use. Once the culture was sufficiently dense 
(using MacFarland No 4 as a reference, BioMerieux, Paris, FR), the tube was centrifuged at 
3500 x g for 15 min (MSE, Mistral 2000R, 4°C), the supernatant was discarded and the 
bacterial pellet resuspended in the same volume with sterile phosphate buffered saline (PBS, 
0.02M phosphate,  Appendix 2.1). After vigorous vortexing, the tube was centrifuged, as 
previously described, and the supernatant discarded. The bacteria were finally resuspended in 
a small volume of sterile PBS, and after vortexing vigorously, the absorbance of the suspension 
was measured at 610 nm using a spectrophotometer (CECIL, CE 2041), using PBS as a 
reference. The optical density (OD) of the suspension was adjusted to 1.00 (±0.05) with sterile 
PBS. 
2.1.3. Storage of bacteria 
2.1.3.1. Long term storage 
Vibrio anguillarum strains were streaked onto plates of TSA+NaCl (2%,  Appendix 1.1) with a 
flamed metal loop and grown overnight in a 22°C incubator. If the colonies which grew showed 
a typical Vibrio-like morphology (Section  1.2.6.1), the bacteria were then further characterised 
by performing a Gram stain and 0/129 test (Section  2.1.4.2 and  2.1.4.3 ). If those tests were as 
expected, the strain was stabbed into 50x12 mm glass vials (Scientific Laboratory Supplies Ltd, 
Nottingham, UK) filled with 2 mL of TSA+NaCl solidified at a 45° angle (slope) and kept at RT. 
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Every 12 months each slope was checked for viability by sub-culturing the bacteria on 
TSA+NaCl plates and if identified as Vibrio anguillarum, the bacteria were stabbed in a new 
slope. Bacterial strains were also stored on cryo-beads (Technical Services Consultants Ltd, 
Heywood, UK) by inoculating a loopful of the strain (collected from a plate) into a cryo-vial, 
followed by shaking and removing the preserving media. The vial was stored at -70°C. To 
revive the strain from both storage media, a bead or loopful of bacteria was collected from the 
cryo-vial or slope and grown overnight in broth (Section  2.1.2) as well as streaking it onto 
TSA+NaCl. 
2.1.3.2. Short term storage at -70°C in glycerol 
To investigate the effect of short term storage at -70°C, in different concentrations of glycerol 
(Sigma-Aldrich, between 5 and 50% in PBS) and the subsequent recovery of bacteria, viability 
cell count ( 2.1.5) was measured. The highest recovery of live bacteria  was found when using a 
15% solution of glycerol.  
Bacteria were grown overnight in TSB+NaCl (Section  2.1.2) and 1 mL of the solution was 
aliquoted into centrifuge tubes, centrifuged at 3500 x g for 15 min and resuspended in 1 mL of 
15% glycerol in PBS. The tubes were then centrifuged as previously described and the 
supernatant discarded, leaving only 40 µL to cover the pellet. The different bacteria were 
stored at -70°C until used. To revive the bacteria, 960 µL of PBS were added to the bacteria of 
interest, and after 5 min at RT the bacteria were vortexed vigorously before centrifugation at 
3500 x g for 15 min. The pellet was then resuspended in 1 mL of PBS and kept on ice until 
used. To estimate the percentage survival of the bacteria, viable cell counts (Section  2.1.5) 
were performed with an average recovery superior to 80% (data not shown). 
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2.1.4. Identification of Vibrio anguillarum 
Vibrio anguillarum is a Gram negative bacterium, described as short and curved rods under the 
microscope, forming creamy colour colonies on non-selective media with a requirement for salt 
(Section  1.2.6.1).  
2.1.4.1. API20E 
API20E is a 20 reactions system test used typically for the identification of enterobacteria 
including amino acid decarboxylation and carbohydrate fermentation. Following the 
manufacturer’s instructions (BioMerieux, FR), different profiles were found for Vibrio 
anguillarum, but the most common reaction profile is shown in Figure  2-1. 
 
Figure  2-1 Typical API20E profile for V. anguillarum NCIMB6 type strain. 
 
2.1.4.2. Gram staining  
The technique used during this study was adapted from Gram (1884). Briefly, part of a colony 
of the bacterium of interest was mixed with one drop of sterile 2% NaCl solution (w/v, Sigma-
Aldrich, Poole, UK) onto a glass slide (Surgipath, Bretton, UK) using a sterile metal loop. The 
slide was left to air dry at room temperature (RT, 20-22°C) and was then passed 3 times 
though the flame of a Bunsen-burner to fix the bacteria. A few drops of Crystal violet solution 
( Appendix 1.3.1) were placed onto the fixed bacteria and left for 1 min at RT. The stain was 
washed off under running tap water and replaced with Iodine solution ( Appendix 1.3.2) and 
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incubated for 1 min. The slide was rinsed in acetone (VWR, Lutterworth, UK) and then under 
running water. Safranin solution ( Appendix 1.3.3) was placed onto the slide and incubated for 2 
min at RT. Finally the slide was rinsed under running tap water and left to air dry at RT. The 
morphology of the colony was then observed using an Olympus BH2 microscope at 100x 
magnification under oil immersion. 
2.1.4.3. 0/129 Vibriostatic test  
One colony of the bacterium under investigation was mixed in 2 mL of sterile 2% NaCl solution 
and vortexed vigorously. Five drops of the solution were spread onto a Tryptone Soya Agar 
plates containing 2% NaCl (TSA+NaCl,  Appendix 1.1) using a sterilised glass rod. The plate 
was left to dry at RT for a few minutes and discs of 10 µg and 150 µg of 2,4-diamino-6,7-
diisopropylpteridine (Oxoid, Thermo fisher Scientific Ltd., Cambridge, UK) were placed on 
opposite sides of the plate using flamed forceps. The plate was incubated overnight at 22°C 
and the size of the growth-inhibition zone was measured. A clearing zone of 9 mm or greater 
around the 150 µg disc was considered as a sensitive result (Bernardet and Grimont, 1989), 
while any inhibition zone around the 10 µg disc was considered sensitive. 
2.1.5. Bacterial concentration using viability counts 
Viable cell counts were carried out using the technique of Miles et al. (1938). First, a standard 
curve for Vibrio anguillarum was constructed. Briefly, 8 different strains of V. anguillarum were 
grown overnight (Section  2.1.2) and after measuring the OD (absorbance at 610 nm), six ten-
fold serial dilutions of the bacteria suspension were made by adding 500 µL of the bacterial 
suspension to 4.5 mL of 2% NaCl (final dilution 10-6). A TSA+NaCl plate was marked in 6 equal 
sectors and 20 µL of the suspension was added to each sector (6 replicates). After incubation 
overnight at 22°C, the number of colony forming units (cfu) was counted in each sector on the 
10-6 dilution plate and multiplied by 5 x107 to obtain the number of cfu.mL-1 of solution. A 
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standard curve (concentration vs. OD) was generated for 8 V. anguillarum isolates after 
estimating the concentration of bacteria using the viability count method previously described 
for different bacterial dilutions, and is represented on Figure  2-2, using SigmaPlot 10.0 software 
(Systat software Inc, Hounslow, UK). 
 
Figure  2-2 Concentration (cfu.mL-1) of different V. anguillarum isolates calculated after 
determining the viable cell counts and absorbance at 610 nm of different dilutions of 
bacteria. 
 
Using the regression curve on the Figure  2-2, the concentration of Vibrio anguillarum can then 
be estimated at any given OD using Equation  2-1.  
Y = (8.41 X + 0.24) x108  
Equation  2-1 Relationship between optical density of Vibrio anguillarum at 610 nm (X) 
in PBS and concentration in colony forming units per mL of solution (Y). 
 
Equation  2-1 gives a concentration of V. anguillarum between 8.23 and 9.07 x108 cfu.mL-1 for 
an optical density of 1.00 ± 0.05 at 610 nm. 
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In order to estimate the number of bacteria in any sample, either the standard curve was used 
after measuring the OD of the bacteria at 610 nm or a viable cell count was carried out 
following the method described earlier. 
2.1.6. Formalin killing of bacteria 
Bacteria were grown overnight in TSB+NaCl (Section  2.1.2) and formalin (Sigma-Aldrich) was 
added at a final concentration of 0.5% (v/v). After incubation overnight at 4°C, the bacteria 
were streaked onto TSA+NaCl plates to ensure that they were dead (no growth recorded after 
24 h at 22°C). The formalin-killed bacteria were then centrifuged at 3500 x g for 15 min and 
resuspended in the same volume of 15% sodium meta-bisulfite (w/v, Sigma-Aldrich) and 
incubated overnight in PBS to neutralise the formalin. The bacteria were then washed three 
times with PBS. The optical density was adjusted to 1.0 in PBS and the bacteria used 
immediately or stored at -20°C. 
2.2. SDS PAGE 
2.2.1. SDS PAGE protocol 
The gel caster (Biorad Labs Ltd, Hemel Hampstead, UK) was assembled according to the 
manufacturers’ instructions. The separating gel (12% polyacrylamide) was made by mixing 5 
mL of SDS separating buffer ( Appendix 2.3) with 7 mL of distilled water and 8 mL of 30% 
acrylamide/Bis acrylamide solution (Severn Biotech Ltd, Kidderminster, UK). The solution was 
degassed for 30 min and 15 µL of TEMED (Sigma-Aldrich) and 70 µL of ammonium 
persulphate (Sigma-Aldrich, 100 mg.mL-1 in distilled water) were added. After mixing by gentle 
inversion, the separating gel was poured into the gel caster and 200 µL of iso-propanol (VWR, 
UK) layered on top. The gel was left to polymerise at RT for 60 min. The stacking gel (4% 
polyacrylamide) was prepared by mixing 2.5 mL of SDS stacking buffer ( Appendix 2.4) with 6.1 
mL of distilled water and 1.34 mL of 30% polyacrylamide solution. The solution was degassed 
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for 30 min and 10 µL of TEMED and 50 µL of APS were added. The solution was added on top 
of the separating gel after washing off the iso-propanol several times with distilled water, and 
was left to polymerise for 60 min. After polymerisation, the gel was assembled in the 
electrophoresis system (BioRad, Labs Ltd) and SDS running buffer ( Appendix 2.5) was added 
to the reservoir tank.  
After growth of the bacteria of interest (Section  2.1.2), 500 µL of each bacterial suspension was 
mixed with 500 µL of 2x SDS sample buffer ( Appendix 2.2). The samples were boiled for 10 
min and vigorously vortexed before aliquoting in 100 µL and stored at -20°C. 
Ten µL of bacterial sample in SDS sample buffer was added to the wells of the gel, as well as 7 
µL of protein marker (New England Biolabs, Hitchin, UK) in the last well. When the gel was 
destined for Western Blotting (Section  2.3), 7 µL of Rainbow marker (Bio-Rad, UK) was used 
instead. The gel was subjected to electrophoresis at 150 V for 20 min (or until the proteins 
reached the 12% gel) followed by 200 V for 40 min (or until the samples reached the bottom of 
the gel). The protein bands were stained with either Coomassie blue staining (Section  2.2.2) or 
Silver staining (Section  2.2.3) or the gel used for Western blotting (Section  2.3). After staining, 
the gel was scanned (EPSON expression 1680 Pro at 600 dpi, using Pagemanager, Presto 
software 4.80.15, Newsoft Inc., Milpitas, US) and dried in a cellophane casting (Section  2.2.4). 
2.2.2. Protein Coomassie Brilliant Blue staining 
The gel was left overnight in 50 mL of Coomassie blue solution diluted following the 
manufacturers’ instructions (Brilliant blue G solution, Sigma-Aldrich). The gel was destained 
with several 10 min washes with destain solution (40% methanol (Thermo fisher scientific Ltd, 
UK), 10% acetic acid (VWR) in distilled water) until the bands clearly appeared. The gel was 
then soaked in distilled water until scanned and dried (Section  2.2.4). 
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2.2.3. Silver Staining 
This staining technique was adapted from Swain and Ross (1995). All the solutions used were 
100 mL unless otherwise stated. Briefly, the gel was fixed overnight in a solution of 10% acetic 
acid (VWR) and 40% ethanol (Thermo fisher scientific Ltd) in distilled water (fixative solution). 
The gel was then rinsed for 10 min in distilled water and incubated for 5 min in the fixative 
solution plus 0.05% gluteraldehyde (v/v, Sigma-Aldrich) and 0.01% formaldehyde (v/v, Sigma-
Aldrich). The gel was rinsed in fixative solution for 20 min and then in distilled water for another 
20 min. The sensitiser solution was added for 1 min (Sodium thiosulphate, VWR, 0.49 mg.mL-1 
in distilled water) and the gel rinsed twice for 1 min in distilled water. The gel was stained with 
silver nitrate (Sigma-Aldrich, 1 mg.mL-1 in distilled water) for 15 min before 2 rinses of 1 min in 
distilled water. The gel was developed in sodium carbonate solution (Sigma-Aldrich, 2.5 
mg.mL-1 in distilled water) with 0.04% formaldehyde. The reaction was stopped by rinsing 
several times in 5% acetic acid (VWR) in distilled water. The gel was then soaked in distilled 
water until scanned and dried (Section  2.2.4). 
2.2.4. Gel Drying  
The gel was dried by placing it between two sheets of hydrated cellophane (VWR) in the middle 
of a drying frame clamped together and left at RT overnight. The dried membrane was then cut 
around the gel leaving a 1 cm margin. 
2.3. Western blotting 
The protocol used was adapted from Wiens et al. (1990). The SDS gel was soaked for 30 min 
in blotting buffer ( Appendix 3.1) together with 6 pre-cut pieces of filter paper (Whatman n°1, GE 
Healthcare, Maidstone, UK) and nitrocellulose paper (Amersham Biosciences, Little Chalfont, 
UK), all cut to the size of the gel. The wet-blotter tank (Thermo fisher Scientific Ltd) was filled 
with the blotting buffer and the blot prepared by placing 3 layers of filter paper on each side of 
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the gel and the nitrocellulose membrane (Figure  2-3). Air bubbles were removed by rolling a 
plastic pipette on top of the stack. 
 
Figure  2-3 Layout of gel/nitrocellulose membrane used for transferring proteins from 
SDS gel to nitrocellulose membrane. 
 
The proteins were transferred from the gel to the nitrocellulose membrane by applying a current 
of 60 V for 60 min. The SDS gel and the filter paper were discarded after ensuring that the 
proteins had transferred to the nitrocellulose membrane (visualised through the transfer of the 
Rainbow marker). The membrane was then blocked overnight in 100 mL of 1% Bovine Serum 
Albumin (w/v, BSA, Sigma-Aldrich) in Tris Buffered Saline (TBS,  Appendix 3.2) at 4°C. The 
paper was rinsed 3 times for 5 min in Tween-TBS (TTBS,  Appendix 3.3) on a rocker at 40 
rev.min-1. The membrane was incubated in 10 mL of neat monoclonal antibody (mAb) 
supernatant (Section  3.3.2.1) for 60 min at RT on a rocker and rinsed 3 times as previously 
described. The membrane was then incubated in 10 mL of goat anti-mouse IgG conjugated to 
Horse Radish Peroxidase (Sigma-Aldrich, 1:400 in TBS) for 60 min at RT on a rocker at 40 
rev.min-1. After rinsing 3 times for 5 min in TTBS followed by one 1 min rinse in TBS, the bands 
recognised by the antibodies were stained by adding the developing solution ( Appendix 3.4) at 
RT for 7 to 10 min. The reaction was stopped with several rinses in distilled water. The 
membrane was then scanned and dried as for the SDS gel. 
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2.4. Enzyme Linked Immuno-Sorbant Assay (ELISA) 
Indirect ELISA was used throughout the study; all the reactions were carried out at RT unless 
otherwise stated. 
The technique used for this assay was adapted from Adams and Thompson (1990). A 96-well 
ELISA plate (Immunlon, Thermo Ficher Scientific) was coated with 50 µL.well-1 of 0.05% poly-
L-lysine (w/v, Sigma-Aldrich) diluted in coating buffer ( Appendix 4.3) and incubated for 1 h. The 
plate was then washed twice in Low Salt Wash buffer (LSW,  Appendix 4.1) and tapped dry. 
One hundred µL of bacteria (Section  2.1.2) or butan-1-ol extracted LPS (Section  3.2.1.2, at 2.5 
mg.mL-1 in PBS) was added to each well (in duplicates) and incubated at 4°C overnight. Fifty 
µL of 0.05% gluteraldehyde (v/v, Sigma-Aldrich) in PBS was added to each well and incubated 
for 20 min to fix the bacteria. The plate was then washed three times in LSW buffer and 250 µL 
of 1% bovine serum albumin (w/v, Sigma-Aldrich) or 3% casein (w/v, Marvel, UK) in distilled 
water was added and incubated for a minimum of 2 h at 37°C. The plate was washed again 
three times in LSW buffer and 100 µL of neat mAbs supernatant (Section  3.3.2.1) was added 
to the appropriate wells for 1 h, 2 wells per bacteria isolate were incubated with PBS instead of 
the mAbs to calculate the cut off point of the reaction (negative background). The plate was 
washed five times in High Salt Wash buffer (HSW,  Appendix 4.2) with the last wash left for 5 
min before tapping the plate dry. The plate was incubated with 100 µL of secondary antibody 
(Goat-anti-mouse HRP conjugated, Sigma-Aldrich, 1:4000 in 1% BSA (w/v) in LSW buffer) for 1 
h. The plate was washed again 5 times as previously described with HSW buffer and 100 µL of 
developing solution ( Appendix 4.4) was added to all the wells and incubated until a blue colour 
appeared for the positive control (1 to 10 min). The reaction was stopped by adding 50 µL of 
2M H2SO4 (VWR). The absorbance was read on a spectrophotometer (DYNEX technologies, 
Worthing, UK) at 450 nm. 
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Chapter 3. 
 
Development of monoclonal antibodies for 
serotyping Vibrio anguillarum 
 
3.1. Introduction 
The principle behind serotyping is the grouping of organisms (bacteria or viruses) based on 
their cell surface antigens. Serotyping establishes groups within a species called serotypes (or 
serovars), but those groups are only defined by their reaction to a particular antibody, so the 
detection of different antigens (or epitopes) on the surface of a bacterium by different 
antibodies can potentially lead to different serotyping schemes, sometimes called epigroups or 
epitypes. 
Complete understanding of serological classification of strains within a bacterial species 
facilitates the development of vaccines, as well as epidemiological studies of the different 
groups of bacteria involved in disease outbreaks. 
Serotyping relies on the interaction of antigens with antibodies. These immunoglobulin 
molecules are produced by plasma cells (fully differentiated antibody producing B lymphocytes) 
through the expression of genes (V-D-J segments of the light anf heavy chain) which have a 
very high number of possible combinations, thus allowing an almost infinite number of epitope 
binding domains to be produced (Ollila and Vihinen, 2005). Each B cell produces a single 
antibody type with a unique specificity, and this is the basis of specific antibody production for 
specific recognition and serotyping. 
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3.1.1. Monoclonal and polyclonal antibodies 
Two types of antibodies are used for serotyping i.e. monoclonal antibodies (mAb), containing 
antibodies able to recognise only one epitope and polyclonal antibodies (pAb), containing a 
mixture of antibodies with different specificities. 
Polyclonal antibody serum is produced by injecting an animal (usually rabbit) with a selected 
antigen (virus, whole bacteria or molecules extracted from the pathogens), this results in the 
production of antibodies reacting against the different epitopes present of the antigens injected. 
The advantage of using pAbs lies in the ease of production and the relatively large quantities of 
serum with high antibody concentrations that can be obtained. One problem with using pAb for 
serotyping arises from the multitude of antibodies present in the serum with different 
specificities. These can react with closely related serotypes because of the presence of 
common epitopes, and thus the serum may need to be cross-absorbed to obtain a specific 
reaction. Cross-absorption is the removal of antibodies from the serum which cross-react with 
other serotypes being investigated, leaving only antibodies which react with the serotype 
against which the serum was made. To study sub-serotypes using pAbs, a large number of 
isolates need to be screened with different cross-absorbed sera, making the task very 
laborious. Another problem is that the supply of the serum is limited and when finished, another 
animal has to be immunised and the serum collected can vary from the original. 
Monoclonal antibodies, compared with pAbs, are produced by a single B-cell clone. This results 
in the production of antibodies with identical specificity to a particular epitope. The innovative 
method for producing mAbs was developed by Kohler and Milstein (1975), who received the 
Nobel Prize for Physiology or Medicine in 1984 for this discovery. They produced B-cell 
descendants after fusing together healthy plasma cells and neoplastic myeloma cells to 
produce so called hybridoma cells which have the combined ability of the plasma cell (to 
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secrete the same specificity immunoglobulins) and the characteristics of a tumour cell (to divide 
in an unlimited fashion, making them virtually immortal). Another advantage of working with 
mAbs is that they are easily produced in culture and are relatively easy to purify (Luttmann et 
al., 2006). The disadvantages are easily compensated by the advantages but the selection of a 
suitable hybridoma cell for a specific epitope can be labour intensive. The cells can also lose 
their ability to produce mAbs (Frame and Hu, 1990), and finally, the production of an epitope 
specific antibody can be a problem for some applications which require a large or broad binding 
capacity. 
Almost any type of molecule can be used as an antigen for antibody production, as long as it 
elicits an immune response. One of the most antigenic molecules of Gram negative bacteria is 
the lipopolysaccharide (LPS) complex (Johnsen, 1977). This molecule, found on the surface of 
bacteria, is a complex of sugars and lipids and is heat-stable (Section 1.2.6.2). For these 
reasons, LPS is often chosen as the antigen for serotyping Gram negative bacteria. 
3.1.2. LPS immunogen 
LPS molecules are very immunogenic and may constitute the most potent and multivalent 
molecule of bacterial origin for mammals (Jacques, 1996). This might be explained by the fact 
that the innate immune system seems to have evolved towards an increased recognition of 
structurally conserved molecules such as fungal cell walls, bacterial LPS and peptidoglycans or 
viral double stranded RNA (Robertsen, 1999). The LPS molecules are present on the majority 
of Gram negative bacteria membranes, this structure is then easily recognised by a number of 
specific binding molecules, such as LPS binding protein (LBP, Tobias et al., 1986) and a 
closely related protein, bactericidal/permeability-increasing protein (BPI, Elsbach and Weiss, 
1993) as well as antibodies. The LBP-LPS complex has been shown to activate some 
branches of the innate immune system of mammals and BPI can exert strong antibacterial 
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activity, acting as an opsonin and having neutralising activity against LPS. In fish, only one 
gene was identified in carp (Thompson et al., 2004), catfish (Xu et al., 2005) and cod (Stenvik 
et al., 2004), showing more homology to the BPI sequence than to the LBP; however in 
rainbow trout two homologous genes where found (Inagawa et al., 2002), which may be the 
precursors of LBP and BPI in mammals. Since it is mainly the activation of the LBP that leads 
to endotoxic shock, this could explain why fish have a higher tolerance to LPS (discussed 
later). There are also questions about the existence of TLR4-mediated cellular responses to 
LPS in fish (Iliev et al., 2005b), which in mammals is involved in the specific recognition of LPS 
motifs. This needs to be clarified but could add weight to the reasons for low LPS toxicity in 
fish. 
Enterobacteria have LPS consisting of three distinct regions (Section  1.2.6.2), the lipid A, the 
core oligosaccharide and the O side chain (or O antigen) as seen on Figure  3-1. The O antigen 
is extensively variable in its composition and conformation (repeating units of oligosaccharides) 
and provides the basis for classification of enterobacteria through sometimes hundreds of 
different thermostable O serogroups, for example Escherichia coli has over 170 different 
serotypes (Caugant et al., 1985). 
 
Figure  3-1 Typical LPS molecule on the surface of Gram-negative bacteria. 
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Lipid A is the toxic component of LPS and with KDO represents the most conserved region 
throughout the Gram negative bacteria (Jacques, 1996). The lipid A has been shown to be a 
good adjuvant and mitogen (Chiller et al., 1973), and responsible for the immuno-modulatory 
effect of this molecule (Robertsen, 1999) in mammals and fish. 
Fish respond differently to LPS than mammals, probably due to the lower toxicity observed in 
fish to LPS (Harbell et al., 1979; Yongjuan et al., 2002). Fish cells survive doses 100 times 
higher than the lethal concentrations found with mammalian cells (Iliev et al., 2005a). When 
interacting with the immune system of fish, LPS basically acts as an immunostimulant (Section 
 1.4.1; Sakai, 1999). It has several stimulatory effects on the immune system by acting on both 
the cellular and humoral parts of the defences. For example, incubation of Atlantic cod 
macrophages with LPS enhanced the production of superoxide anions acid phosphatase 
activity, and increased respiratory burst activity (Sorensen et al., 1997; Steiro et al., 1998). The 
LPS has been shown to activate the complement system of fish with an increase in C5a and 
C3a anaphylatoxins, which act as chemotactic molecules for many immune cells (Kato et al., 
2003; Li et al., 2007). 
The LPS molecules of certain pathogenic bacteria participate in the inhibition of the 
complement system, offering them a great advantage over the immune system (Reeves, 1995). 
The lipid A component seems to be sensitive to the lytic activity of complement, but the O-
antigen chain, present on most pathogenic strains, can protect this structure by binding the C3 
molecules (Reeves, 1995). The length of the O-antigen chain has been correlated with serum 
resistance, e.g. an increase in the length of the LPS molecule in V. anguillarum (after growth in 
fish blood supplemented media), correlated with an increase in resistance to serum killing 
(Mutharia and Amor, 1994). The reverse is also true, isolates with fewer high molecular weight 
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O-antigen (after growth in glucose rich medium), showed a reduced resistance to serum killing 
(Boesen et al., 1999). 
The structure of the V. anguillarum O side chain (O-antigen) has been elucidated by Eguchi et 
al. (1992b) and Sadovskaya et al. (1996) for serotype O2 and O3 respectively. The O-antigen 
structure is easily distinguished between those 2 serotypes on SDS-PAGE, but acid hydrolysis 
of these molecules showed similarities based on the repeat units of tetrasaccharides. The KDO 
molecule has been reported in V. anguillarum (Iguchi et al., 1989) but Salati and Kusuda (1986) 
could not find any in V. ordalii, showing the existence of structural differences between these 
two bacterial species. 
Lipopolysaccharides are found in almost all Gram-negative bacteria, are highly immunogenic 
and a good correlation between LPS profiles and serogroups is often found (i.e. for V. 
anguillarum, Austin et al., 1995), which makes this molecule a very good candidate for the 
production of mAbs for serotyping V. anguillarum. 
3.1.3. Vibrio anguillarum serotypes 
Vibrio anguillarum has 23 known serotypes, as mentioned in Section  1.2.6.3, with two sub-
serotypes identified for both O2 (O2 a and b, Rasmussen, 1987b, or α and β, Bolinches et al., 
1990) and O3 (O3A and O3B, Muino et al., 2001). Espelid et al. (1991) reported the existence 
of additional sub-serotypes within the O2 group, with 4 groups identified using mAbs. The 
mAbs were made to 1 isolate (probably O2b serotype) and if discounting the non reactive strain 
(serotype D), they found 3 serotypes. After correlation of the results with other serotyping 
schemes, the group C seems to be represented by the O2a serotype and the serotype O2b 
was divided into 2 groups (O2b group A and B). Knappskog et al. (1993) also reported the 
existence of a subgroup within the sub-serotype O2b after cross-absorption with a rabbit 
polyclonal serum against O2b. Tiainen et al. (1997a) suggested the existence of additional sub-
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serotypes on the basis of the results obtained with rabbit polyclonal antisera to O2a and O2b 
using slide agglutination as four isolates of V. anguillarum reacted with unabsorbed sera from 
O2a, but not with the O2a or O2b serum (cross-absorbed) and thus proposed the possibility of 
the existance of a new serogroup, which they temporarily named O2c. The loss of reactivity of 
polyclonal serum after cross-absorption with O2a or O2b has also been reported by Larsen et 
al. (1994), for a few isolates. Mikkelsen et al. (2007) suggested a new sub-group within isolates 
classified as O2 serotypes in V. anguillarum strains recovered from diseased cod. They used 
two of the mAbs produced by Espelid et al. (1991), one which reacted with all the O2 serotype 
isolates (6E10) and one with only O2b subgroup strains (1C12). They found that all the isolates 
reacted with 6E10 by ELISA, except for 5 isolates which did not react with either of the mAbs. 
As these isolates reacted with a rabbit polyclonal against O2, they concluded that this group 
belonged to the O2 serotype. It has to be mentioned that the sub-group they found in this study 
is not the same as the sub-groups A and B from Espelid et al. (1991), since those 2 sub-groups 
both reacted with 1C12 and so belonged to the O2b sub-group. For ease of nomenclature and 
discussion, the name O2c will be used for the subgroup identified by Mikkelsen et al. (2007) 
throughout this study. 
3.1.4. Aims 
The aim of this chapter was to investigate the serotyping classification of Vibrio anguillarum in 
order to determine the serological relationship of the different pathogens to different fish 
species. From the results of this study, it is anticipated that a more accurate decision may be 
taken regarding which serotypes and sub-serotypes of V. anguillarum should be included in a 
vaccine to protect Atlantic cod against vibriosis. For this reason a panel of monoclonal 
antibodies was developed, these were selected on the basis of their cross-reaction and 
specificity with the different serotypes and sub-serotypes responsible for cod disease outbreaks 
(i.e. O1, O2a, O2b and O3). Lipopolysaccharide was used in order to screen and select the 
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antibodies, since this molecule is the basis of the existing serotyping schemes for V. 
anguillarum. 
3.2. Materials and methods 
3.2.1. Lipopolysaccharide extraction 
3.2.1.1. Culture of bacteria on cellophane 
The method for collecting large quantities of bacteria using cellophane sheets was adapted 
from Liu (1957). Briefly, circles of cellophane (Medicell International Ltd, London, UK) were cut 
using the lid of a 13 cm Petri dish (Sterilin Ltd, Caerphilly, UK) as a template and stacked with a 
sheet of filter paper (Whatman N°1, GE Healthcare, Maidstone, UK) in between each layers. 
The sheets were hydrated and autoclaved in foil (123°C for 20 min). Each cellophane sheet 
was placed onto a 13 cm TSA+NaCl plate ( Appendix 1.1) and the filter paper removed. 
Different isolates of V. anguillarum were grown overnight in TSB+NaCl (Section  2.1.2) and 1 
mL of the suspension (OD 1, corresponding to 109 cfu.mL-1) was spread with a flamed glass 
rod onto the plate. Five plates were inoculated per isolate. 
The plates were incubated for approximately one week in a 22°C incubator. Once satisfactory 
growth was obtained, the bacteria were collected, using a flame-sterilised metal scraper and 
placed into a pre-weighed sterile glass universal. 
3.2.1.2. Butan-1-ol extraction method 
Butan-1-ol was used to extract the LPS from bacteria using a modification of the procedure 
described by Morrison and Leive (1975). The bacteria collected were resuspended in 20 mL of 
PBS and equally divided between 2 sterile glass universals (10 mL each) which were boiled for 
10 min to kill and disrupt the membrane of the bacteria. An equal volume of butan-1-ol (VWR, 
Lutterworth, UK) was added to the bacteria after transfer into two 35 mL PPCO centrifuge 
tubes (Nalgene, US), and the solution incubated on ice with shaking for 15 min. The solution 
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was then centrifuged at 35000 x g for 20 min at 4°C (Sorvall, Thermo Fisher Scientific Inc., 
Loughborough, UK). The aqueous phase (lower layer) was collected and filtered through a 0.20 
µm Vivaspin concentrator tube (Sartorius, Epsom, UK) by centrifugation at 3000 x g for 30 min 
at 4°C. The high molecular weight particles were removed using a 300,000 Da Vivaspin 
concentrator tube (Sartorius, UK) centrifuged for 60 min at 3000 x g. The filtrate was then 
concentrated using a 10,000 Da Vivaspin concentrator tube (Sartorius) at 3000 x g until around 
1 mL was left. The concentrate was resuspended twice in PBS and centrifuged as previously 
described to remove all traces of butanol. The flow-through was discarded each time and the 
concentrated solution collected. Proteinase K (Sigma-Aldrich, Poole, UK, final concentration 
0.5 mg.mL-1 in distilled water) was added to the solution and incubated overnight at 60°C in a 
water-bath. Nuclease-mix (Amersham Biosciences, GE Healthcare, UK, final concentration 80 
units.mL-1 of DNAse and 1.2 units.mL-1 of RNAse) was added and incubated at RT for 60 min. 
The samples were then boiled for 10 min to inactivate the enzymes and resuspended in 10 mL 
of distilled water. An equal volume of butan-1-ol was added and after incubation on ice for 15 
min, the tubes were centrifuged at 35000 x g for 20 min at 4°C. The aqueous phase was 
collected and filtered through a 10,000 Da concentrator tube for 30 min at 3000 x g, 
resuspended in 5 mL of distilled water in the same tube and re-centrifuged twice. The product 
was aliquoted into freeze-drying vials (Scientific Laboratory Supplies Ltd, Nottingham, UK) and 
frozen overnight at -70°C. The samples were then lyophilised over-night in a freeze-dryer 
(Martin Christ, Osterode am Harz, DE). The final product was collected into sterile 5 mL glass 
vials and kept at -20°C until required. 
3.2.1.3. Quantification of LPS using the Purpald assay 
The quantity of LPS in the samples was measured using the Purpald method described by Lee 
and Tsai (1999). Fifty µL of the LPS standards, ranging from 0.5 to 5 µg.well-1 of butanol 
extracted LPS in distilled water, as well as bacterial samples grown in TSB+NaCl overnight 
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(Section  2.1.2) were placed into a flat bottomed micro-titre plate (Immunlon 4 HBX, Thermo 
Fisher Scientific Inc., UK). Fifty µL of sodium peroxide (Sigma-Aldrich, 32 mM in distilled water) 
was added to each well and incubated for 20 min at RT. Fifty µL of Purpald solution (Sigma-
Aldrich, NaIO4 at 136 mM in 2M NaOH) was added and incubated at RT for 20 min. Another 50 
µL of 64 mM NaIO4 was added followed by 20 µL of propan-2-ol (Sigma-Aldrich) for 20 min at 
RT to stop the solution from foaming. The absorbance was then read on a spectrophotometer 
(Dynex Technologies Ltd, Worthing, UK) at 550 nm.  
3.2.1.4. Analysis of extracted LPS 
Purification of LPS using proteinase K 
In order to compare the LPS profiles produced by butan-1-ol extraction and proteinase K 
treatment, samples were treated with proteinase K according to Hitchcock and Brown (1983). 
Briefly, the bacteria were grown in TSB+NaCl (Section  2.1.2) and 1.5 mL of a bacterial 
suspension was centrifuged at 3500 x g for 15 min. The pellet was resuspended in 50 µL of 2x 
SDS sample buffer ( Appendix 2.2) and boiled for 10 min. Once cooled, 10 µL of Proteinase K 
(Sigma-Aldrich, 2.5 mg.mL-1 in Urea buffer) was added to the solution and incubated overnight 
at 60°C in a water bath. The solution was then boiled for 5 min to inactivate the enzyme and 
frozen at -20°C. 
Protein concentration after LPS extraction 
In order to verify the elimination of the proteins from the purified LPS, the protein content of the 
batun-1-ol extracted LPS (2.5 mg.mL-1 of LPS in distilled water) was assessed for VIB2 and 
VIB3 samples using a BCA kit (Pierce, Thermo Fisher Scientific Inc) following the 
manufacturer’s instructions. 
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SDS-PAGE protocol 
The LPS profiles of the butanol extracted LPS were compared to the profile of LPS extracted 
using only proteinase K. The SDS-PAGE gels (12%) were prepared (Section  2.2.1) and 10 µL 
of the proteinase K treated bacteria or pure butanol extracted LPS at different concentrations 
(1:1 in 1x SDS sample buffer) were loaded into the wells of the gel. Once the gel had run, the 
resulting bands were stained with silver staining specific for LPS (Tsai and Frasch, 1982). 
Briefly, the gels were fixed overnight at RT in 100 mL of Solution A ( Appendix 5.1) in a glass 
staining trough placed on a rocker (RT, 40 rpm). The solution was replaced with 100 mL of 
Solution B ( Appendix 5.2) for 5 min and the gels were washed 8 times for 3 min in distilled 
water. The LPS were stained with Solution C ( Appendix 5.3) for 10 min, followed by 3 washes 
of 10 min each in distilled water. The bands were then developed in 100 mL of Solution D 
( Appendix 5.4) until clearly visible. The reaction was stopped by 3 quick rinses in 0.35% acetic 
acid (VWR, UK) in water and left for at least 1 h in distilled water before scanning and drying 
the gel (Section  2.2.4). 
3.2.2. Monoclonal antibody production 
3.2.2.1. Immunisation of mice 
Five Balb/C mice (3-4 weeks old) were obtained from Charles River Laboratories (Edinburgh, 
UK) and left to acclimatise for 3 weeks in the Animal Facility at the University of Stirling. The 
antigen was prepared by growing V. anguillarum VIB1 (O1 serotype), VIB72T (O2a serotype), 
VIB102 (O2b serotype) and VIB3 (O3 serotype) in TSB+NaCl overnight (Section  2.1.2). 
Bacteria were formalin-killed (Section  2.1.6) and the OD adjusted to 2.0 at 610 nm. Vibrio 
anguillarum VIB102 LPS only (extracted with butanol, Section  3.2.1.2) was also prepared as an 
antigen (280 µg.mL-1 of LPS in PBS) and injected in one mouse. Each solution (formalin killed 
bacteria and LPS) was emulsified (1:1) with Titermax (Interchim S. A. Montlucon, Fr) and 100 
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µL of the different solutions were injected subcutaneously into separate mice. The ears of the 
mice were clipped for differentiation between animals and a pre-injection bleed collected. The 
mice were re-injected after 3 weeks with the same quantity of antigen. A test sample of blood 
was collected a week after each injection in sterile 1.5 mL centrifuge tubes to determine the 
antibody response elicited by each immunisation. The mice were finally boosted after a further 
3 weeks, intravenously into the tail with no adjuvant. After four days, the mice were culled by 
CO2 asphyxiation and bled out by cardiac puncture. The animals were then transported from 
the Animal Facilities to the Aquatic Vaccine Unit laboratory. 
3.2.2.2. Myeloma cell culture 
Myeloma cells (SP2, Sigma-Aldrich) were expanded a week before performing the fusion in 
DMEM* ( Appendix 9.1) with 20% FCS (v/v, Sigma-Aldrich) at 37°C in 5% CO2. The media was 
changed every 2 to 3 days to maintain cells in the log phase. 
3.2.2.3. Fusion 
The fusion of myeloma cells with spleen cells was performed according to the method of 
Campbell (1984) with modifications. All work took place in a laminar flow cabinet and the 
instruments were kept in 70% ethanol to insure sterility during the procedure. The spleen was 
dissected from each individual mice and the cells collected by several passages of DMEM 
through it using a syringe with a 27 gauge needle. The medium containing the spleen cells was 
transferred into a 50 mL sterile centrifuge tube and placed at 37°C with 5% CO2. 
Meanwhile SP2 cells were collected by centrifugation at 150 x g for 7 min and the cells 
resuspended in 5 mL of DMEM* without FCS, this step was repeated to remove all traces of 
FCS.  
Both the myeloma and the spleen cell suspensions were mixed together (around 10 myeloma 
cells per spleen cell). The cells were centrifuged at 100 x g for 10 min, the supernatant 
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discarded, and the pellet gently resuspended by the addition of 1 mL of 50% polyethylene 
glycol (w/v, Sigma-Aldrich, in DMEM) warmed to 37°C over 1 min.  The cells were allowed to 
stand for 60 sec before adding one mL of DMEM over 30 sec, then 3 mL over 30 sec and 
finally 16 mL over 60 sec. The cells were allowed to stand for 5 min before centrifugation at 400 
x g for 5 min. The supernatant was gently discarded, and the pellet was carefully resuspended 
in 4 mL of DMEM* plus 0.3% mouse blood (v/v) and HAT (100 μM hypoxanthine, 0.4 μM 
aminopterin, 16 μM thymidine, Sigma-Aldrich). One hundred and eighty µL of the solution was 
added to each well of 14 96-well plates. The plates were incubated at 37°C with 5% CO2 taking 
care not to disturb the cells for at least 48 h.  
3.2.2.4. Screening, cloning and expansion 
After a week, 100 µL of the 180 µL original media was removed and replaced with 100 µL of 
DMEM*+10% FCS and HT (100 μM hypoxanthine, 16 μM thymidine, Sigma-Aldrich). The 
media was then changed every three days by removing 150 µL of the media, without disturbing 
the clones, and adding 150 µL of fresh media (DMEM*+10% FCS+HT). 
Screening was performed to establish positive hybridoma wells by ELISA (Section  2.4) using 
either butanol extracted LPS (Section  3.2.1.2) or whole bacteria (Section  2.1.2) to coat the 
ELISA plate. 
The first screening took place two weeks after the fusion, and out of the 14 96-well plates 
approximately 100 wells were selected on the basis of the highest reaction with LPS in the 
ELISA. The media from these selected wells was changed and the cells were left to rest for two 
days. The clones were then resuspended and 150 µL of the suspension transferred to a 24-
well plate containing 1.5 mL of DMEM*+10% FCS and mouse red blood cells (0.3%) in each 
well. The strains used to immunize the mice were also used to coat the ELISA plates for the 
second screening. Between 15 and 20 hybridoma wells were selected based on highest optical 
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density by ELISA. These wells were cloned by adding 100 µL of resuspended cells to the top 
left well of a 96-plate, which contained 150 µL of DMEM*+10% FCS + mouse red blood cells 
(0.3%) in each well with an extra 150 µL in the first column. This was then diluted 1:2 down the 
8 wells of the first column before diluting across the plate (also 1:2) up to column 6. The same 
was done for the other half of the plate with another selected clone. 
After 4 days incubating at 37°C with 5% CO2, wells with a single clone were selected (ideally 6 
for each cloning). The third screening was carried out to select clones not only positive for the 
homologous strain used but also against different V. anguillarum serotypes. At this stage the 
positive and non cross-reacting clones, respectively, were re-cloned as described previously. 
Clones cross reacting with O2a and O2b isolates were also selected. The clones with the 
highest reaction in the ELISA were selected and stored in liquid nitrogen (Section  3.2.2.5). 
3.2.2.5. Freeze/Thawing of hybridomas 
Hybridomas with mid-log phase growth were harvested in 15 mL centrifuge tubes and 
centrifuged at 150 x g for 7 min. The cells were resuspended in DMEM*+20% FCS+10% 
DMSO to obtain a concentration of cells around 2 x106 cells.mL-1 and the media aliquoted into 
1.5 mL cryo-vials (Nunc, Thermo-Fisher), wrapped in bubble-wrap and placed at -70°C 
overnight. The following day the bubble-wrap was removed and half the cells were transferred 
to liquid nitrogen, the other half were kept at -70°C. 
In order to recover the hybridomas after storage at -70°C, the cryo-vial containing the 
hybridoma of interest was thawed in a 37°C water bath and immediately layered onto 1 mL of 
FCS and 9 mL of DMEM* (layered above the FCS) in a 15 mL tube. The tubes were 
centrifuged at 150 x g for 7 min and resuspended in 4 mL of DMEM*+20% FCS. The cells were 
then incubated in duplicate wells of a 24-well plate in 2 mL of medium.  
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3.2.2.6. Expansion and harvesting of mAb 
After 24h, the medium of the cells was changed, and after 4 days the cells were transferred to 
a 50 mL flask and 8 mL of DMEM*+10% FCS was added. The cells were checked after 4 days 
and if the growth was satisfactory the medium was replaced by 30 mL of DMEM*+10% FCS. 
After a few days the cells were rechecked and transferred to a 200 mL flask with 100 mL of 
DMEM*+10% FCS. From there, the cells could be grown continuously by transferring the cells 
to a new flask each week and refilling the “mother” flask with fresh medium. The medium was 
changed once on the “daughter” flask before leaving it for 10 days in the incubator to let the 
cells produce mAbs before dying. 
The mAbs were collected by centrifuging the contents of the flasks at 500 x g for 10 min in 50 
mL centrifuge tubes and the supernatant pooled together, aliquoted it into 50 mL centrifuge 
tubes and frozen at -20°C. When required, the mAbs were thawed and 0.01% thimerosal (w/v, 
Sigma-Aldrich) was added. The monoclonals were then kept at 4°C until used. 
3.2.2.7. ELISA and Western blot 
The entire bacterial collection (Section  2.1.1) was screened with the selected mAbs using the 
indirect ELISA method described in Section  2.4. The ELISA results are presented for this 
section as percent cross-reactivity (Table  3-1). These values were calculated for each mAb by 
subtracting the average background from the absorbance recorded for each strain and dividing 
the resulting value by the absorbance of the strain used to produce the mAbs in question, and 
then multiplying by 100. Reactions with over 75% cross reactivity were considered strongly 
positive and values between 30 and 75% cross reactivity considered weakly positive. 
In order to visualise the binding properties of the mAbs selected, as well as verifying that the 
LPS extraction method did not modify the banding patterns of the recognised bands, SDS-
PAGE (Section  2.2.1) and Western blotting (Section  2.3) were carried out using the selected 
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mAbs on selected bacteria, purified butan-1-ol extracted LPS and proteinase K treated whole 
bacteria (Hitchcock and Brown, 1983). 
3.3. Results 
3.3.1. Lipopolysaccharides extraction using butan-1-ol 
3.3.1.1. Yield of LPS extraction 
An average of 5 g of bacteria was collected for each of the 10 different bacterial isolates grown 
on TSA+NaCl covered with cellophane,. The average weight of LPS after extraction with butan-
1-ol from these isolates was 7.8 mg, making the average yield of LPS obtained by butan-1-ol 
extraction 1.56 mg of LPS per g of bacteria. 
The concentration of protein in the LPS preparations of VIB2 and VIB3 (after butan-1-ol 
extraction) was found to be 14.3 and 62.0 µg.mL-1, respectively, which corresponds to 0.6 and 
2.0% protein content in these samples. 
3.3.1.2. SDS-PAGE and Western blot profiles of proteinase K treated 
whole cell bacteria and butanol extracted LPS 
After treatment of whole bacteria with proteinase K, different LPS banding pattern was 
observed for each serotype as represented in Figure  3-2. Differences were evident between 
serotypes in their high molecular weight (HMW) and low molecular weight (LMW) LPS, which 
appeared as 2 distinct regions on the gels, separated approximately around 35 kDa. Each 
serotype can be easily differentiated on the basis of their LPS profile either on the HMW LPS 
region or the LMW LPS bands, but it has to be noted that there seems to be no differences 
between the LPS profiles of serotype O2a and O2b (Figure  3-4) and that the pattern of banding 
can vary slightly between strains of the same serotype (data not shown). Serotype O1 appears 
to have only one broad band in both the HMW and LMW LPS regions which is different from 
the laddering pattern typically observed in most serotype. The LPS of serotype O2 appears to 
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have the typically repetitive pattern in both the LMW and HMW LPS regions, also seen for 
serotype O3. The difference between these two serotypes seems to lie in the distribution of 
bands between the two different regions; both the HMW and the LMW LPS regions in serotype 
O3 profile less dispersed than that of the O2 LPS profile. Nevertheless the same number of 
bands, 6 to 7, is present for both these serotypes in the LMW LPS region. 
 
Figure  3-2 SDS-PAGE profile of proteinase K treated V. anguillarum O1 to O10 
serotypes (O8 missing) Silver stained (Section  3.2.1.4). Lanes: (1): VIB1 (O1); (2): VIB2 
(O2a); (3): VIB3 (O3); (4): VIB4 (O4); (5): VIB5 (O5); (6): VIB6 (O6); (7): VIB7 (O7); (9): 
VIB9 (O9); (10): VIB10 (O10). 
 
The profiles of the LPS extracted using butanol on SDS-PAGE are very similar to those 
obtained with proteinase K digestion (Figure  3-3). The bands present, for both treatments, in 
the HMW and the LMW LPS regions appear at the same location on the gel for serotype O2a 
(VIB2), i.e. the HMW LPS region lays between 37 and 55 kDa for both O2a samples and the 
LMW LPS region between 20 and 32 kDa. Both the regions for O3 LPS appear around the 
same molecular mass but show a narrower range. The spacing of each band within the HMW 
and LMW LPS also seem to correspond between the two preparation methods. The butanol 
extracted preparation appears cleaner than the proteinase K treated samples, with better 
definition of the bands, especially for the O2 samples.  
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Figure  3-3 SDS-PAGE profile of proteinase K treated and butanol extracted V. 
anguillarum Silver stained (Section  3.2.1.4). Lanes: (1) VIB2 protK (O2a); (2) VIB2 But 
(O2a); (3) VIB3 protK (O3); (4) VIB3 But (O3). 
 
On Figure  3-4, some bands in the profile are more easily distinguished in the butanol extracted 
LPS than in the proteinase K treated samples and some bands seem to be present only in the 
butanol extracted LPS as for the VIB7 (lane 3&4). It is impossible to distinguish between O2a 
(VIB2 or VIB72T) and O2b (VIB102) serotypes (Figure  3-4 lanes 1&2 or 5&6 and 7&8, 
respectively). Some protein or carbohydrate still appears to remain in the proteinase K treated 
samples (Figure  3-4, bottom of the gel, lanes 1, 3 and 7) resulting in poor resolution of the low 
molecular weight bands in this region. This intensely stained region at the bottom of the gel 
(<20 kDa) is also present in the VIB7 and VIB102 butanol extracted samples (lane 4 and 8) but 
was not evident in the butanol extracted LPS profiles of the VIB2 and VIB72T samples (lane 2 
and 6). 
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Figure  3-4 SDS-PAGE profile of proteinase K treated and butanol extracted V. 
anguillarum Silver stained (Section  3.2.1.4). Lanes: (1) VIB2 protK (O2a); (2) VIB2 But 
(O2a); (3) VIB7 protK (O7); (4) VIB7 But (O7); (5) VIB72T protK (O2a); (6) VIB72T But 
(O2a); (7) VIB102 protK (O2b); (8) VIB102 But (O2b). 
 
3.3.1.3. Western blot profile of extracted LPS 
The banding pattern observed for both the O2a and O2b serotypes in SDS-PAGE analysis  
using silver staining is clearly visible for both the proteinase K treated and the butanol extracted 
samples (Figure  3-5 A). The comparison between the SDS-PAGE (Figure  3-5, A) and the 
Western blot immunostained with O2a specific mAb (Figure  3-5, B) reveals a similar ladder 
pattern with the exception of the O2a isolate VIB2 butanol extracted LPS, where the mAb used 
bound to a HMW LPS higher than that visualised with the silver staining (red box).
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Figure  3-5 (A): SDS-PAGE gel Silver stained (Section  3.2.1.4) and (B) Western blot profile using O2a specific mAb (V.angO2a mab3)on proteinase K 
treated (protK) and butanol extracted  (But) V. anguillarum. Lanes: (1) VIB2 protK (O2a); (2) VIB2 But (O2a); (3) VIB72T protK (O2a); (4) VIB72T But 
(O2a); (5) VIB102 protK (O2b); (6) VIB102 But (O2b). 
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3.3.1.4. Semi-quantification of LPS by SDS-PAGE 
The extracted LPS were used to estimate the total amount of LPS in a given sample by running 
different concentrations of the purified LPS (of known concentration) by SDS PAGE, and 
comparing band profile intensity with these of a whole bacterial cell sample after silver staining. 
Comparison of the intensity of the LPS standards with the bands obtained with whole cell 
bacteria revealed that the whole cell sample (Figure  3-6, Lane 7) contained between 0.1 and 
0.2 mg.mL-1 of purified LPS (Figure  3-6, lane 6 and 5, respectively). The estimated amount of 
LPS in the sample was 0.15 mg.mL-1 and since it was diluted 1:5 after mixing it 1:1 in SDS 
sample buffer, this represents approximately 1.5 mg.mL-1 of LPS for the sample of VIB2 
bacteria at an OD of 1.0 (109 cfu.mL-1). 
 
Figure  3-6 SDS-PAGE profiles of butanol extracted LPS at different concentrations 
(mg.mL-1) and whole cell V. anguillarum VIB2 (O2a). Silver stained (Section  3.2.1.4). 
Lanes: (1): 2 mg.mL-1; (2): 1.5; (3): 1.0; (4): 0.5; (5): 0.2; (6): 0.1; (7): VIB2 whole cell 
sample at OD 1.0 (diluted 1:1 in SDS sample buffer and 1:5 in distilled water). 
 
3.3.1.5. Quantification of LPS in whole bacteria using purpald assay 
The purpald assay standard curve (Figure  3-7) using butanol extracted LPS gave a good linear 
correlation between the amount of LPS and the optical density measured (i.e. R2=0.99 for 
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VA33 isolate, O2a), confirming that the purpald assay can be used accurately for estimating the 
amount of KDO (and so LPS) in bacterial samples.  
The estimation of the amount of LPS in a given sample cannot be extrapolated from one isolate 
to the next, even if they are from the same serotype, since variations in the standard curve 
occurred between isolates (data not shown). Thus a standard curve needs to be constructed 
for each individual isolate investigated. 
Samples digested with proteinase K could not be analysed by purpald assay since this enzyme 
interfered with the reaction and the absorbance was too high to quantify. 
 
Figure  3-7 Standard curve of butanol extracted LPS in purpald assay using V. 
anguillarum O2a strain (VA33). 
 
The amount of LPS in any given sample can be calculated from the regression equation of the 
standard curve. For example, VA33 strain (O2a serotype) grown in TSB+NaCl overnight 
(Section  2.1.2), diluted to an OD of 1.0, contained 18 mg of LPS per mL of bacteria when 
compared to the corresponding butanol extracted LPS standard. 
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3.3.2. mAbs Results 
3.3.2.1. Monoclonal antibodies 
After the third cloning, 4 monoclonal antibodies were selected for the O1 antigen, labelled 
V.angO1 1.2, V.angO1 2.3, V.angO1 6.3 and V.angO1 7.2. After screening these four mAbs 
and checking their cross reaction against V. anguillarum serotype type strains O2 to O10, 
V.angO1 6.3 and V.angO1 7.2 were found to cross-react with most of the serotypes and were 
therefore not used for any further work (data not shown). The V.angO1 1.2 and V.angO1 2.3 
mAbs were found to react only with O1 type isolates and on the basis of the highest binding 
(data not shown), V.angO1 2.3 was selected as the anti O1 specific mAb. 
Ten mAbs selected from the O2a injected mice were found to cross-react (all of them) between 
the O2a and the O2b strains and no further selection was done. A mAb produced by Fuad 
Matori at the Institute of Aquaculture in 2001 against VIB72T (V.angO2a mab3) was used in 
this study since it was found to be specific to the O2a sub-serotype. 
The third screening for the O2b antigen led to 6 mAbs selected, V.angO2b 3.2, V.angO2b 5.5, 
V.angO2 6.3, V.angO2 7.1, V.angO2b 9.2 and V.angO2b 14.1. The mAbs V.angO2b 5.5, 
V.angO2b 6.3 and V.angO2b 14.1 were found to react only with the O2b type strain (data not 
shown). On the basis of the intensity of the reaction, V.angO2b 6.3 was selected as the mAb 
specific for O2b identification (data not shown). Both V.angO2b 3.2 and V.angO2b 9.2 cross 
reacted with both the O2a and the O2b type strains, but not with any of the O1 or O3 to O10 
type strains (data not shown). V.angO2b 3.2 gave a slight reaction with the O1 strains so taking 
this as a selection factor and on the basis of the intensity of the reaction; V.angO2b 9.2 was 
selected and renamed V.angO2a-b 9.2 since it cross-reacted with both sub-serotypes (data not 
shown). 
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The mAbs produced from the mouse injected with the O3 serotype type strain (VIB3) only 
reacted with this particular isolate and no other O3 isolates, so no further work was carried out 
with these mAbs. 
3.3.2.2. ELISA 
Generally, the results of the classification using the selected mAbs (Table  3-1) agreed with the 
serotypes of previously typed isolates obtained from the different sources (Section  2.1.1). 
There appeared to be some discrepancies regarding the classification of some isolates when 
first serotyped with the mAbs in the ELISA. Some isolates did not appear to belong to the 
serotype under which they had been classified by other researchers and were therefore re-
grown from frozen stock (Section  2.1.3.1) to confirm their classification. The results obtained 
after this second screening agreed with the initial results found with the mAbs. 
Out of the 38 isolates previously classified as O1, 4 were found to be misclassified using this 
set of mAbs (10.5% of the total of O1 strains) and 15 unclassified isolates were found to belong 
to the O1 serotype. The anti-O1 mAb (V.angO1 2.3) generally had a strong reaction in the 
ELISA, the majority of the cross reactivity values were greater than 75% (true positive), weak 
positive values were obtained for isolates VA14, VIB269, VIB64, VA21, VA35 and VA61. Only 
one isolate was just under the cut off value for weak positive, VA59 (25.6% cross reactivity), it 
was recovered from Japan in 2006 and might be a related organism. VIB269 was a Canadian 
isolate collected in 1968 (Evelyn, 1971) and could have changed over the numerous years of 
sub-culturing. 
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Table  3-1 Percentage cross-reactivity of the anti-V. anguillarum monoclonal antibodies (Anti O1: V.angO1 2.3; Anti O2: V.angO2a-b 9.2; Anti 
O2a: V.angO2a mab3; AntiO2b: V.angO2b 6.3) with the V. anguillarum collection by ELISA. 
Isolate Serotype Anti O1 Anti O2 Anti O2a Anti O2b  Isolate Serotype Anti O1 Anti O2 Anti O2a Anti O2b 
VIB1 O1 100.0 6.8 6.9 4.9  VIB68 O1 105.1 3.9 2.6 1.3 
78 skid O1 88.3 2.6 1.6 1.2  VA45 O1 100.6 4.7 1.8 1.1 
VA10 O1 96.8 3.1 2.0 1.4  VA47 O1 85.0 0.4 0 0 
VA12 O1 75.7 4.0 2.1 0.7  VA17 Untyped 88.8 0 3.4 0 
VA13 O1 83.5 0.3 0.8 0  VA18 Untyped 82.9 4.2 5.5 0.8 
VA14 O1 63.0 3.7 2.2 0.4  VA20 Untyped 89.4 3.8 2.4 1.4 
VA15 O1 83.2 3.0 2.2 0.5  VA21 Untyped 68.6 4.3 5.5 1.2 
VA16 O1 96.5 6.0 2.1 3.1  VA22 Untyped 98.6 7.5 3.2 1.0 
VA24 O1 123.3 10.0 2.1 8.1  VA23 Untyped 107.8 4.9 3.0 1.9 
VA40 O1 109.7 3.4 5.0 0.9  VA35 Untyped 71.8 2.5 1.4 1.4 
VA41 O1 95.6 3.3 1.0 0  VA58 Untyped 91.9 2.8 1.6 1.0 
VA42 O1 121.5 4.6 2.3 0.9  VA59 Untyped 25.6 2.7 1.1 0.7 
VA43 O1 91.4 3.4 2.0 1.4  VA60 Untyped 88.1 5.9 1.2 0.4 
VA44 O1 106.4 4.8 4.9 1.9  VA61 Untyped 45.9 3.9 3.3 1.1 
VA46 O1 102.6 3.9 3.2 0.6  VA62 Untyped 80.2 2.7 2.0 0 
VA48 O1 97.1 5.0 1.2 1.8  VA64 Untyped 101.0 4.9 4.5 0.9 
VA57 O1 103.9 4.8 5.5 0.1  VA66 Untyped 102.4 3.7 2.9 1.2 
VIB134 O1 91.3 2.8 1.8 1.6  VA67 Untyped 93.0 3.1 1.3 1.8 
VIB135 O1 103.4 2.0 0.1 0  VIB126 O1 1.2 0.4 0.5 1.3 
VIB226 O1 92.0 3.5 1.7 1.3  VIB195 O1 1.8 2.5 1.5 0.6 
VIB227 O1 88.6 3.1 1.5 0.9  VIB217 O1 0 0 0 2.1 
VIB236 O1 96.8 3.6 3.2 1.1  VIB266 O1 0.8 1.6 2.3 0.8 
VIB238 O1 91.1 3.1 2.5 0.8        
VIB253 O1 93.9 3.3 0.8 0.9  VIB2 O2a 0 77.8 61.2 3.9 
VIB269 O1 34.9 1.4 0.9 0.3  VA25 O2 7.5 85.4 67.3 0 
VIB546 O1 75.4 4.3 3.3 2.6  VA27 O2a 3.6 82.5 72.8 1.9 
VIB549 O1 100.9 0 0 0  VA33 O2a 1.1 79.1 74.7 31.0 
VIB605 O1 124.8 9.6 2.3 2.3  VA36 Untyped 8.2 84.9 66.8 6.2 
VIB64 O1 66.5 1.7 0.8 0.9  VA56 O2 2.4 101.2 66.5 1.4 
VIB65 O1 83.2 4.7 4.1 0.4  VIB242 O2a 4.3 98.6 64.2 0.2 
VIB67 O1 91.9 2.2 1.3 0.5  VIB2A O2a 11.3 88.7 66.8 2.9 
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Table 3-1 Percentage cross-reactivity of the anti-V. anguillarum monoclonal antibodies (Anti O1: V.angO1 2.3; Anti O2: V.angO2a-b 9.2; 
Anti O2a: V.angO2a mab3; AntiO2b: V.angO2b 6.3) with the V. anguillarum collection by ELISA (Cont.) 
Isolate Serotype Anti O1 Anti O2 Anti O2a Anti O2b  Isolate Serotype Anti O1 Anti O2 Anti O2a Anti O2b 
VIB2B O2a 16.0 111.3 88.5 11.9  VA9 O2 1.6 1.1 0.2 0.6 
VIB72T O2a 9.4 84.7 100.0 8.9  VA70 O2a 0.08 0 0 0.08 
VIB77 O2 5.4 107.3 63.6 0  VA74 O2c 0 2.16 0.43 0.11 
VIB98 O2a 10.8 92.4 83.9 3.9  VA75 O2c 0 0.64 0.25 0.66 
VIB99 O2a 8.6 99.1 80.5 2.4  VA76 O2c 3.32 0.66 0.45 0.05 
VA68 O2a 0 72.92 57.54 1.83        
VA69 O2a 0 54.64 49.87 0.74  VIB3 O3 0.5 3.5 1.9 2.2 
V4 V. ordalii 0 91.7 70.0 5.6  VA11 O3 2.6 1.9 1.0 1.4 
VIB102 O2b 4.8 100.0 1.3 100.0  VA8 O3 0.8 3.1 1.2 0.9 
VIB102A O2b 0 85.9 0 84.2  VIB111 O3 2.0 1.8 0.3 0 
VIB102B O2b 2.6 104.0 2.0 96.4  VIB604 O3 0.8 3.2 1.9 1.0 
VIB103 O2b 0 77.8 0 121.3        
VIB103A O2b 5.5 99.4 1.9 102.6  VIB4 O4 2.4 3.5 1.3 0.8 
VIB104 O2b 0.5 87.3 1.5 86.4  VA49 O4 3.5 4.0 1.7 1.0 
VIB105 O2b 1.2 80.4 2.2 80.0  VIB114 O4 4.6 4.8 3.9 1.5 
VA34 O2b 5.1 105.4 6.3 69.1        
VA64 Untyped 3.6 82.4 3.5 83.8  VIB5 O5 3.0 4.4 2.5 1.0 
B02061 Untyped 7.2 104.4 3.9 103.3  VIB118 O5 3.6 4.7 1.6 1.8 
B03064 K1 Untyped 7.2 91.1 2.4 91.8        
B03064 Lesion Untyped 8.2 95.2 2.3 84.5  VIB6 O6 6.2 2.1 0.9 3.1 
B03068 Untyped 3.3 92.8 2.0 97.9        
VA71 O2b 0.61 83.17 1.84 77.78  VIB7 O7 2.9 3.1 1.4 1.4 
VA72 O2b 6.68 82.35 3.56 86.42  VIB122 O7 2.9 3.3 2.0 1.2 
B01103 2(1) Untyped 3.2 99.0 4.3 2.1        
B01103 5-4 Untyped 3.6 95.7 2.4 2.0  VIB8 O8 5.5 3.0 1.6 1.0 
B02006 SLC1 Untyped 6.6 92.9 0.9 1.4        
VA73 O2b 0.34 67.43 0.82 0.96  VIB9 O9 6.0 2.4 0.9 1.3 
VA5 O2a 0 0 0 0        
VIB100 O2a 0 1.0 1.8 0.6  VIB10 O10 2.3 4.3 0.9 1.4 
VIB140 O2a 0.5 2.6 1.3 1.1        
VA7 O2 1.1 2.8 2.0 0.7  VA37 O11 4.8 2.6 0.8 1.2 
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Table 3-1 Percentage cross-reactivity of the anti-V. anguillarum monoclonal antibodies (Anti O1: V.angO1 2.3; Anti O2: V.angO2a-b 9.2; 
Anti O2a: V.angO2a mab3; AntiO2b: V.angO2b 6.3) with the V. anguillarum collection by ELISA (Cont.). 
Isolate Serotype Anti O1 Anti O2 Anti O2a Anti O2b  Isolate Serotype Anti O1 Anti O2 Anti O2a Anti O2b 
VIB606 O11 5.5 2.6 1.3 0.9  VIB149 VaNT2 4.9 5.6 7.2 1.3 
       VIB82 VaNT2 5.2 2.9 1.6 0.8 
VA38 O12 6.2 2.9 2.3 1.2        
       VA4 Untyped 4.4 3.1 0.9 2.0 
VA39 O13 4.0 5.0 0.6 1.1  VA50 Untyped 3.2 2.8 1.3 1.8 
VIB608 O13 4.5 1.6 1.1 1.1  VA51 Untyped 3.2 2.9 1.0 1.6 
       VA52 Untyped 1.6 2.4 0.9 0.3 
VA31 O17 5.9 2.4 17.5 3.0  VA53 Untyped 3.2 3.7 2.5 1.8 
       VA6 Untyped 7.6 2.4 0.6 0.8 
VIB127 O18 13.2 2.2 1.0 0.8  VIB130 Untyped 9.7 2.6 0.6 1.2 
VIB216 O18 3.1 5.0 4.2 1.6  VIB547 Untyped 11.6 2.2 1.1 2.2 
       VIB555 Untyped 2.2 2.1 1.4 0.6 
VIB129 O19 5.6 2.5 0.6 0.4  VIB558 Untyped 0.8 0.7 0.0 0 
VIB215 O19 5.6 1.6 0.4 1.5  VIB66 Untyped 6.7 1.4 0.4 0.6 
       VIB808 Untyped 8.4 2.4 2.3 1.2 
VIB197 O20 6.5 3.5 2.0 1.8        
VIB198 O20 3.8 3.2 3.2 2.0  V10 V. ordalii 5.3 2.6 1.3 1.0 
VIB199 O20 5.3 2.5 0.9 1.2  V11 V. ordalii 7.4 3.8 1.6 1.0 
VIB200 O20 3.2 4.8 2.2 1.1  V5 V. ordalii 4.2 15.0 19.0 2.0 
VIB201 O20 3.0 3.2 1.3 0.8  V6 V. ordalii 10.9 1.9 1.3 1.6 
VIB202 O20 3.9 3.2 4.9 0.6  V7 V. ordalii 1.2 5.9 7.5 2.4 
       V8 V. ordalii 0.8 11.7 16.2 1.8 
VA29 O21 2.4 5.3 4.2 1.5  V9 V. ordalii 5.2 2.4 1.6 2.6 
VA30 O21 3.4 2.7 0.8 1.0        
       V1 V. carchariae 3.1 3.4 2.5 1.6 
VA32 O22 3.6 2.4 0.8 0.2        
       V3 V. vulnificus I 2.8 2.9 1.6 0.4 
VIB128 VaNT2 2.3 4.0 1.0 0.8  V2 V. vulnificus II 2.9 2.7 0.9 0.8 
VIB141 VaNT2 3.4 4.0 1.8 1.0        
VIB142 VaNT2 2.1 5.3 4.5 0.5  V12 V. harveii 3.3 1.3 0.0 1.0 
 
Dark grey cells: true positives, light grey cells: weak positives (Section  3.2.2.7). Isolates in bold are strains used for the preparation of the mAbs, VIB1, VIB72T and VIB102. 
Average absorbance at OD of 450, VIB1 Anti O1: 1.24; VIB72T Anti O2: 1.18, Anti O2a: 1.77; VIB102 Anti O2: 1.37, Anti O2b: 1.31 
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Regarding the classification of O2 serotype isolates, 21 isolates previously classified as O2 
grouped with this serotype; 7 were added (5 O2b, 1 O2a and one isolate previously classified 
as Vibrio ordalii re-classified as O2a), 3 were sub-typed (previously known as O2, 2 were O2a 
and 1 O2b) and 6 were found to have been misclassified in the O2 sero-group, which 
represents 13.6% (6/44) of the isolates from this group. None of the 6 misclassified isolates 
reacted with any mAbs used. The three isolates classed as O2c did not react either with any of 
the monoclonal antibodies used in this study. The majority of the isolates which reacted with 
the O2 specific mAb (V.angO2a-b 9.2) reacted with either the O2a or the O2b specific mAb, 
confirming that this antibody reacted with both sub-serotypes. There were 4 isolates, B01103 
2(1), B01103 5-4, B02006 SLC1 (recovered from Atlantic cod, Machrihanish fish farm, Argyll, 
Scotland) and VA73 (recovered from Atlantic cod, Norway), which reacted with the O2 specific 
antibody, but with neither the O2a nor the O2b mAbs. 
The overall reactivity of V.angO2b 6.3 and V.angO2a-b 9.2 was very good, with both of them 
reacting strongly with cross-reactivity percent over 75; reactions against V.angO2a mab3 were 
weaker but this was due to the very high absorbance of the VIB72T isolate used for calculating 
the cross-reactivity (1.77). The only weak positive values recorded for the anti-O2b mAb were 
for VA33, and VA34, both recovered from Atlantic cod in Norway. The isolate VA33 gave a 
higher result with the O2a mAb (74.7%) than with the O2b (31.0%) and was considered to 
belong to the O2a serotype, whereas the isolate VA34 was considered to belong to the O2b 
group. 
All the other isolates (non-O1 and non-O2), 18 groups and a group of untyped isolates, did not 
react significantly with any mAbs used in this study. 
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All the mAbs selected were tested against two non-Vibrio type strains Aeromonas hydrophila 
(V16-NCIMB 9240) and Edwardsiella tarda (V17-NCIMB 2034) and did not cross-react by 
ELISA with any of the selected mAbs (data not shown). 
3.3.2.3. Western blotting using the selected mAbs 
The anti-O1 mAb (V.angO1 2.3) did not react with any bacteria in Western blot analysis even 
with the strains known to be of an O1 serotype (data not shown). 
The anti-O2 mAb (V.angO2a-b 9.2) reacted with all the O2a, O2b and O2 strains tested, but 
not with the O1 strains (Figure  3-8, Lane 1 and 2). This mAb reacted the strongest with O2a 
isolates (lane 3 and 4) than with the O2b or the O2 non-O2a non-O2b strains (lane 5 to 8) as 
seen with the HMW LPS, between 75 and 200 kDa. The LMW LPS, between 20 and 35 kDa, 
was very similar for all the O2a, O2b and O2 strains, with around 7 distinct bands stained. A 
very low molecular weight non-protein molecule was also detected by V.angO2a-b 9.2 with a 
molecular weight below 15 kDa and was present in all O2a, O2b or O2 strains. 
 
Figure  3-8 Western blot of proteinase K treated V. anguillarum isolates with O2 specific 
mAb (V.angO2a-b 9.2). Lane1&2: O1, VIB1 & VIB227; 3&4: O2a, VIB2 & VIB72T; 5&6: 
O2b, VIB102 & VIB103; 7&8: O2, B01103 2(1)&B02006 SLC1. 
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Only O2a isolates were detected using the mAb specific for O2a serotype (V.angO2a mab3, 
Figure  3-9 A, lane 3 and 4) and no staining was detected against the O1, the O2b or the O2 
(non-O2a non-O2b)isolates. The HMW LPS were stained more strongly than on Figure  3-8, 
and the banding pattern extended lower, down to 55 kDa. The LMW LPS presented same 
staining pattern as with the V.angO2a-b 9.2 mAb (Figure  3-8), with 7 distinct bands  
The O2b specific mAb (V.angO2b 6.3) bound to HMW LPS on both of the O2b isolates (Figure 
 3-9 B, lane 5&6) which was not the case when the anti-O2 mAb was used (V.angO2a-b 9.2, 
Figure  3-8, lane 5&6). The staining of the O2b antibody was especially strong for the HMW 
LPS of the isolate VIB103 (lane 6). The number of LMW LPS bands stained seems to be lower 
than that detected using the V.angO2a-b 9.2 mAb, only 5 bands were detected by mAb 
V.angO2b 6.3. 
 
Figure  3-9 Western blot of proteinase K treated V. anguillarum isolates with A: O2a 
specific mAb (V.angO2a mab3); B: O2b specific mAb (V. angO2b 6.3). Lane1&2: O1, 
VIB1 & VIB227; 3&4: O2a, VIB2 & VIB72T; 5&6: O2b, VIB102 & VIB103; 7&8: O2, B01103 
2(1)&B02006 SLC1. 
 
None of the O2 strains (B01103 2(1) and B02006 SLC1) reacted with either the V.angO2a 
mab3 or the V.angO2b 6.3. 
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3.4. Discussion 
3.4.1. Lipopolysaccharides 
The most common method used for the extraction of LPS from Gram-negative bacteria is 
based on the procedure developed by Westphal and Jann (1965). It relies on the solubilisation 
of LPS in phenol by heating the samples to 60°C in a phenol solution, after which the solution 
is centrifuged to obtain a two-phase solution; the aqueous phase is then collected and 
concentrated. Phenol is a very dangerous chemical, which produces toxic fumes, burns the 
skin and has anaesthetic properties, thus an individual does not immediately feel the burns and 
severe injuries can occur. 
An alternative method to this dangerous procedure is the use of butan-1-ol to replace the 
phenol (Morrison and Leive, 1975). Butan-1-ol has the advantage of being much safer than hot 
phenol, and does not affect the biological activity of the LPS. 
The butanol extraction procedure used here was simple, rapid and gave satisfactory yields of 
LPS. Phenol extraction tends to give higher yields of LPS compared with butanol extraction 
(Morrison and Leive, 1975; Salmani et al., 2008). Bogwald and Hoffman (2006) extracted LPS 
using the phenol-chloroform method from V. salmonicida and obtained a yield of 1.5% (w/w) 
which is ten times higher than found here (0.16%) but they used dried bacteria compared to 
semi dry in our study, which might explain the high difference in the yields obtained. In addition, 
the amount of LPS on the surface of bacteria varies from species to species and serotype to 
serotype, such as for V. anguillarum serotype O2 and O3 (J-O-2) where 2% and 0.77% (w/w) 
of LPS were extracted by the phenol method (Eguchi et al., 1992a; Sadovskaya et al., 1996). 
The yield of LPS obtained with the butanol extraction method was low compared to phenol 
extraction, but could possibly be increased by permeabilising the membrane of the bacteria in 
order to release LPS molecules with enzyme treatment such as lysozymes (Salati and Kusuda, 
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1986) or proteinase K, prior to the extraction. Due to the amount of enzyme required, these 
pre-treatments are not feasible for the production of large quantities of LPS, such as in this 
study. The amount of bacteria used for the extraction could be increased by growing the 
bacteria in large volumes of broth instead of on cellophane sheets. Optimisation of LPS 
extraction of Brucella abortus using either phenol or butanol has recently been published 
(Salmani et al., 2008), with extraction yields improved by 70% and 17%, respectively, 
compared to the original methods (Westphal and Jann, 1965; Morrison and Leive, 1975). This 
optimised butanol extraction method was modified by the alternative use of ethanol 
precipitation followed by tri-chloro-acetic acid (TCA) treatment. The amount of LPS on the 
surface of the bacteria could also be increased by growing the bacteria in different media, for 
example supplemented with fish blood (Mutharia and Amor, 1994). The possibility that the two 
extraction methods could yield structurally different products could also explain the different 
yields recorded. However the products from both these extraction methods seem to be fairly 
similar (Morrison and Leive, 1975), with corresponding properties (chemical as well as 
immunological); the authors highlighted that butanol extraction is a milder procedure to phenol 
extraction with less denaturation of the LPS. 
Quantification of the LPS using the purpald assay, (Lee and Tsai, 1999) relies on the 
measurement of the amount of KDO. This method was found to be very reliable for the 
quantification of LPS in this study since the standard regression curve was very good 
(R2=0.99). The improved extraction protocol using butanol presented by Salmani et al. (2008) 
resulted in an increase of KDO molecule far higher than the increase in LPS extraction yield, 13 
times more KDO was observed for an increase in LPS yield of 17% only. This could imply that 
free KDO molecules, not covalently linked in LPS molecules, were present in the final product. 
Since purpald reacts with KDO molecules, it is possible if free molecules are present, that the 
total amount of LPS could be over-estimated. However, KDO are small molecules (estimated 
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molecular mass, 238 Da) and the use of a 10 kDa filter in the extraction procedure of this study 
should have removed free KDO molecules. 
The quantification of LPS using the purpald assay is very simple, rapid (only taking an hour), 
accurate and could be used to investigate the total amount of LPS present after culturing the 
bacteria in different growth or biological media. 
Butan-1-ol extracted LPS were used to screen the mAbs for V. anguillarum specificity, because 
this screening requires large amounts of antigen to coat the ELISA plates, and the use of 
purified LPS (at very low concentrations, 2.5 µg.mL-1) allowed a large number of 96-well plates 
to be coated without having to grow large quantities of bacteria for this purpose. 
The quality of the extracted LPS was satisfactory for our requirements. The profile of the 
butanol extracted LPS on SDS-PAGE was very similar to the whole cell LPS after proteinase K 
treatment and the use of mAbs specific to V. anguillarum LPS showed that the antigenicity of 
the butanol extracted LPS was conserved as shown by ELISA and Western blotting. 
Extraction of lipopolysaccharides using butan-1-ol is simple, fast and safe even if not leading to 
the highest yields. It would also be interesting to investigate the molecular structure of the LPS 
extracted by this method in comparison with the phenol extracted products by nuclear magnetic 
resonance (NMR) spectroscopy (Bogwald and Hoffman, 2006) to make sure that no structural 
modifications occur when using butanol. The use of LPS extracted with this method could give 
insights into the interaction of the bacterial LPS from different serotypes of any isolate of V. 
anguillarum with the cod immune system, such as the serum killing inhibition, the complement 
activation and cellular activation (respiratory burst priming). Bacterin vaccines for V. 
anguillarum elicit high protection in salmonids, but the specific immune system in cod does not 
seem to respond to these vaccines; injection of purified LPS into cod could prove very valuable 
from a protection point of view  (Salati et al., 1989). It is also possible that the lower antibody 
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response in ayu associated with low rearing temperature shown in this study could be linked 
with the metabolisation of LPS at low temperature. The possibility of injecting LPS extracted 
from different serotypes of V. anguillarum, in the form of a polyvalent vaccine, may also 
overcome antigenic competition, which sometimes results when a multivalent vaccine is used 
(Nikoskelainen et al., 2007). 
3.4.2. Monoclonal antibody characterisation 
The mAbs were produced by injecting different serotypes of V. anguillarum (O1, O2a, O2b and 
O3) as formalin inactivated whole cells into four mice. In order to cut the number of hybridomas 
to be cloned and to only select hybridomas producing antibodies which would be useful for the 
serotyping scheme, the mAb clones were screened with butan-1-ol extracted LPS. This allowed 
a selection of clones reacting only with the molecule of the serotypes of interest to be made. 
All the mAbs selected (anti O1-V.angO1 2.3; anti O2a-V.angO2a mab3; anti O2b-V.angO2b 
6.3; anti O2-V.angO2a-b 9.2) reacted with the LPS in ELISA, but the anti-O1 mAb did not react 
with any of the strains used by Western blot. This problem of loss of reactivity between ELISA 
and Western blot has been previously reported. Mutharia and Amor (1994) observed this with a 
rabbit pAb (cross reacting with O2a and O2b on ELISA) which lost reactivity with O2b on 
Western blot. Tiainen et al. (1997a) also reported that strains of an O2 serotype, reacting 
positively by slide agglutination with rabbit polyclonal serum, lost their reactivity when analysed 
by Western blotting using the same serum. The most likely explanation for this loss of reactivity 
is that the epitope recognised by ELISA had lost its conformation after treatment with SDS and 
so no longer reacts in Western blot. Since this mAb was selected against LPS, it is possible 
that an LPS-LPS or protein-LPS complex was lost during the Western blotting process 
(Mutharia and Amor, 1994). Another hypothesis is that the LPS from the O1 serotype bound 
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less efficiently (or did not transfer) on the nitrocellulose membrane as described for V. ordalii 
(Mutharia et al., 1993). 
The reaction of the different mAbs raised against the O2 sub-serotypes (V.angO2a mab3, 
v.angO2b 6.3 and V.angO2a-b 9.2) allowed a visualisation of specific regions of the different 
sub-serotypes. The fact that the anti-O2a-b mAb reacted with the LMW region of the LPS 
indicates that this was a common region between all of the O2 isolates. This mAb also reacted 
with a band lower than the repetitive pattern found at the very bottom of the gel (around 10-15 
kDa), which could be the lipid A-core oligosaccharide. This is supported by Chart and Trust 
(1984) who showed that the shared epitopes between V. ordalii and V. anguillarum O2 are 
mostly localised in the very low molecular region on SDS PAGE with a molecular weight of 15 
kDa (also described by Mutharia et al., 1993).The anti-O2a-b mAb also reacted with some of 
the HMW LPS of the O2a strains which means that the binding epitope is also expressed in this 
region. This reaction was unexpected since this mAb was prepared using an O2b strain and so 
it would be more logical that it would react with the HMW LPS from only this sub-serotype. Both 
the anti-O2a (V.angO2a mab3) and the anti-O2b (V.angO2b 6.3) mAbs recognised both the 
HMW and the LMW LPS regions on each respective sub-group. Thus, from these results, the 
sub-grouping specificity appears to lie in the HMW part of the LPS, and the LMW region of the 
LPS is identical in these strains, as described by Mutharia et al. (1993). This was also observed 
by Espelid et al. (1991) who found that 2 out of 3 mAbs they produced were specific for a sub-
group of O2 reacting in the HMW LPS region of the profile, and the one cross-reacting between 
those sub-groups reacted mostly with the LMW LPS region. 
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3.4.3. Serological classification of V. anguillarum 
The analysis of 154 different bacteria, 143 belonging to V. anguillarum and 11 to other Vibrio 
species, gave a good correlation between the anticipated results and the reactions actually 
obtained using the selected mAbs described previously. 
As described in Section  3.1.3, V. anguillarum O2 serotype has been reported to possibly have 
a third sub-group, but on analysis of the studies by Espelid et al. (1991) and Mikkelsen et al. 
(2007), it seems that actually 4 groups could be discerned in the O2 serotype, the O2a sub-
group, the two sub-groups of O2b described by Espelid et al. (1991) and another different 
group described by Mikkelsen et al. (2007). 
Regarding the results obtained during this study, a third group of Vibrio anguillarum belonging 
to the O2 serotype was found, which reacted positively to the mAb V.angO2a-b 9.2 but neither 
with the O2a or the O2b specific antibodies. These isolates (B01103 2(1); B01103 5-4, B02006 
SLC1 and VA73) were all isolated from vaccinated cod that died of suspected vibriosis. The 
comparison of these isolates with the O2c strain (non-O2a non-O2b strains from Norway, kindly 
provided by Dr Duncan Colquhoun), revealed that these 4 isolates did not belong to the O2c 
sub-group since none of these reacted with any of the mAbs used in this study. For the ease of 
analysis, this group (O2 but non-O2a non-O2b highlighted in this study) was labelled O2d. The 
O2d group identified in this study has not been previously reported, and could very well be 
related to the third group mentioned by Espelid et al. (1991), however, further investigation is 
required to determine this. It should be noted that in the study by Mikkelsen et al. (2007), this 
group of strains were not given a name but rather described as non-O2a non-O2b and that we 
used in this study the name O2c for facilitating the discussion. Furthermore, the O2c sub-group 
found was grouping quite far apart from the O2a and O2b serotype strains when analysed by 
AFLP. From the results of our study, we have doubts whether the O2c sub-serotype should be 
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grouped within the O2 serotype; it could represent another serotype (maybe O24). It would be 
very interesting to investigate the AFLP dendrogram of the O2d sub-group to see if these 
isolates are grouping close to the O2a and O2b strains. It is also imperative to screen the 
strains used from these different studies (Espelid et al., 1991; Knappskog et al., 1993; Tiainen 
et al., 1997a; Mikkelsen et al., 2007), using the mAbs developed here, to ensure that these 
groups are well characterised. 
It is important to have a fuller understanding of the classification of the O2 isolates of V. 
anguillarum involved in cod disease. To do this, it is necessary to screen as many isolates from 
this group as possible, especially from Scandinavian countries, where cod aquaculture is an 
important economical activity. This study revealed some unsuspected differences between the 
isolates which compose the O2 serotype of V. anguillarum. Since the isolates grouping within 
this possibly new O2d sub-serotype were recovered from diseased fish, this finding could be of 
significant importance for vaccine formulation as well as epidemiological studies. 
The lipopolysaccharide extraction method presented here was successful at producing LPS for 
the purpose of screening mAbs. The quality of these extracted products was also satisfactory 
for its application to other areas of fish immunology. The mAbs developed during this study will 
be useful for examining the prevalence of different serotypes of V. anguillarum involved in the 
vibriosis outbreaks recorded in vaccinated cod in Scandinavia, as well as more basic diagnostic 
tools for the rapid screening of isolates. 
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Chapter 4. 
 
Study of the pathogenicity of Vibrio anguillarum in 
vitro in Atlantic cod 
 
4.1. Introduction 
The Vibrio inactivated whole cell  vaccine is considered the most successful vaccine in marine 
aquaculture (Sakai, 1999), however, protection of Atlantic cod against V. anguillarum has not 
been as straight-forward as for salmonids, and after a decade of research, outbreaks are still 
occurring in vaccinated fish (Hellberg et al., 2005-2006-2007; Mikkelsen et al., 2007). The 
formulation of vaccines to protect cod more efficiently against V. anguillarum will require a 
better understanding of the virulence mechanisms employed by the bacterium and the 
elucidation of how the cod immune system responds to Vibrio infections. 
Fish rely on their innate immune system more than their mammalian counterparts, possibly 
because of their more ancient origin (Magnadottir, 2006) or due to different evolutionary 
pathways. The development of acquired immunity in cod following infection with V. anguillarum 
has still not been fully elucidated (Section  1.3.2.5) and due to the importance of innate 
immunity in this species for pathogen clearance (Magnadottir, 2006), it is clear that further 
investigations are needed into the innate immune response of cod to V. anguillarum. 
4.1.1. Innate immune response 
Destruction of bacteria by phagocytic killing is a major mechanism in the prevention of 
colonisation of pathogenic bacteria (Stuart and Ezekowitz, 2005). Phagocytosis involves the 
ingestion and intracellular destruction of microbial pathogens, as well as apoptotic host cells 
and debris (Ernst, 2000; Djaldetti et al., 2002; Heale and Speert, 2002; Stuart and Ezekowitz, 
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2005). As previously mentioned in Section  1.3.1.1 and  1.3.2.3, the non-specific nature of 
phagocytosis is a very important feature of cod defence mechanisms. The ingestion of bacteria 
involves the attachment of the bacterium by the phagocytic cell and its intake within a 
phagosome (Secombes, 1996). The recognition of common antigens on the surface of 
bacteria, i.e. PAMPs by PRRs, activates the engulfment processes, involving actin 
polymerization (Heale and Speert, 2002). Once internalised, phagocytic and lysosomic 
granules migrate and fuse together to form a phago-lysosome (Ross and Auger, 2002). 
Bacterial killing in the phago-lysosome can occur through two separate processes: oxygen 
dependant or independent mechanisms which take place within the first hour of internalisation 
for most animal species. The lysosome fuses with the phagosome (acidification) within 15 
minutes of ingestion in mammals (Ross and Auger, 2002). Reactive oxygen species (ROS, 
oxygen dependant) are produced in the phago-lysosome by the reduction of oxygen to 
superoxide anion (O2-) and hydrogen peroxide (H2O2) catalysed by NADPH (Babior, 1984). The 
oxygen free radicals are very toxic to bacteria through damage to their cell membranes and 
DNA (Hampton et al., 1998). The resting level of those ROS can be greatly increased through 
the activation effect of several chemicals (Section  1.3.2.3). Another type of oxygen dependant 
molecule used by the cells for bacterial killing is nitric oxide species (NOS) and its 
intermediates. It has been shown that, as for ROS, the basal level of NOS can be increased 
after cell activation by LPS and IFN-γ (Nathan and Hibbs Jr, 1991). Nitric oxide, which itself is 
not particularly toxic, can lead to the production of more toxic substances such as peroxidising 
(OH-), nitrating (NO2) or nitrosating (N2O3) species. These are toxic to bacteria by inactivating 
DNA and proteins and have the ability to damage membrane integrity (Kaplan et al., 1996). 
Oxygen-independent processes of the cellular innate immunity are also involved in the killing of 
bacteria within the phago-lysosome, such as the acidification of the vesicle, sequestration of 
iron or other nutritional requirements of the bacteria (Heale and Speert, 2002). In addition, 
  100
antimicrobial peptides (elastases, collagenases, lipases, sulfatases, phosphatases and 
defensins) present in the lysosome are able to form pores in the bacterial membrane (Heale 
and Speert, 2002) and cationic proteins and various enzymes such as lysozymes and 
hydrolytic molecules are also involved (Wilson et al., 2002). 
The humoral innate immunity is also heavily involved in the defences against pathogens. 
Complement is probably the main component in the serum to interact with bacteria, and is a 
much more ancient system than the adaptive immune response (Nonaka, 2001). The function 
of this system in mammals is to provide antimicrobial substances to (i) bind to particles and 
enhance their phagocytosis through opsonisation, (ii) enhance inflammatory events through 
production of chemo-attractants (anaphylotoxins) and antibody formation and (iii) directly kill 
the bacteria by the lytic complex (Wilson et al., 2002). Briefly, complement acts in several ways 
but the C3 molecule seems to have a central role; when activated, it splits into C3a (binding to 
leukocytes and initiating an inflammatory response) and C3b (opsonising the pathogen 
recognised); the membrane attack complex (MAC), a combination of C5 to C9 molecules can 
also directly lyse the micro-organism (Boshra et al., 2006). The complement of Atlantic cod 
does not seem to present multiple forms of the C3 molecules as found in other fish species 
(Olivier et al., 1992), although this study is not conclusive and more research is needed to 
confirm it. Complement is however not the only component in serum that has antimicrobial 
properties (Section  1.3.1.1). Cod serum has been reported to have some peculiar 
characteristics compared to other bony fish (Section  1.3.2.4) such as its haemolytic activity or 
the lack of lysozyme activity. The opsonisation of normal cod serum has been shown to be 
poorer, compared to rainbow trout serum, regarding the increase in respiratory burst levels 
against Aeromonas salmonicida (Nikoskelainen et al., 2006), but this could be due to the 
specific immune system differences in these two fish rather than due to complement. This 
bacterium was also reported to be resistant to cod serum (Magnadottir, 2000), which could be 
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due to a specific avoidance of C3 binding (Rautemaa and Meri, 1999). Nevertheless, cod 
serum has some strong antimicrobial properties that have been shown to be drastically 
increased by vaccination with V. anguillarum (Section  1.4.2). 
4.1.2. Evasion of the immune system by Vibrio anguillarum, 
virulence factors 
The definition of pathogenesis according to the online Oxford English dictionary is: “The 
production or development of disease; the events occurring during the development of a 
particular disease; the mechanisms whereby a disease is produced” (http://www.oed.com). 
The evolution of pathogenic bacteria and the counter-measures developed by the immune 
system of fish is a two-way process, the goal of which is ultimately the survival of the host or 
the pathogen (Wilson et al., 2002). There are a few requirements in order for a pathogenic 
bacteria to create a disease in its host,: (I) once in contact with its host, the pathogen needs to 
establish itself in the host; (II) it must then avoid being destroyed or expelled by the host’s 
immune system and at the same time obtain essential nutrients for its survival; (III) it must 
escape from its host for transmission to another individual (Wilson et al., 2002). 
There are hundreds of different mechanisms that bacteria use to survive attack by the immune 
system, maybe as many as there are ways of the immune system defending itself against 
pathogens, as shown in Figure  4-1. 
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Figure  4-1 Different strategies of pathogenic bacteria to avoid host immune defences 
(Wilson et al., 2002). 
 
Pathogenic bacteria manipulate the cells and humoral components of the host’s immune 
system in order to survive. Most of the mechanisms used rely on secreted or membrane-bound 
chemicals and target mainly the cytoskeleton or the intracellular signalling pathway of the cell 
(Bhavsar et al., 2007). Manipulation of the host cell sometimes involves the injection of 
specialised effector molecules to subvert the machinery of the cell such as YopH (potent 
phagocytosis blocking agent) through Type III Secretion System (T3SS) (Cornelis and Wolf-
Watz, 1997; Frihtz-Lindsten et al., 1997), or the disruption of the nuclear factor (NF) -κB 
regulatory pathway by T3SS molecules (Bhavsar et al., 2007). 
Bacteria can inhibit phagocytosis (reviewed in Wilson et al., 2002) by either direct interaction 
with the cell, blocking internalisation (Ernst, 2000) or the oxidative killing once it is internalised 
(Buchmeier and Heffron, 1991; Bliska and Black, 1995). Processing pathways resulting in the 
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presentation of antigens on the surface of the phagocytic cells can also be blocked (Noss et al., 
2001) and sometimes the phagocytic cells can be destroyed through apoptosis (Bhavsar et al., 
2007). Inhibition of the binding of complement molecules is also a common mechanism of 
many bacteria to avoid opsonisation and phagocytosis. Avoidance of complement binding is 
therefore another very important virulence factor encountered in many pathogens and as 
shown in Figure  4-1, bacteria have evolved many systems to inhibit (active) or avoid (passive) 
the killing mechanisms in serum (reviewed in Rooijakkers and Strijp, 2007). These mechanisms 
are intimately linked to surface molecules that help protect the integrity of the bacterium, such 
as sialic acid, and LPS molecules (reviewed in Boshra et al., 2006). 
Vibrio anguillarum is highly pathogenic to many fish species (Section  1.2.2) and is easily 
cultured in vitro (Section  2.1.1), making it a very good model for host-pathogen interactions. 
However, most of the studies of this pathogen have concentrated on the immune response of 
the fish to the pathogen using dead bacteria, so little is known about the defence mechanisms 
of the live pathogen. Phagocytic cells from many different fish species have been shown to be 
capable of phagocytosing V. anguillarum e.g. sea bream (Sparus aurata L.) (Esteban et al., 
1998), Coho salmon (Oncorhynchus kisutch) (Balfry et al., 2001), rainbow trout (Lamas et al., 
1994) and sea bass (Dicentrarchus labrax L.) (Sepulcre et al., 2007). Very few studies have 
compared the pathogenic mechanisms between live isolates of the same species (between or 
within serotypes). Boesen et al. (2001) studied the interaction of different live isolates of V. 
anguillarum (O2a) with trout leukocytes, while a few other studies can be found using other fish 
pathogens such as Edwardsiella tarda (Ishibe et al., 2008), Aeromonas salmonicida 
((Karczewski et al., 1991; Olivier et al., 1992; Lamas and Ellis, 1994), Photobacterium 
damselae subsp. piscicida (Skarmeta et al., 1995). 
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Some strains of V. anguillarum are able to resist trout serum killing (Boesen et al, 1999) and 
some of the growth inhibitors present in serum, such as the mechanisms resulting in iron 
sequestration through the presence of the plasmid pJM1 (Crosa et al., 1977) or its 
chromosomal equivalent (Toranzo et al., 1983). However, other mechanisms are involved in 
serum resistance as shown by the work of Trust et al. (1981) with V. anguillarum mutant 
isolates. Differences in the resistance of different serotypes of V. anguillarum to serum killing 
has also been shown, with O1 being sensitive to killing via the classical complement pathway 
(antibody mediated) and O2a seemingly resistant (Boesen et al., 1999). A good correlation was 
found between the resistance of V. anguillarum to serum killing and pathogenicity (Austin et al., 
1995; Boesen et al., 1999), showing that resistance to serum is one of the main mechanisms 
involved in the progress of the disease. The influence of LPS in resistance to serum killing has 
been clearly shown, through the use of LPS-deficient mutants (Welch and Crosa, 2005) as well 
as the use of different growth media (Section  3.1.2). 
Protease activity of V. anguillarum has also been investigated (Zhang et al., 2006) and it was 
reported that strains grown in gastrointestinal mucus of Atlantic salmon produced five de novo 
proteins of which four form part of the membrane fraction of V. anguillarum (Garcia et al., 
1997). Using the same type of experiment, a nine-fold increase in the extracellular protease 
activity was reported compared to bacteria grown in bacteriological media (Denkin and Nelson, 
1999). It is still unclear if protease secretion by the bacterium is directly linked to virulence 
since contradictory results have been published using protease deficient mutants (Norqvist et 
al., 1990; Milton et al., 1992). 
4.1.3. Assessment of virulence and pathogenicity 
The use of in vitro assays is becoming more common for studying the pathogenesis of bacteria 
due to advances in cellular and molecular techniques, as well as the pressure on scientists to 
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reduce, replace and refine the use of animals in experimental work (UK Home Office, Animals, 
Scientific Procedures Act, 1986). Moreover, conventional assays to study the pathogenesis of 
bacteria in vivo are costly. Although in vitro assays are unlikely to completely replace testing in 
vivo, they can offer a valuable alternative. 
In the last 30 years, the techniques used to investigate bacterial pathogenicity have come a 
long way from toxicity studies examining cell survival to nowadays more elaborate experiments 
where thousands of genes expressed in response to infection are measured using micro-
arrays. The use of knockout animals has also greatly increased the understanding of the 
pathways and interactions taking place in healthy and diseased animals. 
Flow cytometry is a fairly recent technology (dating from the early 80s) which allows the 
properties of individual particles to be examined (in most cases cells, but bacteria can also be 
analysed) (Sklar, 2005). It is based on the principle of acquiring information on single particles 
in a sample regarding their ability to scatter light emitted from a laser source. Light scatter is 
recorded by two detectors, a Forward Scatter Channel (FSC) where the intensity of the light 
detected provides information about the size of the cell, and a Side Scatter Channel (SSC) 
which provides information about the granular content of the particles (Shapiro, 2003). A 
number of other channels detect fluorescence at specific wavelengths. The specific binding of 
fluorochrome-associated molecules onto cells allows a very wide range of applications such as 
the identification and quantification of distinct populations of cells, detection of particular 
markers within or on the cell surface, quantification of biological processes, and studies on 
nucleic acids or apoptosis. 
The advantages of flow cytometry are numerous, but the speed of measurements (up to 50,000 
cells per sec, potentially 100,000 samples a day) and the possibility of multiplexing the assay (4 
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different lasers recording simultaneously different fluorescent markers) can allow a huge 
number of highly statistically relevant parameters to be measured (Sklar, 2005). 
Many areas of biology can find an application for flow cytometry (e.g. diagnostics, therapeutics, 
agriculture, reproductive biology, protein engineering, etc…) and immunology and bacterial 
pathogenesis research have benefited immensely from the data acquired by flow cytometry 
(Valdivia and Falkow, 1998). Investigations of phagocytic activity by labelling bacteria with 
fluorescent dyes (commonly FITC but other dyes are available, Drevets and Elliott, 1995) and 
discriminating between internalised (phagocytosed) and adhered bacteria (through the use of 
quenching (Van Amersfoot and Van Strijp, 1994) or inhibiting agents (Steinkamp et al., 1982; 
Mansfield et al., 2000), has generated data that has contributed to a better understanding of 
the interaction between pathogenic bacteria and the immune system (Lehmann et al., 2000). 
Assessment of the effect of opsonisation with specific antibodies (Bassoe and Bjerknes, 1984; 
Drevets and Elliott, 1995; Lehmann et al., 2000; Rodriguez et al., 2001), and respiratory burst 
which results after phagocytosis can actually be measured together through a combined 
staining protocol (Perticarari et al., 1991; Smits et al., 1997; Busque et al., 1998). 
Recently, aquaculture and fish immunology researchers have been applying the use of flow 
cytometry in their analysis. One of the most simple application is the discrimination of different 
cell populations in fish, based on either granularity/size (FSC/SSC) (Stafford et al., 2001; 
Belosevic et al., 2006) or by staining cells with a fluorescent label (Inoue et al., 2002). The use 
of mAbs that recognise different cell types also allow the differentiation and quantification of 
populations such as leukocyte populations in healthy cod (Ronneseth et al., 2007), or after 
treatment with immunostimulants (Huttenhuis et al., 2006), but specific antibodies to many fish 
markers are still missing. 
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Studies of fish phagocytic and respiratory burst activity have been applied to many species 
such as rainbow trout (Chilmonczyk and Monge, 1999; Boshra et al., 2006), sea bream 
(Esteban et al., 1998; Ortuno et al., 2000; Chaves-Pozo et al., 2004), ayu (Plecoglossus 
altivelis) (Moritomo et al., 2003), Brook trout (Salvelinus fontinalis) and brown trout (Salmo 
trutta) (MacKenzie et al., 2003). Most of these studies used latex beads as a target for the 
phagocytic cells and only a few used labelled inactivated bacteria (Esteban et al., 1998; Coteur 
et al., 2002; Chaves-Pozo et al., 2004). 
The status of bacteria, i.e. whether live or dead, can also be determined by flow cytometry. It is 
possible to discriminate (different emmision wavelength) between stained live plus dead 
bacteria with Thiazole Orange, which stains all cells, and damaged plus dead bacteria 
incorporating Propidium Iodide (G. Nebe-von-Caron  et al., 2000). This technique is very useful 
since bacteria do not need to be cultured and cfu counts performed for enumeration. The 
procedure has many applications such as determining the bactericidal activity of individual sera 
(Virta et al., 1998), the testing of disinfectants (Wozniak-kosek and Kawiak, 2005) or 
antimicrobial agents like antibiotics (Durodie et al., 1995; Alvarez-Barrientos et al., 2000). 
4.1.4. Aim of the study 
The aim of this study was to investigate the mechanisms behind the ability of V. anguillarum to 
avoid being killed by the innate immune system of Atlantic cod. A set of in vitro assays were 
developed to examine interactions between different isolates of the same serotype of V. 
anguillarum and the main innate defences (i.e. phagocytosis, respiratory burst and serum 
killing) of cod. These assays were developed as an alternative to in vivo strain selection. 
Ultimately, this work would provide a better understanding of the virulence mechanisms of V. 
anguillarum and in turn would enable more appropriate strains to be included in the vaccine 
formulation and thus provide a better V. anguillarum vaccine product for cod ( Chapter 5). 
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4.2. Materials and methods 
4.2.1. Fish and cell collection 
Forty healthy unvaccinated Atlantic cod were obtained from Machrihanish fish farm (West coast 
of Scotland) and transported to the University of Stirling in oxygenated bags. The fish 
(approximately 80 g in weight) were housed in 4 circular tanks (1.5 m diameter and 1.5 m 
deep) independent from the main recirculation system, with individual pump and oxygenation 
systems. The temperature was maintained at 12°C. 
The cod were left to acclimatise for a minimum of 3 weeks and fed on commercial cod sinking 
pellets (BioMarine Pearl, BioMar) at 1% of their body weight per day. 
The fish (106.1 ± 8.9 g and 22.75 ± 0.61 cm) were then euthanised with an overdose of 2-
phenoxyethanol (Sigma-Aldrich, Poole, UK, 1 mL.L-1 in sea water) and the brain immediately 
destroyed by dissection. The fish were bled using a Vacuette (Greiner Bio-One) and the blood 
left to clot overnight at 4°C. The head kidney was aseptically dissected and kept on ice in 5 mL 
of Leibovtz media (L15*,  Appendix 9.2) plus 15 IU.mL-1 of heparin (Sigma-Aldrich). The serum 
was collected by centrifuging the clotted blood at 3000 x g for 7 min. It was aliquoted in 1.5 mL 
centrifuged tube and kept at -20°C until used. 
Leukocytes were extracted from cod head kidney following the method of Braun-Nesje et al. 
(1981) with slight modifications. All cell work took place in a laminar flow cabinet. The head 
kidney was immediately transported to the laboratory and passed through a cell strainer (100 
µm mesh, BD Falcon, Oxford, UK) in a sterile Petri dish. The cells were collected by adding 5 
mL of L15* and centrifuged for 10 min at 200 x g. The supernatant was discarded and the cells 
resuspended in 10 mL of L15* (without FCS) and layered on top of a discontinuous Percoll 
gradient ( Appendix 8). The tubes were centrifuged at 400 x g for 45 min at 7°C and the 
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leukocyte band located at the interface of the 34%/51% layers collected using a disposable 
sterile Pasteur pipette. The medium containing the cells was made up to a volume of 15 mL 
with L15* and the cell suspension centrifuged for 10 min at 200 x g. The supernatant was 
discarded and the cells resuspended in 10 mL of L15*. The cell concentration was estimated 
using a Haemacytometer (improved Neubauer, 0.0025 mm2) following the manufacturer’s 
instructions and kept overnight in the incubator set at 12°C. 
4.2.2. Bacteria 
The bacteria used in this study (Table  4-1) were cultured in TSB+NaCl (Section  2.1.2) from 
stocks maintained on cryo-beads. The bacteria were also cultured on TSA+NaCl to check the 
purity and biochemical characteristics of the isolates (Section  2.1.4). Bacteria were either 
stained with FITC on an orbital rotator (Stuart Scientifics) for the phagocytosis assay according 
to Weingart et al. (1999) with modifications, where different concentrations of FITC and 
incubation times were tested on one isolate (VIB2), or left unstained for the respiratory burst 
assay. The bacteria were kept thereafter as 1 mL aliquots in a 15% glycerol solution at -70°C 
until used (Section  2.1.3.2). 
Table  4-1 Vibrio anguillarum isolates used in the phagocytosis, the respiratory burst 
and the serum killing assays. 
Vibrio strain Serotype Origin Vibrio strain Serotype Origin 
VIB1 O1 Trout, DK VIB102 O2b Cod, DK 
VIB227 O1 Turbot, FR VIB103 O2b Cod, DK 
VA40-78skid O1 Salmon, UK VIB104 O2b Cod, DK 
VA65 O1 Turbot, ES VIB105 O2b Turbot, DK 
VIB2 O2a Cod, DK VA64 O2b Cod, UK 
VIB72T O2a Cod, NO VIB3 O3 Trout, DK 
VA25 O2a Sole, ES VIB149 Untyped Water, DK 
VIB98 O2a Turbot, NO V5 V. ordalii Salmon, US 
VA34 O2b Cod, NO    
 
Isolate VA65 was not used for the respiratory burst or serum killing assays. 
 
To revive the frozen stocks of prepared bacteria, 1 mL aliquots of stained or unstained bacteria 
were removed from the -70°C, centrifuged at 3500 x g for 10 min and resuspended in 1 mL of 
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sterile PBS. The effect of the freezing in 15% glycerol (Section  2.1.3.2) was investigated by 
flow cytometer to ensure that it did not affect the staining of the FITC label. 
4.2.3. Phagocytosis and respiratory burst assay 
Different reaction conditions were tested to optimise the assay before performing the analysis. 
The phagocytosis assay was carried out according to Esteban et al. (1998) and the respiratory 
burst according to Richardson et al. (1998). Briefly, to optimise the assays, different 
bacteria:leukocytes ratios were used (from 1:1 to 1000:1), the time for maximum ingestion of 
the bacteria by the phagocytes was established (5 min to 6 h), and different blocking agents 
(for the phagocytosis assay) were examined. The inhibition of phagocytosis was necessary in 
order to discriminate between phagocytosed bacteria and bacteria attached onto the surface of 
the phagocytes, which could lead to an over-estimation of the total positive cells. The agents 
tested included different concentrations and incubation times of paraformaldehyde (Sigma-
Aldrich) or sodium azide (Sigma-Aldrich) to kill the leukocytes and Colchicine (Sigma-Aldrich) 
and 2,3 butanedione monoxime (BDM) to block the phagocytosis in these cells. Cells for the 
negative control in the phagocytosis assay were supplemented with 20 µL of BDM (Sigma-
Aldrich, 420 mM), according to Mansfield et al. (2000) and incubated for 1 h at 12°C. 
Cod leukocytes prepared in Section  4.2.1 were centrifuged at 200 x g for 10 min and diluted to 
5 x106 cells.mL-1 in L15*. The leukocyte suspension of each fish was aliquoted into sterile 
FACS tubes (BD Falcon) at 200 µL.tube-1. Twenty µL of each selected bacterial suspension 
prepared in Section  4.2.2 was added to one of the tubes at a bacteria:leukocyte ratio of 20:1, 
gently vortexed and centrifuged at 150 x g for 3 min. Additional tubes without bacteria or cells 
treated with BDM were used as negative controls. The tubes were then returned to the 
incubator (12°C) for 2 h to allow phagocytosis or respiratory burst to occur. 
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Phagocytosis assay: 
After incubation of the cells with bacteria (negative controls containing no bacteria), for 2 h, 500 
µL of ice cold PBS +1% BSA (w/v, Sigma-Aldrich) was added to each tube which was then 
gently vortexed and centrifuged for 5 min at 200 x g. The supernatant was discarded and the 
cells resuspended in 1 mL of ice cold PBS +1% BSA. The tubes were again centrifuged as 
described above, and the cells resuspended in 500 µL of PBS +0.02% (w/v) EDTA (Sigma-
Aldrich) and immediately acquired on the flow cytometer. 
A 100 µL sample was collected from a few samples just before analysis on the flow cytometer. 
Cytospin preparations were made of these by adding 100 µL of 10% FCS to the sample and 
centrifugation for 5 min at 117 x g in a Cytospin3 centrifuge (Thermo-Shandon, Runcorn, UK). 
The smears were then stained with Rapid Romanowski stain (Raymond A Lamd, Eastbourne, 
UK) after optimisation of the staining for cod leukocytes, briefly 30s in solution A, 2 x 20 sec in 
solution B and 2 x 15 sec in solution C. This was done to visualise if the pre-treatment of cells 
with BDM and the centrifugation were efficient in inhibiting phagocytosis and removing 
unphagocytosed bacteria from the surface of the phagocytes, respectively. 
Respiratory burst assay: 
After incubation of the cells and bacteria for 2h, 100 µL of Dihydrorhodamine 123 (DHR, 
 Appendix 6.1) was added to all the tubes and incubated for 5 min at RT followed by 30 min at 
12°C. Five hundred µL of ice cold L15* was then added to each tube and the level of 
respiratory burst activity immediately measured on the flow cytometer. Positive controls 
consisted of leukocytes incubated with DHR and stimulated by adding 100 µL of PMA  
( Appendix 6.2) after the 5 min incubation at RT, and the negative controls comprised 
leukocytes with 100 µL of PMA but no DHR. The auto-respiratory burst of cod leukocytes were 
also measured by incubating cod leukocytes with DHR only. 
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4.2.4. Serum killing assay 
Sera collected from individual cod (the same fish as used in the phagocytosis and respiratory 
burst assays) were defrosted and half the serum heat inactivated by heating it to 56°C for 30 
min. The sera were then diluted 1:10 in sterile PBS and filtered through a 0.20 µm syringe filter 
(Sartorius Minisart, Epsom, UK) before use. Twenty fish sera were used to analyse VIB1 and 
VIB227 while only 10 sera (Fish1 to Fish10) were used for the remaining isolates tested (Table 
4.1). 
The serum killing assay was performed on the cod sera based on the protocol of Virta et al. 
(1998) but several parameters needed to be optimised. Naïve serum from either rainbow trout 
or Atlantic salmon was used to validate the assay using V. anguillarum isolate VIB87 (serotype 
O1), known to be sensitive to the serum of these fish species. Briefly, the sera (normal and 
heat inactivated by heating at 56°C for 30 min) from 2 fish per species was diluted 1:10 in PBS. 
The assay was performed using the same protocol as outlined for the cod serum except that 
the temperature was set at 25°C. 
Bacteria (Table  4-1, except VA65) were grown overnight and diluted to an OD of 1 at 610 nm 
(Section  2.1.2). The bacteria were diluted 1:10 in sterile PBS and 10 µL of bacteria was added 
to 90 µL of serum (normal or heat inactivated) plus 100 µL of serum buffer ( Appendix 7.1) in 
FACS tubes. The tubes were gently vortexed and incubated for 2 h at 12°C. After incubation, 
500 µL of ice cold PBS+EDTA (1 mM EDTA) was added to each tube, vortexed quickly and 
centrifuged at 3000 x g for 10 min. This wash was repeated and the bacteria resuspended in 
500 µL of PBS+EDTA. The staining procedure was based on the BD cell viability kit protocol 
(Alsharif and Godfrey, 2002). Three µL of Thiazole Orange ( Appendix 7.2) and 3 µL of 
Propidium Iodide (Sigma-Aldrich, 4.3 mM in PBS) were added to each tube, incubated for 5 
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min at RT and placed on ice until read. Negative controls comprised bacteria without serum to 
make sure that the protocol did not affect the survival of the different isolates. 
4.2.5. Flow cytometry settings and Statistics 
4.2.5.1. Phagocytosis and respiratory burst assay settings 
The settings of the flow cytometer (FACScalibur, Becton Dickinson, Oxford, UK) were set 
separately for the phagocytosis and the respiratory burst to obtain the best repartition of the cell 
population on the FSC/SSC dot plot; for both experiments, the Threshold (set on SSC-H 
primary parameter) and the Compensation levels were not modified (Figure  4-2). 
Regarding the respiratory burst assay, the following modifications were applied to the settings: 
FSC: 2.02; SSC: 2.76; FL1: 258 and FL2: 258. All the other settings were left as for the 
phagocytosis assay. 
The data were collected from the flow cytometer for both assays using CellQuest (Version 3.3, 
Becton Dickinson, UK). Five thousands events were recorded after gating the population of 
phagocytic cells (red polygon on Figure  4-2). The data were expressed as the percent of 
positive cells (i.e. fluorescent) over the background level for the relevant assays, after 
transformation according to Equation  4-1 in order to normalise the data. 
xi = Log (x) 
Equation  4-1 Transformation formula applied to the percentage data of the 
phagocytosis and respiratory burst data prior to statistical analysis. 
 
The phagocytosis data were calculated by subtracting the results of the phagocytosis blocked 
with BDM from the data acquired without the blocking agent. 
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Figure  4-2 Settings of the flow cytometer for phagocytosis assay; red polygon represents the gating of the phagocytic leukocyte 
population (Software: CellQuest version 3.3). 
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The normality of the distribution, as well as the equal variance test (Anderson-Darling and 
Bartlett’s tests, respectively), were run using Minitab 15.1.0 (Minitab Inc., Coventry, UK). All 
data are normally distributed unless otherwise stated. The test chosen to establish the 
significance of the differences was a General Linear Model (GLM) with the output: log of the 
percentage of positive events (Equation  4-1) and the factors: bacterial strain, serotype and fish. 
The fish parameter was set as a random factor due to the high variation known to exist 
between individual cod. The test was followed by a pair-wise comparison procedure (Holm-
Sidak method). 
The different graphs presented in this chapter were produced using SigmaPlot 10.0 software 
(Systat software Inc, Hounslow, UK). Figures 4-8, 4-9, 4-10 and 4-12 were plotted using the 
median of data sets with the inter-quartile range represented by vertical bars. This was carried 
out to simplify the interpretation of the values due to the non-normal distribution of the data or 
the very large standard deviation encountered. It is much more useful to express the data in 
this way than to use standard deviations as it is less affected by outliers (Dytham, 2003). Figure 
4-5 was plotted using the mean of the data set and the vertical bars represent one standard 
deviation. 
4.2.5.2. Serum killing assay settings 
Instructions to set the flow cytometer for the bacteria live/dead assay from Alsharif and Godfrey 
(2002) were followed and the settings used are shown in Figure  4-3 A. 
The plot of fluorescence channels FL1/FL3 (Figure  4-3 B) was used to gate the bacteria falling 
in one of the three possible categories: Live (Figure  4-3 B lower right quadrant), Dead (Figure 
 4-3 B upper left quadrant) or Injured (Figure  4-3 B upper right quadrant). The data were 
collected from the flow cytometer using CellQuest (Version 3.3, Becton Dickinson) and 10,000 
events were acquired in the gate encompassing these 3 populations. 
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Figure  4-3 Settings of the flow cytometer for the serum killing assay; A: laser settings; B: dot plot used to calculate the bacteria state (live, 
injured or dead). Software: CellQuest version 3.3. 
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The statistics were run on the ratio of dead + injured to live bacteria of different isolates using 
Minitab software. An example of these data can be found on Figure  4-3 in the “Quadrant 
Statistics” box, where the lower left (LL) quadrant encompass the debris, upper left (UL) the 
dead bacteria, lower right (LR) the live ones and upper right (UR) the injured bacteria.  
4.3. Results 
4.3.1. Phagocytosis assay 
4.3.1.1. FITC staining 
The FITC staining of V. anguillarum was investigated using VIB2 strain (O2a) by adding 
different concentrations of the FITC for 1h or over-night. The data were analysed on the flow 
cytometer as shown in Figure  4-4. The highest fluorescence intensity recorded on the FL-1 
channel (A-2 to G-2) was observed with 0.05 (F-2) and 0.1 mg.mL-1 (E-2) of FITC for 1 h. 
Visually, the distribution of the bacteria plots recorded on the FSC/SSC (Figure  4-4, A-1 to G-1) 
revealed that the FSC/SSC graphs with 0.05 (F-1) and 0.1 mg.mL-1 of FITC (E-1) as well as the 
over-night incubation with 0.05 mg.mL-1 of FITC (A-1) were visually the most similar to the 
control graph (B-1). The intensity of the staining with 1 mg.mL-1 for 1 h (C-2) seems to have two 
peaks of fluorescence intensity, a very high peak of fluorescence and a lower one. 
The survival of the bacteria after staining with different concentrations of FITC was investigated 
to ensure staining did not affect the viability of the bacteria (Figure  4-5). The bacteria were 
incubated for 1 h with the different concentrations of FITC and cfu numbers were determined to 
assess the viability of the bacteria (Section  2.1.5). 
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Figure  4-4 Flow cytometry data after staining V. anguillarum with FITC. (A): 12h incubation with 0.05 mg.mL-1 FITC; (B to G): 1 h incubation 
with 0.01 to 1 mg.mL-1 FITC. (1): FSC/SSC plots of the bacteria; (2) FL1 histogram of the fluorescence intensity. 
  119
 
Figure  4-5 Survival of V. anguillarum after incubation in different concentrations of 
FITC for 1 h. 
 
Concentrations of FITC over 0.05 mg.mL-1 for 1 h were shown to have a detrimental effect on 
the survival of the bacteria; below this concentration, no survival differences were seen 
between the control (no FITC) and the stained bacteria. 
With respect to the intensity of the staining (Figure  4-4, A-2 to G-2), the distribution of the 
bacteria (Figure  4-4, A-1 to G-1) and survival of the bacteria (Figure  4-5), the optimum 
concentration of FITC for staining V. anguillarum was found to be 0.05 mg.mL-1 for 1 h on an 
orbital shaker. 
The effect of storing the bacteria at -70°C, prior to use, was investigated regarding the retention 
of FITC stain. From the results shown in Figure  4-6, the intensity of the fluorescence appeared 
to be higher and the peak narrower in the thawed frozen samples (A to C), which could be due 
to a lower uptake of the stain by the isolates which were not frozen (D to F). 
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Figure  4-6 Flow cytometry data (FL1 histogram of the fluorescence intensity) of FITC 
stained V. anguillarum at 0.05 mg.mL-1 for 1 h. Stored bacteria overnight at -70°C (A to 
C); same bacteria stained on the day (D to F). 
 
All together, freezing the stained bacteria at -70°C did not seem to interfere with the intensity of 
the FITC stain on the bacteria. 
4.3.1.2. Phagocytosis inhibition 
Sodium azide and paraformaldehyde were used to kill the leukocytes and were found to be 
efficient at killing the phagocytes but paraformaldehyde caused the cells to auto-fluoresce and 
could therefore not be used. Sodium azide changed the morphology of the leukocytes, making 
it harder to gate them and compare the results with live cells. 
Colchicine and BDM were both found to block phagocytosis without changing cell morphology, 
as observed from the FSC/SSC dot plot and they did not cause any auto-fluorescence of cells 
(data not shown). BDM used at a concentration of 38.3 mM for a minimum of 60 min at 12°C 
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was found to be more efficient at blocking phagocytosis than colchicine (data not shown) and 
was chosen as the blocking agent. 
4.3.1.3. Phagocytosis assay 
Examination of cod leukocytes under light microscopy after 2 h phagocytosis revealed that a 
small proportion of the macrophage and neutrophil populations had internalised bacteria (data 
not shown). Within each positive cell, an average of 4 to 5 bacteria, with up to 10 bacteria, 
could be clearly seen within the cytoplasm (Figure  4-7). 
 
Figure  4-7 Light microscopy of V. anguillarum (VIB149) bacteria engulfed in the 
cytoplasm of a cod macrophage (magnification x1000). n: nucleus; b: bacteria (arrows). 
 
The phagocytosis values obtained by FACS analysis for each isolate were significantly higher 
than that obtained for the leukocytes incubated without bacteria, with the exception of VIB1. It 
can be seen from the inter-quartile range in Figure  4-8, that the variation within the data set for 
each isolate was very high. This was also the case with the standard deviation (sd); for 
example, for VIB2, the phagocytosis level was 7.34 % ± 8.46 (mean ± 2x sd). 
The lowest level of phagocytosis was obtained with an O1 serotype isolate, VIB1, with 0.1% of 
the cells having phagocytosed bacteria. The highest level of phagocytosis was found with an 
O2a serotype isolate, VIB2, with 7.3% of the cells having phagocytosed bacteria after 2 h 
incubation. 
n 
b 
  
122
 
Figure  4-8 Phagocytosis of different strains of V. anguillarum and V. ordalii (V5) by cod phagocytic leukocytes after 2h incubation at 12°C. 
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Each serotype was analysed separately since the purpose of the assay was to investigate the 
ability of the different isolates within a serotype to be phagocytosed by cod leukocytes. 
A significant difference was found (p<0.001) between the phagocytosis of the strains of the O1 
serotype and the pair-wise comparison showed that the level of phagocytosis of VIB1 was 
significantly different from that of VIB65 and 78skid but not VIB227, and that the phagocytosis 
of 78skid was different from that of VIB1 and VIB227 but not VIB65. 
The difference between the phagocytosis of the O2a serotype strains was also significant, and 
the pair-wise analysis revealed that only the phagocytosis level of cod leukocytes towards 
VIB98 and VA25 was not significantly different from each other. The average phagocytosis of 
VIB2 was 3 times greater than that seen with VIB98, and approximately 15 fold greater than 
phagocytosis observed with VIB72T. 
A significant difference was found in the level of phagocytosis within serotype O2b, isolate 
VA34 level of phagocytosis was significantly higher than all the other O2b strains (mean 
phagocytosis of 5.3%). The mean value of phagocytosis obtained with the other isolates in this 
group ranged from 0.3 % with VIB103 and 1.2% with VA64, with the phagocytosis of isolates 
VIB102 and VIB103 not significantly different to each other, and a third group composed of 
isolates VIB104, VIB105 and VA64, had an intermediate level of phagocytosis, not significantly 
different from each others. 
When statistical analysis was carried out between each of the serotypes as groups, significant 
differences were found (normality test passed) between the groups represented in Figure  4-9. 
The fact that O3, non-pathogenic V. anguillarum (Non-Patho) and V. ordalii groups are only 
represented by 1 isolate diminishes largely the relevance of the statistical analysis. The non 
pathogenic isolate to rainbow trout, VIB149 (Non-Patho group) was the highest phagocytosed 
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bacteria, with 4.8% of the cells showing phagocytosis, followed by O2a with 2.9%; the minimum 
was found for the VIB3 (O3) isolate with only 0.2% of the cells containing phagocytosed 
bacteria. The Holm-Sidak test performed following GLM model analysis of this data revealed 
that the phagocytosis of the Non-Patho group and the sub-serotype O2a were significantly 
higher than that of all the other groups. 
 
Figure  4-9 Phagocytosis of different serotypes of V. anguillarum and V. ordalii by cod 
phagocytic leukocytes after 2h incubation at 12°C. 
 
4.3.2. Respiratory burst assay 
The data collected for the respiratory burst assay were transformed using Equation  4-1 and 
analysed in the same manner as for the phagocytosis assay. Figure  4-10 represents the 
median of the respiratory burst activity of cod leukocytes with the inter-quartile intervals 
presented. 
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Figure  4-10. Respiratory burst of cod leukocytes after 2h incubation at 12°C with different isolates of V. anguillarum and V. ordalii (V5). 
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Only a few strains of V. anguillarum had a significantly higher level of respiratory burst activity 
compared with the background level of auto-respiratory burst, measured in a tube containing 
leukocytes with DHR but no bacteria. These isolates are VIB2 (O2a), VIB98 (O2a), VA34 
(O2b), VIB149 (Non-Patho) and the positive control (no bacteria +DHR +PMA). The cod 
leukocytes incubated with isolate VA34 had the highest number of cells undergoing respiratory 
burst with 10.7% of the gated phagocytic cells showing a positive activity. Both isolates VIB2 
(O2a) and VIB149 (Non-Patho) activated approximately 7.5% of the total phagocytic cell 
population. The lowest percentage of cells which were still significantly different from the 
negative control (DHR only) was with isolate VIB98 (O2a) where only 5.6% of the leukocytes 
were undergoing respiratory burst. The positive control cells stimulated with PMA contained a 
mean value of 23.4% of the phagocytic cells undergoing respiratory burst. 
There appeared to be two distinct phagocytic populations undergoing respiratory burst 
(contributing 44 and 56% of the phagocytic population), observed in the positive control for 
each fish, determined by their difference in fluorescence intensity (Figure  4-11), but the 
size/granularity dot plot did not allow clear differentiation between these two populations (data 
not shown).  
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Figure  4-11 Fluorescence intensity (FL2) of cod leukocytes incubated with DHR and 
PMA against size of the cells (FSC). 
 
4.3.3. Serum killing assay 
As shown in Figure  4-12, all the isolates of V. anguillarum seem to be resistant to the killing 
activity of Atlantic cod serum, with both normal or heat-inactivated serum. The highest rate of 
killing was found for isolate VIB105 (O2b) with only 0.1% of the bacteria dead or injured after 2 
h incubation in normal serum diluted 1:10. 
Incubation of Vibrio ordalii, isolate V5, with normal or heat inactivated serum resulted in 4.9 and 
4.5% death, respectively. This result has to be considered carefully and it may have been due 
to an artefact when gating the different populations, since V. ordalii appear to have a different 
size/granularity to V. anguillarum (data not shown). 
 
 
  
128
 
Figure  4-12 Serum killing activity of cod serum (normal and heat-inactivated) after incubation of different strains of V. anguillarum and V. 
ordalii (V5) for 2 h at 12°C. 
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4.4. Discussion 
4.4.1. General considerations on the Atlantic cod leukocytes, 
serum and V. anguillarum bacteria 
Three assays were developed to examine the interactions between V. anguillarum and the 
immune response of cod in vitro. The assays included phagocytosis and respiratory burst by 
head kidney leukocytes, and a serum killing assay, which were optimised by modifying 
methods reported in the literature. 
Extraction of leukocytes from cod head kidney was performed following the methods of Braun-
Nesje et al. (1981), Steiro et al. (1998) and Sorensen et al. (1997). The cod leukocytes could 
be incubated at 12°C for 24 h using the conditions described in Section  4.2.1 without any major 
loss of cell viability. Steiro et al. (1998) showed that macrophage viability and function, i.e. 
phagocytosis, respiratory burst or cell attachment, was optimal at 4-6°C and performed less 
efficiently at 12°C, while Magnadottir (2000) observed the optimal temperature for serum killing 
with cod serum to be 37°C. In order to perform all the assays at the same temperature, 12°C 
was chosen specifically as it was the temperature the fish were reared at. 
Atlantic cod serum was kept at -20°C for 3 weeks prior to examination of the serum killing 
capacity on V. anguillarum. The haemolytic activity, usually attributed to the alternative 
complement pathway, has been shown to be unaffected by storage at this temperature 
(Magnadottir et al., 1999a; Magnadottir et al., 1999b). 
Due to the dynamic relationship between host and pathogen (Drevets and Elliott, 1995), live 
bacteria should be used in pathogenicity experiments. Therefore, live bacteria were used in this 
study, however, it was not possible to prepare bacteria and perform the assays on the day of 
the experiment, bacteria (stained or not) were stored at -70°C prior to use (Trust et al., 1981) 
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and a survival recovery from the frozen stocks of approximately 75% (data not shown) was 
considered satisfactory. 
The state of the bacteria could have affected the outcome of the experiments performed. 
Storage of the pathogen (e.g. on slopes, subcultures, lyophilisation) can lead to a reduction in 
the virulence or pathogenicity of the bacterium as well as differential expression of regulatory 
genes or the loss of plasmids, all of which has been previously documented Yamamoto et al., 
1993; Pedersen, 1997; Lesne et al., 2000; Somerville et al., 2002). The isolates used in this 
study were all laboratory isolates, subcultured many times on TSA+NaCl and this may have 
lowered the virulence of these isolates compared to when they were first recovered. The use of 
isolates freshly recovered from outbreaks or passaged several times through fish would have 
been more relevant but due to the number of isolates tested in this study and the fact that no 
field sampling was scheduled, this could not be done. 
Due to the fact that each bacterial isolate was treated in the same manner within each 
experiment, the results obtained are considered to be a true reflection of the differences 
between the various isolates examined at the time of investigation, regarding both their 
interaction with and evasion mechanisms towards cod leukocytes. This does not mean that the 
in vitro model used here reflects exactly what is happening in vivo since the interaction of the 
various components of the immune system (humoral and cellular) were not assessed together 
(e.g. leukocytes without serum for the phagocytosis assay and respiratory burst assay, and 
serum without leukocytes for the bacterial killing assay). 
4.4.2. In vitro flow cytometry assays 
Flow cytometry is extremely useful for processing a large number of samples, but it required a 
certain amount of expertise to become familiar with its settings, and published protocols had to 
be adapted for use with Atlantic cod leukocytes. 
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The bacteria used in the phagocytosis assay needed to be labelled with a fluorochrome (FITC, 
(Boesen et al., 2001) for analysis on the flow cytometer. The FITC staining proved to be a 
simple method for labelling bacteria, although some researchers have used the insertion of a 
green fluorescent protein (GFP) gene into the genome of bacteria. In hindsight, GFP labelling 
of V. anguillarum may have been a better alternative than using FITC labelling due to the 
potential problems associated with this fluorochrome. The FITC covalently binds to amines on 
the amino acids present on the N terminus of proteins and on lysine residues (Grunwaldt et al., 
2002). It was shown that this binding reduced the adenylate cyclase toxin activity of Bordetella 
pertussis, and in turn increases the number of bacteria phagocytosed by human neutrophils 
compared with GFP labelled bacteria (Weingart et al., 1999). The authors concluded that since 
FITC labelling affected the activity of the adenylate cyclase toxin, interference of FITC with 
activity of other immune proteins could not be ruled out. GFP labelling has been shown to 
conserve all pathogenic traits of the bacteria (Weingart et al., 1999; Chu and Lu, 2008) and 
also to give a more stable fluorescent signal. Many studies have however successfully used 
FITC staining of bacteria to investigate host-pathogen interactions. Drevets and Elliott (1995) 
did not report any differences in the phagocytosis of Listeria monocytogenes labelled with 
carboxy-X-rhodamine (CR), hydrazine derivate of fluorescein (FH) or Lucifer Yellow (LY) by 
mice macrophages compared to unlabeled bacteria. 
The detection of the intensity of fluorescence of a gated population (thought to be phagocytes) 
was used to quantify the proportion of cod leukocytes which had engulfed fluorescent bacteria. 
These cells can be recorded positive (intensity above a threshold) either because they have 
internalised FITC labelled bacteria or the labelled bacteria have attached non-specifically to the 
surface of the cell. Different methods are available for discriminating between attached and 
internalised bacteria. Quenching fluorescent bacteria attached to the surface of the 
macrophage or neutrophils is a very efficient way to overcome this problem, but the bacteria 
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have to be dead to allow penetration of the quenching agent into the organism (Van Amersfoot 
and Van Strijp, 1994). The quenching of live bacteria is more problematic, and attempts to do 
so using Crystal Violet or Trypan Blue gave unsatisfactory results (data not shown), even after 
permeabilising the membrane of the bacteria with different concentrations of lysozyme. The 
other method used in this study to overcome this problem was to inhibit phagocytosis with a 
chemical agent and from this measure the number of cells with only attached bacteria. The 
level of cells with surface bound bacteria after blocking with BDM was found to be different for 
each isolate, and so blocking phagocytosis was necessary for each bacterial isolate analysed. 
It might also have been possible to mark the bacteria attached to the surface of the cells using 
specific antibodies (Section  3.3.2.1) labelled with a different fluorochrome instead of calculating 
a negative background. This would have avoided the use of any chemicals on the cells such as 
BDM which can modify the adherence of the bacteria to the cell surface. Peak levels of 
phagocytosis were reached within 2h of incubation (data not shown), as found by Esteban et al. 
(1998), with as much as 10 bacteria per macrophage (Figure  4-7). 
4.4.2.1. Vibrio anguillarum and cellular innate immunity studies 
Vibrio anguillarum is a very heterogeneous species of bacteria with differences in biochemical 
profiles within each serotype (Section  1.2.6.1). The interaction of this bacterium with cod 
phagocytic cells has been reported, with less phagocytosis occurring with this species 
compared to other bacteria species as seen with a pathogenic and a mutant strain of A. 
salmonicida (Nikoskelainen et al., 2006), but no studies have been published on the different 
mechanisms used by V. anguillarum to resist cod innate immunity. 
The phagocytic capacity of cod leukocytes was found to be between 0.1% for isolate VIB1 
(serotype O1) to over 7% for VIB2 (O2a serotype). Within serotypes O1, O2a and O2b, cod 
leukocytes phagocytosed to a higher extent isolates 78skid, VIB2 and VA34 respectively, with 
the serotype O3 the most resistant to phagocytosis when compared by serotypes (Figure  4-9). 
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These results are much lower than the levels of phagocytosis found with sea bream leukocytes 
using V. anguillarum serotype O1, where Esteban et al. (1998) reported approximately 80% of 
the leukocyte population had phagocytosed bacteria using flow cytometry. The main 
differences between these two experiments were the fish species used and Esteban et al. 
(1998) used dead bacteria while live bacteria were used in the present study. The latter could 
have a large impact on the level of phagocytosis of bacteria because dead bacteria could loose 
their ability to actively resist this mechanism. However, in pre-experiments using dead bacteria, 
no significant differences could be seen between the level of phagocytosis by cod leukocytes of 
live and dead bacteria (data not shown). The isolate VIB2 from O2a serotype was 
phagocytosed by 7% of the cells gated in Figure  4-9; this represents 28% of the total 
macrophage and neutrophil population which could undergo respiratory burst (Section  4.4.2.2) 
having phagocytosed at least one bacteria. This level of phagocytosis by cod macrophages is 
similar to the results found by Boesen et al. (2001), i.e. 25%, using the same serotype of V. 
anguillarum with trout phagocytes after 2 h incubation at a ratio of 5:1 (bacteria:leukocytes). In 
the present study, a ratio of 20:1 was found optimal (data not shown). If the same calculation is 
applied to the most phagocytosed bacteria, VIB2, serotype O2a, 7.3% of the total phagocytic 
population equates to 64% of the macrophages (able to undergo respiratory burst) having 
phagocytosed a least one bacteria. 
The phagocytic ability of cod leukocytes was found to vary between individual fish, individual 
isolates of V. anguillarum and between serotypes. The range of different phagocytic values 
obtained with individual isolates reflects the wide heterogeneity found among V. anguillarum 
isolates; a hundred times more cells had phagocytosed VIB2 (7.2%) than VIB1 (0.08%). 
Only a low percentage of the gated cells underwent respiratory burst after incubation with 
bacteria (i.e. higher than the auto-respiratory burst level). This level (DHR only in Figure  4-10) 
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was found here to be approximately 2% of the cells and this has been reported by others 
(Nikoskelainen et al., 2006). This, coupled with the fact that a very low level of respiratory burst 
was observed for most bacterial strains reduced the power of the analysis of the data. The 
highest respiratory burst was found when incubating the non pathogenic strain (VIB149) with 
cod leukocytes (approximately 6% underwent a respiratory burst), which corresponds to 24% of 
the total macrophage and neutrophil population capable of undergoing respiratory burst 
(Section 4.4.2.2). The serotype which produced the lowest percentage of cells positive for a 
respiratory burst was O1, giving a level similar to the negative control (data not shown). 
Respiratory burst by cod leukocytes has been reported to be very variable between individuals 
(Sorensen et al., 1997), as found here. Some authors have observed the level produced by the 
addition of PMA to be twice as high in cod leukocytes as in rainbow trout (Steiro et al., 1998), 
but others have shown that this level is generally lower than in other fish species 
(Nikoskelainen et al., 2006). Since the respiratory burst is linked to phagocytosis, it is 
interesting to compare these results in order to investigate the possible inhibition of the 
respiratory burst once V. anguillarum has been phagocytosed. Boesen et al. (2001) showed 
that V. anguillarum was able to block the respiratory burst of rainbow trout leukocytes, also 
shown for sea bass (Sepulcre et al., 2007), which might be the case for cod too. The 
relationship between the respiratory burst and the phagocytic activity of cod leukocytes is fairly 
good, with the same isolates of V. anguillarum highly phagocytosed also producing a high level 
of respiratory burst. This implies that a possible inhibition of the respiratory burst by V. 
anguillarum is unlikely since a lower level of respiratory burst would be expected compared to 
phagocytosis. There was actually a higher respiratory burst level for almost all strains than 
phagocytosis (i.e. VA34 with 5.2% of the cells positive for phagocytosis and 10.7% of the cells 
undergoing a respiratory burst). The fact that more cells underwent respiratory burst after 
incubation with the same number of bacteria than for phagocytosis assay implies either an 
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under-estimation of phagocytosis level in this assay or that these isolates actively trigger the 
macrophage and neutrophils to undergo a respiratory burst without prior phagocytosis. The 
discrepancy noted here could also be due to the preparation of the samples since the bacteria 
used for the respiratory burst were not stained with FITC and this may have influenced the 
overall phagocytic capacity of cod leukocytes. The possibility of double staining for measuring 
the proportion of the population positive for phagocytosis and respiratory burst at the same time 
(mentioned in Section  4.1.3) could have given more information on the interaction of the 
pathogen with the cod leukocytes; it would also have reduced the time and increased the 
accuracy of the assay. 
To verify if the respiratory burst was inhibited by live V. anguillarum, it would have been useful 
to incubate the cod leukocytes with both live and heat-inactivated bacteria to establish if any 
differences in the level of respiratory burst could be detected. Alternatively, triggering 
respiratory burst with PMA post-phagocytosis would have shown if the phagocytic cells had a 
reduced ability to undergo respiratory burst (Boesen et al., 2001). It would be also very 
important  to assess the killing of the bacteria after phagocytosis and respiratory burst since the 
bacteria can survive within the phagocytic cell such as seen with Edwarsiella tarda (intracellular 
pathogen, Rao et al., 2001). 
4.4.2.2. General considerations of the different cell populations 
In order to increase the number of cells recorded by the flow cytometry assay using cod 
leukocytes, a gate was drawn around the cells thought to be phagocytic (Figure  4-2). It is 
possible to obtain information about the different cell populations undergoing a respiratory burst 
by flow cytometry. Since only macrophages and neutrophils have the ability to produce reactive 
oxygen species after triggering this mechanism using PMA, the total proportion of reactive 
phagocytes within the gated population can be estimated. In this study around 25% of the 
gated cell population was able to produce a respiratory burst higher than the threshold limit set 
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(Figure  4-10). Since the population gated was fairly well defined on the SSC/FSC dot plot, it is 
believed that these cells were only macrophages and neutrophils but an investigation by light 
microscopy after cell sorting would elucidate if there was any “contamination” of other cell 
types. Two populations were distinguishable on the flow cytometer after triggering respiratory 
burst in samples containing only cod leukocytes (Figure  4-11), identified by the difference in 
respiratory burst intensity. The neutrophil population is known to produce a higher level of free 
radical species than macrophages (Secombes, 1996). If Atlantic cod neutrophils and 
macrophages behave the same way, it seems possible to estimate the relative percentage of 
these two populations using this method. In this study, the neutrophil:macrophage ratio was 
56:44, where 62:38 was found by light microscopy observation of head kidney cells (Sorensen 
et al., 1997). If the values found for the ratio of neutrophils and macrophages are related to the 
total population gated, then these represent respectively 14 and 11% of the gated population 
(total phagocytes 25%). Sorting the gated cell populations by FACS and then identifying them 
morphologically under light microscopy would help establish if this assumption is correct. 
4.4.2.3. Vibrio anguillarum and humoral innate immunity study 
Atlantic cod serum bactericidal activity has not been extensively studied despite the importance 
of this system in fish and the fact that the specific immune response in Atlantic cod is still open 
to debate (Section  1.3.2.4). Specific antibodies to V. anguillarum are not found (or in very low 
quantities) in cod after infection or vaccination (Section  1.3.2.5), this seems to suggest that the 
non-specific or non-antibody based defence system is playing a central role in Atlantic cod. The 
opsonisation capacity of V. anguillarum by cod serum, measured by respiratory burst activity, 
has also been shown to be poorer than with trout serum (Nikoskelainen et al., 2006). 
Magnadottir (2000) reported that Aeromonas salmonicida seems to be completely resistant to 
cod bactericidal activity. This fish pathogen is notoriously resistant to serum killing mostly due 
to the A layer protein on its surface (Munn et al., 1982; Merino et al., 1994). 
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After 2 hours incubation in normal cod serum diluted 1:10, all strains of V. anguillarum seemed 
able to resist membrane lysis by cod serum. This result was surprising in respect to the known 
heterogeneity of resistance to complement killing within serotypes (Boesen et al. 1999). Heat 
inactivation of serum tends to inhibit bacterial killing, but in this study, inactivation of the serum 
had no marked effect on its ability to kill the bacterium. This was not unexpected since 
Magnadottir (2000) showed a very moderate loss of haemolytic activity in cod serum heated at 
63°C for 30 min, concluding that the haemolytic activity was partially heat-stable and so might 
be only relying partially on complement activity. Regarding the dilution, Boesen et al. (1999) 
showed that immunised serum from trout could be diluted up to 1:8192 and still kill 30% of V. 
anguillarum O1, unfortunately data regarding the normal levels of serum killing were not 
presented in this study. Neat serum from normal rainbow trout was shown to kill some V. 
anguillarum strains (mostly from serotype O1) after 48 h incubation at 20°C (Boesen et al., 
1999), and maybe in our study cod serum needed to be used neat and incubation with the 
bacteria for more than 2 h to obtain any bactericidal activity. Complement-mediated killing via 
the classical pathway (antibody dependant) can be faster acting than the alternative pathway in 
lysing bacteria (Traub and Kleber, 1976), and since cod might rely only partially (if at all) on 
specific antibodies, the killing of V. anguillarum by cod serum may need longer incubation times 
to be effective. Nevertheless, Caipang et al. (2008) showed that Atlantic cod normal serum 
(PBS injected fish) did not have an effect on V. anguillarum mortality after incubation for 48 h at 
15°C in 1:1 bacteria solution:serum. This reinforces the results found here that V. anguillarum 
is resistant to killing by cod serum. 
The investigation of serum killing activity of serum using flow cytometry allowed rapid 
measurement of the bactericidal activity of cod serum towards V. anguillarum.  This type of 
assay has the advantage over the classical protocol (cfu enumeration after growth on agar 
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plates) to be extremely quick, very precise and able to take into account the potential non-
culturable bacteria. 
Several factors could have influenced the serum assay, firstly the temperature of the assay was 
set at 12°C, but Magnadottir (2000) reported higher serum haemolysis activity at 37°C. In 
preliminary experiments conducted in this study, the cod bactericidal activity with normal serum 
of V. anguillarum VIB87 (serotype O1) incubated at 37°C was found to be around 4%, with no 
differences between normal and heat inactivated serum (data not shown), which is a lot higher 
than the results found at 12°C presented here. In the same experiment rainbow trout serum 
was found to kill 70% of the same bacterial isolate at 25°C, with the inactivated trout serum 
value under 1% (data not shown). 
LPS is a very important outer membrane molecule on the surface of V. anguillarum and is 
responsible for triggering a whole cascade of events e.g. cytokine production (Caipang et al., 
2008), and activation of the complement system (Boshra et al., 2006), but they may also play a 
part in avoidance of phagocytosis (Rittig et al., 2003) or serum inhibition (Magnadottir, 2000). It 
would be very interesting to do the same type of assays as presented here with a reduced 
amount of LPS on some strains (Boesen et al., 1999) or using some LPS deficient mutants to 
establish the role of this molecule in relation to the avoidance of phagocytosis as well as the 
respiratory burst or serum killing. 
4.4.3. Pathogenicity of Vibrio anguillarum 
Vibrio anguillarum is a very heterogeneous group of bacteria, and even within each serotype 
differences are found in their biochemical profiles (Austin et al., 1995), genetic make-up 
(Pedersen and Larsen, 1993) or pathogenicity (Boesen et al., 1997). The high heterogeneity of 
the results in the different assays was expected, with the majority of the strains highly resistant 
to the different defence mechanisms tested and a few presenting a lower resistance to the cod 
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cellular innate immune system. This high resistance trend was expected since most of the 
isolates were from V. anguillarum outbreaks in fish and so these strains were expected to be 
highly virulent (Table  4-1). Regarding the results of the phagocytosis assay, considering the 
average for each serotype (Figure  4-9), it seems that serotype O3, O2b and O1 would be more 
susceptible to produce an infection in Atlantic cod since these isolates, on average, were less 
phagocytosed than O2a. In reality, O2a and O2b subseroytpes are the most pathogenic. 
Altogether the assays described here allowed an insight into the individual virulence 
mechanisms between isolates of the same bacteria species, with VA40-78skid (O1), VIB2 
(O2a) and VA34 (O2b) the most phagocytosed and VIB1 (O1), VIB72T (O2a) and VIB103 
(O2b) the most resistant to phagocytosis by Atlantic cod leukocytes. 
The problems encountered in Norway of outbreaks in vaccinated fish (Hellberg et al., 2005-
2006-2007) and of the different vaccines giving variable protection require a better 
understanding of what makes an isolate pathogenic and which strains are more prone to 
produce a disease state in Atlantic cod. Vibrio anguillarum is obviously able to bypass the cod 
immune system defences since O1, O2 and O3 serotypes are able to produce the disease in 
healthy fish. These evasion mechanisms are not fully understood and the evasion of the 
phagocytosis as well as the serum resistance (shown in this study) are not the only virulence 
factors that the pathogenic strain possess but seem to be part of the most important resistance 
mechanisms. 
When presented with a catalogue of sometimes hundreds of possible candidates for use in the 
development of a vaccine, we believe that the study of some of the factors involved in the 
pathogenesis in vitro through the use of flow cytometry, coupled with a reliable serotyping 
scheme, provides valuable information for making an educated and scientific decision towards 
which isolate, within each serotype, should be included in the vaccine. 
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Chapter 5. 
 
Efficacy of whole cell vaccine in cod against 
Vibrio anguillarum 
 
5.1. Introduction 
Vibrio anguillarum was one of the first bacterial diseases of fish to be investigated by 
bacteriologists, immunologists and vaccinologists, because of its significant impact on 
salmonids when first cultured. From the late 60’s to the end of the 70’s, most of the studies 
related to vibriosis vaccines were published by researchers in the USA (Antipa, 1976; Amend 
and Fender, 1976; Antipa and Amend, 1977; Croy and Amend, 1977; Gould et al., 1979) and 
Japan (Hayashi et al., 1964; Kusuda et al., 1978; Nakajima and Chikahata, 1979). The results 
of these studies showed that heat or formalin-killed preparations of V. anguillarum were very 
efficient in protecting salmonids and ayu from vibriosis. 
Commercial vaccines for vibriosis in salmonids generally consist of a mixture of 2 or 3 different 
serotypes of V. anguillarum (O1, O2a and sometimes V. ordalii). These serotypes are usually 
combined with other inactivated fish pathogens in a polyvalent vaccine formulation, and tend to 
cover the main pathogens associated with heavy losses of fish. Intervet-Schering-Plough, for 
example, produce a vaccine, Norvax® Minova 6, which protects against 5 different diseases 
(furunculosis caused by Aeromonas salmonicida subsp. salmonicida, vibriosis caused by Vibrio 
anguillarum, coldwater vibriosis caused by Vibrio salmonicida, cold water ulcer disease caused 
by Moritella viscosa and Infectious Pancreatic Necrosis caused by IPN virus). Many 
commercially devastating diseases are mostly covered by vaccines, but vaccines protecting 
against viral diseases are also being produced. Many of the viral vaccines are still at an 
experimental stage, as shown in Table  5-1 (Biering et al., 2005; Hastein et al., 2005). 
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Table  5-1 Selection of bacterial and viral diseases controlled by vaccination. 
Bacterial disease Bacteria  Virus Family 
Yersiniosis Yersinia ruckeri  IPNV* Birnaviridae 
Pasteurellosis Photobacterium damselae subsp piscicida  IHNV* Rhabdoviridae 
Edwardsiellosis Edwardsiella ictaluri  VHSV Rhabdoviridae 
Streptococcosis Streptococcus iniae  SVCV Rhabdoviridae 
Lactococcosis Lactococcus garviae  SPDV* Togaviridae 
Warm water vibriosis V. alginoliticus, V. vulnificus, V. parahaemolyticus  SDV Togaviridae 
Flavobacteriosis Flavobacterium columnare  SJNNV Nodaviridae 
Flexibacteriosis Tenacibaculum maritimum  ISAV* Orthomyxoviridae 
Vibriosis V. anguillarum; V. ordalii; V. salmonicida  KHV Herpesviridae 
Piscirickettsiosis Piscirickettsia salmonis  LCDV Iridoviridae 
Furunculosis Aeromonas salmonicida subsp. salmonicida    
MAS Aeromonas hydrophila    
Bacterial kidney 
diseases (BKD) Renibacterium salmoninarum    
 
MAS: Motile Aeromonas Septicaemia; IPNV: Infectious Pancreatic Necrotic Virus; IHNV: Infectious 
Haematopoietic Necrosis Virus; VHSV: Viral Hemorrhagic Septicaemia Virus; SVCV: Spring Viraemia Carp Virus; 
SPDV: Salmon Pancreas Disease Virus; SDV: Sleeping Disease Virus; SJNNV: Stripped Jack Nervous Necrosis 
Virus; ISAV: Infectious Salmon Anaemia Virus; KHV: Koi Herpes Virus; LCDV: Lymphocystis Disease Virus. * 
indicates commercial viral vaccine available. 
 
Vibrio vaccines are available commercially for many fish species such as rainbow trout, sea 
bass, sea bream, barramundi (Lates calcarifer), tilapia (Tilapia spp), Japanese amberjack 
(Seriola quinqueradiata), turbot, yellowtail amberjack (Seriola dumerili and S. lalandei), white 
trevally (Pseudocaranx dentex) and channel catfish (Ictalurus punctatus) (Hastein et al., 2005). 
Atlantic cod can be infected by V. anguillarum, principally O2a and O2b serotypes, the 
vaccines developed to protect salmonids and used for Atlantic cod lacked the second sub-
serotype, leaving Atlantic cod vulnerable to infection by this group of bacteria (Section  1.4.2). A 
very important difference between Atlantic cod and salmon in their vaccination strategy is that 
the salmonid first life cycle occurs in fresh water, where they are vaccinated against V. 
anguillarum and where infection very rarely occurs. For Atlantic cod, from the time they are only 
a few grams, they can encounter V. anguillarum and the vaccination has to happen at a lot 
earlier stage. Nowadays, both Pharmaq and Intervet-Schering-Plough, arguably the two 
leading fish vaccine manufacturers, have developed a Vibrio vaccine formulation specifically for 
this species, under the names Alpha Marine® and Norvax Vibriose Marine®, respectively. 
These formulations include Vibrio isolates belonging to serotypes O1 and O2a, but also O2b. 
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Norway is the largest aquaculture producer of cod in the world (FAO stats, 2006), as well as 
the largest supplier of injectable oil-based fish vaccines (Gravningen and Berntsen, 2007). 
Numerous outbreaks of vibriosis in vaccinated Atlantic cod have been reported from this 
country (Hellberg et al., 2005-2006-2007; Samuelsen et al., 2006), despite the systematic 
vaccination strategy implemented at 1 and 5 g (dip vaccination) and again at 30 g 
(i.p.vaccination). A possibly new serotype of V. anguillarum, isolated from cod in Norway, 
(referred to as O2c in this study) has been shown to be genetically and immunologically 
different to O2a and O2b isolates and, as yet, has not been included in any commercial 
vaccines (Mikkelsen et al., 2007). The authors showed that the protection of the Pharmaq 
commercial vaccine was fairly poor against this (O2c) serotype isolate (RPS 32%), and thus 
could explain why outbreaks of vibriosis are still occurring in commercially-reared vaccinated 
cod, even if the number of outbreaks due to this particular serotype is low. 
Numerous studies comparing the different serotypes of V. anguillarum suggested that 
representative isolates from all the relevant sub-groups should be included in future Vibrio 
vaccines (Airdrie et al., 1989; Tiainen et al., 1997a; Mikkelsen et al., 2004), to protect cod 
against as broad a range of relevant V. anguillarum serotypes as possible. It should be kept in 
mind that the grouping of isolates into different serotypes is based on the use of mammalian 
antibodies (mouse mAbs and rabbit pAbs), and there is no indication that fish antibodies are 
able to differentiate between the different serotypes in the same way as mammalian antibodies, 
i.e. mAbs might reveal differences that may not be recognised by fish (Espelid et al., 1991; 
Mutharia et al., 1993; Jakobsen et al., 1999). 
As mentioned in Section  1.4.1, several different types of vaccines are under development for 
aquaculture, and the “new technology” vaccines, such as DNA or subunits vaccines, offer the 
greatest choice of formulation since single molecules (or combinations of these) can be 
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injected, fine-tuning the immune response for a particular type of response (Rogan and Babiuk, 
2005). These have been developed as an alternative to the “traditional” approach of vaccine 
development (i.e. inactivated pathogens) where the latter had been ineffective. Nonetheless, 
the simplest and most cost effective way of making a commercial vaccine, is to incorporate 
(after inactivation) all the representative and relevant isolates of a pathogen family belonging to 
different serotypes. Since inactivated whole cell vaccines have been shown to offer good 
protection against V. anguillarum in many species of fish (Sakai, 1999), this approach was 
used in the formulation of a vaccine to protect Atlantic cod from the bacterium. 
Autologous vaccines, also called “emergency vaccines” or autogenous vaccines are tailored for 
use at a particular farm by including some (or all) of the isolates recovered from this farm in the 
vaccine. The licensing regulations for this type of vaccine are fairly minimal (The Veterinary 
Medicines Regulations 2007, No 2539); and they have been found to be extremely effective but 
protection against other isolates of the same species can be “hit or miss” (Gudmundsdottir and 
Gudmunsdottir, 1997). This type of vaccine has been used for Atlantic cod since the 
commercial vaccines have been awarding incomplete protection, but a product offering a broad 
spectrum of protection is a commercial necessity for the cod industry. 
The aim of this chapter was to investigate the protection elicited by a multivalent whole cell 
inactivated vaccine against V. anguillarum in Atlantic cod. From the analysis performed in 
 Chapter 3, four groups of V. anguillarum O2 serotype were identified and one isolate from each 
of these was included in the vaccine; an isolate from serotype O1 was also included, see 
Section  5.4.1. As mentioned previously, the immune system of Atlantic cod appears different 
from other fish species, mostly in its inability to produce measurable specific antibodies to V. 
anguillarum. Keeping this point in mind, we took the approach of trying to identify specific 
isolates from serotypes O1, O2a and O2b which were phagocytosed by cod leukocytes at a 
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higher level than other isolates within the same serotype. Since only a very small proportion of 
an injected antigen is involved in the immune response (Nossal, 1995), the presentation of this 
antigen is considered to be a limiting factor for the immune response (Paglia and Colombo, 
2002). Maximising antigen uptake and resulting antigen presentation has been shown to 
increase the immune response (antibody production), with this type of approach well 
characterised when adjuvants are used in the vaccine formulation (Dupuis et al., 1998). In 
order to increase the antigen uptake of the different components of the vaccine, the V. 
anguillarum isolates resulting in the highest number of positive phagocytic cod leukocytes and 
therefore also resulted in higher proportion of phagocytic cells undergoing respiratory burst, 
were selected. The capacity of cod serum to kill the different selected isolates of V. anguillarum 
could not be used since all isolates were found resistant. These assays were carried out in 
order to include isolates which theoretically offered the highest level of antigen presentation 
and subsequently protection within each serotype. The choice of which isolate to include from 
sub-serotypes O2c and O2d was made randomly due to the fact that their existence was 
unknown prior to performing the pathogenesis studies carried out in  Chapter 4. 
5.2. Materials and methods 
All the infection experiments took place at the Marine Environmental Research Laboratory 
(MERL), Machrihanish, Argyll, Scotland. This facility was supplied with natural seawater, the 
temperature of which was maintained at 10°C. The average salinity of the water was 33 ppt 
and the light regime used was 12:12 (L:D). 
5.2.1. Determination of challenge-dose 
The challenge-dose experiment was carried out in order to find the optimal dose of V. 
anguillarum necessary to achieve a level of mortality in unvaccinated fish of approximately 
60%. 
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5.2.1.1. Vibrio anguillarum challenge isolates 
The Vibrio anguillarum isolates used in the challenge-dose experiment were chosen from 
serotype O2 strains recovered from Atlantic cod Vibrio outbreaks (Table  2-1) which included 
the sub-serotypes O2b (isolate VIB102b), O2c (isolate 04.09.412) and O2d (isolate B01103 5-
4). These isolates were different to the isolates used in the vaccine (heterologous design). 
5.2.1.2. Pre-challenge protocol 
The 3 isolates of V. anguillarum selected as challenge strains were grown in two sterile 1 L 
bottles containing 750 mL each of TSB+NaCl and incubated for 48h with agitation (Section 
 2.1.2). Two concentrations of bacteria (Table  5-2) were used to estimate, after measuring the 
OD of the solution, the optimal lethal dose with 60% mortality (LD60), using a waterborne 
exposure protocol established at MERL (104 cfu.mL-1) as a guideline. 
Six groups of 6 unvaccinated Atlantic cod, average weight 270 g, were placed in 6 tanks (1.36 
m diameter, 450 L) housed in the Isolation Unit (IU) of MERL. The volume in each tank was 
lowered to 100 L and the water flow stopped. Two doses were tested for each challenge isolate 
by pouring 500 mL and 1 L of each of the 3 bacterial suspensions in the respective tanks 
(Table  5-2) and the fish exposed to the bacteria for an hour. Oxygenation was increased and 
the O2 concentration monitored every 10 min during this time. The water flow was then restored 
and the mortality recorded twice daily until 2 consecutive days without any mortality was 
recorded. 
Table  5-2 Concentration of V. anguillarum isolates used in the challenge-dose 
experiment. 
Serotype Isolate Bacterial load (cfu.mL-1) 
O2b VIB102b Dose 1: 3.60 x10
6 
Dose 2: 1.80 x106 
O2c 04.09.412 Dose 1: 7.40 x10
6 
Dose 2: 3.70 x106 
O2d B01103 5-4 Dose 1: 8.90 x10
6 
Dose 2: 4.45 x106 
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A swab of the head kidney of two moribund fish per tank was streaked onto TSA+NaCl plates 
( Appendix 1.1) and incubated at 22°C to confirm the presence of V. anguillarum. After 48 h, 
colonies resembling those of V. anguillarum (Section  1.2.6.1) were subcultured and identified 
by Gram staining, Vibriocidal test 0/129 and API20E (Section  2.1.4), as well as polyclonal 
antibody agglutination test (Bionor MonoVa, following the manufacturers’ instructions) and 
ELISA (Section  2.4) using the mAbs described in Section  3.3.2.1. Head kidney and spleen 
were also collected from the same fish and stored in 4% buffered formalin. 
5.2.2. Vaccination 
5.2.2.1. Vaccination isolates 
One isolate from each of the five serotypes deemed as important constituents to the vaccine 
(O1, O2a, O2b, O2c and O2d) were selected from the results obtained in  Chapter 4. The 
isolates used for the vaccination as well as their origin are summarised in Table  5-3. 
Table  5-3 Vibrio anguillarum isolates used in the vaccine preparation. 
Serotype Isolate name Origin of the isolate Concentration (cfu.mL-1) 
O1 VA40-78skid Salmo salar, S-P UK 4.36 x109 
O2a VIB2-1173/1 Gadus morhua, HWU 4.23 x109 
O2b VA34 Gadus morhua, NVI 4.60 x109 
O2c 06.09.28 Gadus morhua, NVI 4.29 x109 
O2d 07.09.297 Gadus morhua, NVI 4.46 x109 
 
NVI: National Veterinary Institute, Section for Fish Health, Dr D. Colquhoun, Oslo, Norway; HWU: Heriot Watt 
University, Dr Dawn Austin, Edinburgh, United Kingdom; S-P UK: Intervet-Schering-Plough, Prof P. Smith, Saffron 
Walden, United Kingdom. 
 
 
5.2.2.2. Vaccination protocol 
Vaccine preparation 
The bacteria were grown in 2 x 50 mL of TSB+NaCl (Section  2.1.2) from the original bacterial 
slopes. After 24 h, the bacteria were collected, the supernatant kept and the bacteria formalin-
killed as described in Section  2.1.6. Both tubes were combined and the optical density of each 
isolate adjusted to a final concentration in the vaccine of approximately 4.5 x109 cfu.mL-1. The 
isolates were centrifuged at 5525 x g for 30 min and the pellet resuspended in 5 mL of the 
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previously collected supernatant, after sterilising it using 0.22 µm filters. The bacteria were then 
mixed all together (1:1:1:1:1), making 25 mL of vaccine. The concentration of each isolate used 
in the vaccine can be found in Table  5-3. No adjuvant was used for this study and the vaccine 
was stored at 4°C for 2 weeks. 
Vaccination of Atlantic cod 
Three hundred cod (average weight 269.9 g) were injected intraperitoneally with 100 µL of 
either the vaccine (200 fish) or sterile PBS (100 fish). The fish were anaesthetized in 50 ppm 
solution of MS222 (Sigma-Aldrich) in sea water until the fish were observed unresponsive, 
vaccinated IP and weighed. The vaccinated fish were then separated into 2 tanks labelled V1 
and V2 (100 fish per tank, 2 m diameter, 1500 L) and the PBS vaccinated fish were placed in a 
third tank, labelled C (100 fish). 
5.2.3. Challenge 
Seven weeks post-vaccination, the three groups of fish (2 vaccinated and 1 control) were 
experimentally challenged with the bacteria. The fish were transferred before infection from 
their on-growing tanks to the IU and divided randomly and equally in 3 tanks per group (9 x 450 
L, 30 fish per tank, 1.36 m diameter). 
The bacteria recovered from the pre-challenge were grown in three 2 L bottles containing 1.5 L 
each of TSB+NaCl and incubated for 72h with agitation (Section  2.1.2). The optical density of 
the bacterial suspension was measured just prior to the challenge. 
The bath-challenge procedure of vaccinated fish was the same as that carried out in the pre-
challenge experiment (Section  5.2.1.2), with the only difference being the number of fish used 
per tank and the number of tanks used. The challenge dose used was chosen from the results 
of the challenge-dose experiment to reach an LD60 in the control group. Briefly, the water in 
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each tank was lowered to 100 L, the water flow stopped and the oxygen monitored. Five 
hundred mL of the bacterial solution prepared from the different isolates was poured into the 
corresponding tanks (Table  5-4) and after 1 h, the water flow was restored. 
Table  5-4 Experimental design for the bath-challenge of vaccinated cod with V. 
anguillarum O2b, O2c and O2d isolates. 
Challenge strain Bacterial load (cfu.mL-1) Group Fish number Tank N° 
V1 30 2 
V2 31 9 O2b 1.25 x106 
C 28 7 
V1 30 1 
V2 30 5 O2c 3.45 x106 
C 28 3 
V1 29 4 
V2 30 6 O2d 1.8 x106 
C 27 8 
 
The fish mortality was recorded for 2 weeks, at which point the challenge was terminated. 
Kidney swabs were taken from fish that died during the challenge. They were plated on 
TSA+NaCl and kept at 22°C until colonies had grown. The colonies were then analysed by 
agglutination test (BioNor) and ELISA (Section  2.4) using the mAbs developed in  Chapter 3. 
At the end of the challenge period, 10 fish were collected from each of the tanks and their 
infection status examined by taking a swab from the spleen of each fish and inoculating on one 
half of a TSA+NaCl plate (i.e. 90 samples in total). The plates were incubated at 22°C for 48 h. 
An average of 3 different bacterial colony types could be observed on each plate (around 250 
different colonies). Those resembling V. anguillarum colonies (Section  1.2.6.1) were screened 
by Gram staining (Section  2.1.4.2) and the bacteria similar to V. anguillarum were grown in the 
presence of Vibriocidal 0/129 discs (Section  2.1.4.3). The isolates, which were selected after 
this test, were grown overnight in TSB+NaCl (Section  2.1.2) and analysed by ELISA (Section 
 2.4), as described previously. 
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5.2.4. Analysis of the mortality data 
The Relative Percent Survival (RPS, Amend, 1981) was calculated according to Equation  5-1. 
Equation  5-1 Formula of the Relative Percent Survival 
 
 
The statistical differences in mortality between vaccinated and control groups were determined 
running a one-tailed Fisher’s Exact Test. The test was considered significant if the p value was 
less than 0.05. 
5.3. Results 
5.3.1. Determination of challenge-dose (pre-challenge) 
The mortality of cod recorded following a bath challenge with V. anguillarum after 2 weeks is 
summarised in Table  5-5. 
Table  5-5 Percentage mortality recorded after pre-challenge using different doses of 
three different V. anguillarum isolates. 
Serotype Isolate Bacterial load (cfu.mL-1) Mortality % 
3.6 x106 83% (5/6) 
O2b VIB102b 
1.8 x106 66% (4/6) 
7.4 x106 33% (2/6) 
O2c 04.09.412 
3.7 x106 33% (2/6) 
8.9 x106 83% (5/6) 
O2d B01103 5-4 
4.45 x106 66% (4/6) 
 
All the isolates recovered from the dead fish after pre-challenge were identified as V. 
anguillarum, except for one from Tank 15 (O2c, low dose), which did not agglutinate using the 
BioNor anti-Vibrio anguillarum polyclonal antibody. The reaction of the mAbs in ELISA revealed 
that the isolates recovered from both challenge dose from the O2b and O2d groups belonged 
to the correct subserotype. 
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One identified isolate from each of the serotypes tested (O2b, O2c and O2d), recovered from 
the pre-challenge experiment was selected to be used in the challenge post-vaccination. 
The lower dose of bacterium for serotype O2b and O2d (VIB102b at 1.8 x106 cfu.mL-1 and 
B01103 5-4 at 4.45 x106 cfu.mL-1) gave satisfactory levels of mortality (i.e. 4 out of 6 fish died, 
66%) in the pre-challenge experiment and these concentrations were therefore selected as the 
challenge dose for future challenges. Only 33% of fish died with the highest dose of the 
serotype O2c isolate 04.09.412 when used at 7.4 x106 cfu.mL-1, and therefore a higher dose 
was deemed necessary to produce a higher level of mortality. 
5.3.2. Vaccinated Atlantic cod bath challenged with V. 
anguillarum 
The levels of mortality obtained in vaccinated fish 2 weeks after challenging them with V. 
anguillarum are shown in Table  5-6.  
Table  5-6 Levels of mortality in vaccinated Atlantic cod after bath-challenge with V. 
anguillarum. 
Serotype Group Mortality % RPS 
Vaccinated 0%  (0/61) 
O2b 
Control 14.3%  (4/28) 
100% 
Vaccinated 0%  (0/60) 
O2c 
Control 0%  (0/28) 
0% 
Vaccinated 1.7%  (1/59) 
O2d 
Control 48.1%  (13/27) 
96.4% 
 
The mortality data from both vaccinated tanks were combined. 
Mortality (number of dead fish/total number of vaccinated fish), 2 fish died in the O2c vaccinated group but their 
death could not be attributed to vibriosis and so do not appear in this table. 
 
Isolates recovered from the dead or moribund fish sampled during the challenge period (5 fish 
from Tank 8 (O2d control), 3 from Tank 7 (O2b control) and 1 fish from Tank 5 (O2c 
vaccinated)) were all identified as V. anguillarum (by the BioNor agglutination test) except for 
the isolate obtained from Tank 5 (O2c) which showed no agglutination with the BioNor test. All 
the other isolates (5 recovered from Tank 8 (O2d) and 3 from Tank 7 (O2b)) were identified as 
the expected serotypes of either O2b or O2d. The dynamics of the challenge mortality in the 
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control tanks can be seen in Figure  5-1. No mortalities occurred in control fish infected with the 
O2c isolate (Tank 3). The mortalities in the control fish infected with serotype O2b (Tank 7) 
started after 5 days and did not seem to plateau by the end of the experiment (2 fish dying on 
Day 14). The mortality in the control fish infected with O2d (Tank 8) was regularly increasing 
until the experiment was stopped on Day 15. 
 
Figure  5-1 Percent cumulative mortality in control tanks of fish challenged with O2b, 
O2c and O2d V. anguillarum sub-serotypes. 
 
Ten fish per tank were sampled at the end of the experiment to establish if they were infected 
with the bacterium. Of the 250 bacterial isolates recovered from the spleen samples, only 5 
bacteria were found to react positively with the mAbs used. Two isolates recovered from Tank 
7 (challenged with serotype O2b) were grouped with the sub-serotype O2b (as expected) and 3 
isolates recovered from Tank 8 (challenged with serotype O2d) presented an O2d reaction 
profile. Both these tanks were control tanks with mortality still occurring when the challenge had 
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to be terminated (Figure  5-1). No V. anguillarum were recovered from any of the vaccinated 
fish. 
The level of infected fish at the end of the experiment was extrapolated to the total population 
of fish in the tanks and since no mortality in the vaccinated groups occurred as a consequence 
of an infection by V. anguillarum, the Figure  5-2 only represents the control groups. The 
prevalence of infection established in Tank 7 was 20% and 33% in Tank 8, this means that 4 
fish were infected but not dead at the end of the experiment in Tank 7 (20% of 24 fish live) and 
4 fish were infected in Tank 8 (33% of 14 fish live). 
 
Figure  5-2 Cumulative mort, infected and uninfected control fish after challenge with 
different serotypes of V. anguillarum. 
 
There was a significant difference between the number of mort in the vaccinated and control 
tanks for the O2b (p=0.0084) and the O2d (p<0.0001) serotypes (Table  5-6). 
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5.4. Discussion 
5.4.1. Experimental design and vaccine formulation 
The formalin-inactivated Vibrio anguillarum vaccine used in this study was designed to include 
4 sub-serotype isolates from O2 (O2a, O2b, O2c and O2d) as well as an O1 isolate. Serotype 
O1 is shown to be pathogenic to some marine species, but outbreaks in Atlantic cod are rare 
(Larsen et al., 1994). Toranzo et al. (1997) suggested that it was not necessary to include this 
strain in the vaccine; nevertheless the O1 serotype was included in the vaccine because it was 
designed to be potentially used in other fish species. The possibility of a shift in the prevalence 
of a particular serotype to another one in disease outbreaks is also a possibility (Section  6.2.3). 
It was decided to use a water-based vaccine preparation, not containing any adjuvant. It has 
been shown that the short term protection of Atlantic cod after bath-vaccination was not 
improved by the addition of an adjuvant (Mikkelsen et al., 2004). Oil adjuvants have been used 
in cod and were shown to be well tolerated, although adverse reactions to adjuvants have been 
observed in other bony fish, such as the development of adhesion (Samuelsen et al., 2006; 
Schroder et al., 2006a). These side effects are considered acceptable when the benefits of 
vaccination are taken into consideration (Gravningen et al., 2005a). 
In the vaccine preparation, the supernatant from the bacterial preparation following 
centrifugation was used to resuspend the bacteria. This was done so as to also include the 
ECP secreted by the bacteria during its growth, as this may contain protective antigens. 
It has been shown that vaccinating and challenging fish by the same route (IP) can temporarily 
protect them against infection, through development of local immunity at the site of injection 
(Nordmo and Ramstad, 1997), possibly masking the effect of any antigen-specific protection. It 
is recommended that the experimental infection should be performed using a natural route of 
infection (Griffin, 2002). The fish were vaccinated via IP injection and challenged through bath 
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exposure. The pathogen is therefore exposed to the full repertoire of immune mechanisms (gut, 
skin and mucus), which might be bypassed by injecting the bacteria straight into the peritoneal 
cavity of the fish. Nevertheless, the European Pharmacopoeia regulation requires that 
experimental challenge be administered by injection for vaccine licensing tests (Midtlyng, 
2005). 
There was a difference in the virulence between the different isolates of V. anguillarum used to 
challenge the fish. Serotype O2b and O2d were found to be highly virulent, while the isolate 
used from serotype O2c was found to be less virulent since 4 times more bacteria was required 
to achieve only half the number of mortalities in the pre-challenge, compared with the other two 
serotypes (i.e. 33% Vs 66%) and no mortality occurred in the actual challenge of the 
vaccinated fish. This finding reflects the results of Mikkelsen et al. (2007), where isolates of the 
O2c serotype appeared to be less virulent to cod than the classical O2a and O2b, with only 50 
to 75% mortality occurring after bath-challenge at a high dose (106 cfu.mL-1). 
The concentrations of bacteria used to infect adult Atlantic cod in this study were fairly similar 
(1.8 to 8.9 x106 cfu.mL-1) compared to those generally used by other researchers. 
Concentrations of bacteria added to the tank during the bath-challenge in other studies usually 
ranged from 5 x105 to 5 x107 cfu.mL-1 (Gilberg and Mikkelsen, 1998; Pedersen et al., 2004; 
Samuelsen and Bergh, 2004; Vik-Mo et al., 2005; Schroder et al., 2006a), with fairly variable 
mortality rates reported, especially since different V. anguillarum isolates were used. Generally, 
the mortality levels in the control tanks were over 75%. 
In the current study, the size of the fish could also have had an influence on the outcome of the 
challenge since in most studies, the fish vaccinated are around 20 g. The temperature at which 
the challenge took place was fairly low (10°C) and since outbreaks in the wild tend to happen 
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during summer, when the sea temperature is rising ( 1.2.4), this could have participated to the 
low mortalities observed. 
The doses used to challenge the vaccinated fish in this study did not achieve the target level of 
mortality in the control groups of 66%, as obtained in the pre-challenge response experiment. 
The final mortality levels obtained in the control fish in the vaccine trial were 14.3, 0 and 48.1% 
after infection with O2b, O2c and O2d, respectively. The recommended levels of mortality for 
vaccine studies is over 50% (Griffin, 2002). The lower levels of mortality obtained compared to 
the pre-challenge response trial were probably due to the lower level of bacteria used (i.e. O2c, 
3.45 x106 vs. 7.4 x106, respectively). There were practical reasons for the difference in bacterial 
dose used for the two experiments. Firstly the assumption was made that different volumes of 
broth would sustain the same growth rate of V. anguillarum (750 mL for the pre-challenge and 
1.5 L for the vaccination challenge). The absorbance of the bacterial suspension was made at 
Machrihanish, just prior to the challenge. The MERL is a 4 h drive away from the Institute of 
Aquaculture and time constraints did not allow postponing the challenge once it was realised 
that the level of bacteria was lower than the pre-challenge dose. The scaling up of the fish 
numbers from the pre-challenge to the vaccination-challenge experiments (from 6 to 30 fish per 
tank), could also explain the low mortality in the control groups since the number of bacteria 
available per fish was reduced by a factor of 5. Maybe the challenge could have been carried 
out with the exact same protocol as the challenge-dose experiment, bathing fish in groups of 6 
and then transferring them into another tank. 
Variability in the level of infection has also been reported by other researchers when bath-
challenge has been used. This method of infection, although artificial, mimics a more natural 
route; however the IP route of infection is generally far more reproducible. Schroder et al. 
(2006a) reported a 77% level of mortality in their pre-challenged fish by bath administration with 
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an O2b isolate (5 x105 cfu.mL-1), but levels of mortalities of 18 and 40% in duplicate tanks and 
up to 89% in another experiment, all using the same challenge protocol. Mikkelsen et al. (2007) 
found inconsistencies in their challenge experiments, with mortalities of 75% obtained with a 
dose of 9.3 x106 cfu.mL-1, while 83% mortalities were obtained with a dose 10 times lower. 
Corripio-Miyar et al. (2007) reported a similar problem when challenging haddock 
(Melanogrammus aeglefinus L.) with V. anguillarum O2 serotype by bath. The mortality 
recorded reached 60% in the pre-challenge and only 28% in the experimental challenge. 
The isolates used to challenge the vaccination fish (O2b, O2c and O2d) were re-isolated from 
fish that died during the pre-challenge experiment. On reflection, these isolates should have 
been the same bacteria that were used in the pre-challenge experiment and not the ones 
recovered from the pre-challenge experiment. An error could have been made during the 
recovery of the isolates, especially regarding the O2c isolate since it does not react with any of 
the mAbs used in this study and could only be confirmed as V. anguillarum by using the BioNor 
agglutination test. 
The number of bacteria recovered post vaccination (at the end of the experiment) was fairly 
high and it is possible that another disease occurred during this experiment. No identification of 
these other bacteria was carried out but the fish had to be transported from the challenge 
facilities (Machrihanish) to the laboratory (Stirling university) on ice and this transport took 10 
hours, which could explain why the number of bacteria isolated was high. 
The two fish that died in the vaccinated group challenged with serotype O2c (Tank 5) were not 
thought to be infected with V. anguillarum. The first of the two mortalities occurred the day of 
the challenge and could be stress related. No V. anguillarum could be recovered from the 
second dead fish in this tank (BioNor negative) and so it seems that the challenge of this group 
of fish failed. No vaccine safety testing (toxicity of the vaccine formulation), by injecting twice 
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the dose of the vaccine in 10 fish, was done and it would be very important to do so in order to 
prove that the death of these two fish was not due to the vaccine itself. Nevertheless, this 
possibility seems remote since no fish died for the 6 weeks post vaccination. 
5.4.2. Vaccine protection 
Excellent protection was achieved in two of the three groups challenged with V. anguillarum at 
12 weeks post vaccination. The vaccine was very efficient in protecting against heterologous 
isolates of serotypes O2b and the O2d, with RPS values of 100% and 96.4%, respectively. The 
proportion of fish dying in the O2d serotype control group, at almost 50%, was statistically 
different to the mortality in fish vaccinated, while the low mortality in the O2b group (only 4 fish 
out of 28) was also shown to be statistically different from the vaccinated group. These results 
suggest that the vaccine formulation may protect Atlantic cod against isolates of V. anguillarum 
not included in the vaccine formulation. The fact that no V. anguillarum were recovered from 
the vaccinated fish indicates that the vaccine formulated allowed the fish to clear the pathogen. 
However, the vaccination study should be repeated on a larger scale to confirm this. It was 
shown that some fish (i.e. 20 and 33% of the control fish challenged with serotypes O2b and 
O2d, respectively) were infected with the bacteria but did not die or develop signs of the 
disease. The protection elicited by the vaccine against O2c is still uncertain and the experiment 
would need to be repeated. A more thorough investigation of its virulence (challenge-dose) in 
cod should also be performed. In addition, as well as the development of characterisation tools 
(mAbs) to help screen or detect this serotype, it is important to evaluate the protection of the 
vaccine against more isolates from each serotype (O2b, O2c and O2d) and also against O2a 
and maybe O1, to prove that the vaccine elicits broad-spectrum protection, as suggested from 
the results of this study. 
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Experiments in our laboratory have shown that the specific antibody response to vaccination or 
infection could not be detected by ELISA (data not shown) and thus no antibody levels were 
measured post-vaccination. 
5.4.3. Measuring the protection elicited in Atlantic cod 
In the search for an effective vaccine, achieving protection against all of the different strains of 
a pathogen, the vaccinologist is faced with a number of questions: (I) how to make an antigen 
immunogenic, or select the most antigenic strain, (II) how to induce the right type of response 
in the fish, eliciting good protection for an extended period of time and (III) how to determine 
the effectiveness of a pilot vaccine (Secombes, 2008). 
Regarding the design of V. anguillarum vaccines, the lipopolysaccharide layer of Gram 
negative bacteria has been shown to elicit a strong immunological response and is specific for 
the different V. anguillarum serotypes of the species (Grisez, 1997). So, as long as all the 
representative strains of the pathogen are included in a polyvalent vaccine, the fish should be 
protected to the infection. Nevertheless, the injection of purified LPS as antigen would increase 
drastically the production cost of vaccines and currently immunisation of fish with whole cells is 
generally very effective ( 5.4.2). The question of how to specifically tailor a vaccine to stimulate 
a particular immune response in the fish, such as a strong and long-lasting memory T cell 
response (Salerno-Goncalves and Sztein, 2006), is not easy to answer since cellular immune 
responses in fish are still being unravelled. One way to increase the potential effectiveness of 
vaccines is related to measuring the fish response to vaccination. Experimental infections of 
hundreds of vaccinated fish (if not thousands) is the common method for testing whether a 
vaccine is protective, but such trials are becoming increasingly expensive, generate limited 
information (Secombes, 2008), as well as challenge the replacement, reduction and refinement 
of animal use in scientific experiments (Home Office Act 1986). Another common way of 
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measuring the relative effect of a vaccine is to measure the antibody response of the fish after 
vaccination, which can be done fairly easily and in a non-lethal sampling but the relationship 
between antibody levels and protection has to be verified (Reitan and Secombes, 1997). 
Unfortunately, direct detection of anti-V. anguillarum IgM by ELISA in vaccinated or infected 
fish is not a reliable method for cod (Bricknell et al., 2006). 
In order to investigate the effect of vaccination in Atlantic cod, other components of the immune 
system can be measured which may give an indication of the reaction of the cod immune 
system to vaccination. Since cod seems to be protected against V. anguillarum by vaccination 
for almost a year (44 weeks, Lund et al., 2007), a particular type of specific (and long-lasting) 
immune response has to be present in the vaccinated animals. A possible explanation is that 
Atlantic cod do in fact produce specific antibodies which are not detectable by ELISA (Dr Tony 
Ellis, personal communication). Opsonophagocytosis, the increase in phagocytosis after 
incubation with immune sera, of a particular pathogen has been shown to increase post-
vaccination (Verho et al., 2005). This indirect measurement of antibodies in cod could help 
determine the effectiveness of a vaccine formulation, even if preliminary experiments in our lab 
did not shown any increase in the phagocytic activity of cod leukocytes after incubation with 
immune sera. The expression of the signalling molecules such as cytokines could also give 
indications of the effectiveness of the vaccination (Secombes, 2008). Other components of the 
immune system of cod could also explain the increased resistance to challenge such as acute 
phase proteins or antibacterial activity (G-type lysozyme, BPI/LBP and Transferin genes and 
serum killing of V. anguillarum). Both these factors, as well as several cytokines (IL-1β and IL-
8), apolipoprotein and natural cytokine cell receptor protein genes have been shown to 
increase shortly after vaccinating fish (Caipang et al., 2008). Nevertheless, most of the genes 
previously mentioned are part of the acute phase response and are thought to be involved in 
early and not long term protection. More work should be conducted to determine why Atlantic 
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cod remain protected against V. anguillarum weeks or months after vaccination, when most of 
the acute phase proteins should have reduced back to pre-vaccination levels and so should 
offer no more protection than before the vaccination. 
Research on Atlantic cod B and T cells is under way by several laboratories and it seems that, 
at the moment, there is no plausible explanation for the lack of specific immune response after 
vaccination or infection. Hopefully, through the advancement of cell characterisation and the 
understanding of the molecular mechanisms involved in the specific immunity of Atlantic cod, a 
working hypothesis can be developed. This would give great insights into the general 
understanding of the immune system of cod and possibly help design more effective vaccines. 
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Chapter 6. 
 
General Discussion 
 
6.1. Atlantic cod Aquaculture 
Norway was the first country in the world to farm Atlantic cod and, at the moment, is the only 
country where cod aquaculture is well established. In 2006, there were 213 active cod farming 
concessions (sites) in Norway, with a total of 500 licenced sites and production of 100,000 T 
authorised by the government. The actual production was an estimated 12,000 T in 2007 
(Hellberg et al., 2005-2006-2007), which makes an average of a little over 50 T per farm per 
year. 
Cod aquaculture in Norway seems to be flourishing under the governmental motto “Go for 
Cod”. At the moment, the vast majority of the licences are exploited by a few companies with 
the 18 largest owning over 200 licences, and 120 companies having a single licence. The three 
major companies are Spon Fish (capacity of 22,000 T), Marine Harvest (20,000 T) and 
Codfarmers (15,000 T) (www.Worldfishing.net, Norway, 2007). The estimated production of the 
cod aquaculture industry is estimated at around 100,000 T by 2010-2015 (Rosenlund and 
Skretting, 2006), with potential to quadruple this amount. 
The total aquaculture industry in Scotland was estimated to be worth £400 million in 2006. This 
comprised £382 million for farmed salmon, approximately £10 million for rainbow, brown and 
sea trout, £6 million for shellfish and approximately £2 million for halibut and cod 
(www.scotland.gov.uk). The cod industry produced 543 T (and 233 T of halibut), accounting for 
0.3% of the total aquatic farming value. 
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The bankruptcy of the Shetland based Johnson Seafood, No Catch operation, in February 
2008 saw the end of industrial production of Atlantic cod in the UK, after only 4 years of 
production. No Catch, producing “organic” cod, was selling their fish in 13 different countries 
through major supermarket retailers and was planning to supply 10% of the British market by 
2010 with an estimated production of 30,000 T. Thus, today, aquaculture production of Atlantic 
cod in the UK is zero, but this does not mean that the Norwegian model cannot be successfully 
implemented, especially in Scotland since the environment, infrastructure (based on salmon 
farms) and aquaculture companies such as Marine Harvest are all present. At the moment, the 
UK is importing over 90% of the cod consumed, approximately 300,000 T (www.seafish.org), 
which leaves scope for future development. 
6.2. Atlantic cod vaccines and Vibrio anguillarum 
serotypes 
6.2.1. Vaccines and Atlantic cod vibriosis 
Disease is the major hindrance to the cod industry, and Vibrio anguillarum is still considered 
the most important bacterial disease affecting cod (Section  1.1). 
Virtually all Atlantic cod produced in Norway are vaccinated with the most up-to-date vaccine 
available (composed of V. anguillarum O2a and O2b isolates), but as mentioned in Section  5.1, 
outbreaks of vibriosis are still occurring on farms, illustrating that the current commercial 
vaccines used, need to be improved. 
The general trend in V. anguillarum outbreaks in vaccinated cod from 2003 to 2007 has shown 
the number of infections due to V. anguillarum O2a sub-serotype to have decreased in 
proportion to outbreaks caused by O2b (Section  1.2.6.3 and Table  6-1). Vibrio anguillarum has 
been responsible for 30 reported cases of disease outbreaks from 19 farm sites in Norway in 
2006. The identification of a new variant of the O2a sub-serotype was also reported (Schroder 
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et al., 2006b) and a comprehensive study published the following year (Mikkelsen et al., 2007). 
Retrospectively, it was found that this new variant (called O2c in this work) was identified in 
samples dating from 2001 and may have been responsible for some of the outbreaks recorded 
since then. The proportion of O2c outbreaks seems to be increasing rapidly, but since this sub-
serotype has only been identified very recently, this might not represent a true trend. 
Table  6-1 Summary of the number of V. anguillarum outbreaks identified in Norway 
(Hellberg et al., 2005-2006-2007). 
 Year 
Serotype 2003 2004 2005 2006 2007 
O1 Not found Not found Not found Not found Not found 
O2a 6 9 1 5 5 
O2b 11 18 17 15 15 
O2c    3 6 
Total farms 
investigated 19 27 18 19 19 
 
Some isolates have not been serotyped and some had multiple serotypes present. 
 
Thus, the number of outbreaks reported in Norway by the National Veterinary Institute 
(Hellberg et al., 2005-2006-2007), shows very clearly that vaccines still need to be improved. 
Reformulation of the vaccine used appears to be the most appropriate way to address this 
issue. Therefore, the first part of this study investigated the classification of V. anguillarum with 
respect to identifying the different V. anguillarum serotypes responsible for disease outbreaks 
in the cod industry. 
6.2.2. Monoclonal antibodies 
A set of monoclonal antibodies were developed during this study to identify the different 
serotypes of V. anguillarum responsible for disease outbreaks in Atlantic cod as well as in other 
fish species ( Chapter 3). After selection of O1 (V.angO1 2.3), O2a (V.angO2a mab3), O2b 
(V.angO2b 6.3) and O2a-b (V.angO2a-b 9.2) specific mAbs, the entire V. anguillarum 
collection, shown in Table  2-1, was screened using these antibodies. A new sub-serotype 
belonging to the O2 group was identified and referred to as O2d, which reacted with the O2 
  164
specific mAb but not with the O2a or O2b sub-serotype specific mAbs. Further analysis of V. 
anguillarum isolates from Norway (courtesy of Dr D. Colquhoun), revealed that (I) the O2c sub-
serotype did not appear to react with any of the mAbs developed in this study, suggesting it 
was a completely different serotype (II) the serotype of some of the isolates previously 
identified did not match with the results of this study (i.e. the serotypes of some isolates had 
been misclassified), and (III) the O2d sub-serotype was not restricted to Scottish waters, but 
was also present in Norway. 
These findings show that the set of V. anguillarum specific mAbs developed in this study are 
useful tools for identifying isolates recovered from outbreaks to a sub-serotype level, or for use 
in studies of virulence or pathogenicity. After presumptive identification of V. anguillarum by 
Gram staining and the 0/129 test, isolates could be screened with commercially available 
polyclonal antibodies specific for V. anguillarum (Mono-Va, BioNor) and the set of mAbs 
developed here to confirm the identity and the serotype of the V. anguillarum associated with a 
disease outbreak. The results expected for the corresponding serotypes are summarised in 
Table  6-2. 
Table  6-2 Presumptive results of diagnostic test for serotyping V. anguillarum 
recovered from Atlantic cod. 
 Isolate serotype 
Antibody O1 O2a O2b O2c O2d 
BioNor (Mono-Va) + + + + + 
O1 specific mAb + - - - - 
O2a specific mAb - + - - - 
O2b specific mAb - - + - - 
O2a-b specific mAb - + + - + 
 
6.2.3. Evolution of the V. anguillarum serotypes affecting cod 
The use of vaccination has profound effects on the pathogen population being targeted. For 
example, it might mean that these V. anguillarum strains (included in the vaccine), may 
disappear from the V. anguillarum population or at least decrease in infection due to a 
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decrease in number. This may lead to accelerated pathogen evolution (Martcheva et al., 2008), 
sometimes referred to as immune escape, with the result that more pathogenic strains may 
evolve in the environment, as was shown for Marek’s disease in poultry (Gimeno, 2008). The 
increase of other pathogenic species may also occur following vaccination. Such a 
phenomenon has been reported when Staphylococcus aureus infection was found to be 
increasing in human ear otitis cases after vaccination against Streptococcus pneumoniae 
(Bogaert et al., 2004). The possible adaptation of the pathogen, to avoid detection by the 
immune system, is also possible, for example antigenic drift observed with the influenza virus 
(Boni, 2008). 
The evolutionary pressure of vaccination (Day et al., 2008) can also lead to changes not only 
within the pathogen, as described above, but within the pathogen population, with a rise of new 
serotypes not included in the vaccine. This phenomenon, reported in mathematical and 
epidemiological models as well as field observations, is described as “vaccine-induced 
pathogen strain replacement” (Martcheva et al., 2008). It explains the emergence and 
subsequent dominance of a once-rare pathogen strain induced by vaccination (or 
chemotherapy) which has a differential effectiveness towards different pathogenic strains. This 
theory is relatively new and has been applied mostly to humans pathogens, primarily for 
pneumococcal diseases such as Haemophilus influenza and Streptococcus pneumoniae 
(Carrat and Flahault, 2007; Martcheva et al., 2008). The reasons for the rise of the non-vaccine 
strains are numerous and complex, but can be mainly attributed to competition for the niche; 
the dominant strain previously dominating this niche, is removed from the environment through 
vaccination, enabling the sub-dominant strain to emerge. 
This phenomenon does not appear to have been described for fish pathogens or aquaculture 
systems, but logically it can be assumed that it occurs. Some examples from the infection of 
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Atlantic cod with V. anguillarum seem to “fit” fairly well with this theory. As mentioned 
previously, isolates recovered from outbreaks of vibriosis in the early 2000’s in farmed cod 
belonged mostly to the O2a serotype, but with the successful vaccination of Atlantic cod using 
vaccines designed for salmonids (containing O2a but not O2b), a rise in the number of 
outbreaks of serotype O2b was observed and is now considered to be the main pathogenic 
sub-serotype in this fish species. Recently, serotype O2b was included in the vaccine for cod 
but it now appears that two “new” sub-serotypes (O2c and O2d) have been recovered in 
Norway and Scotland. 
Vaccine-induced pathogen strain replacement should be kept in mind when designing vaccines 
and the possibility of making the situation worse could be an outcome by allowing a more 
virulent (but less infectious) strain to establish itself in the host, a phenomenon described as 
scrambling competition in ecology (De Jong and Bouma, 2001). The vaccinologist has to be 
aware that this is a possibility and that even the removal of a particular pathogen could allow 
another species to establish itself. This may be what has been happening with Francisella 
philomiragia subsp. noatunensis and Vibrio ordalii in Norway in recent years, which are 
increasing in prevalence (Hellberg et al., 2005-2006-2007). Nevertheless several other factors 
are most probably also involved in the emergence of these pathogens. 
6.3. Vaccine formulation 
For the reasons described above, it is important to include all the serotypes (if feasible) 
responsible for outbreaks in a vaccine, even the ones that are not as significant regarding the 
number of cases, thereby increasing the breadth of the vaccine. Including antigens shared 
between these serotypes, targeting vulnerable features common to all strains (Martcheva et al., 
2008), is also important. This is why a recommendation was made here to leave the O1 
serotype in the vaccine, as it is known to be pathogenic to Atlantic cod, and maybe also include 
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the O3 and O5 serotypes which have been isolated in sporadic outbreaks (Larsen et al., 1994). 
This would provide the cod aquaculture industry with a vaccine that is not only able to respond 
to the threats experienced at the moment, but hopefully protect the cod population in 
aquaculture for extended periods without the need to update the vaccine after serotype 
replacement occurs. 
The first part of the vaccine design was achieved by understanding which serotypes to include 
in the vaccine ( Chapter 3), in order to elicit protection in Atlantic cod against a wide range of 
strains, with representative isolates from each of the serotypes. 
In the present study, the inactivated whole cell approach was taken because bacterin vaccines 
against Gram-negative bacteria generally give very good protection (Section  1.4.1). 
As described in Section  1.4.1, the identification of protective antigens in bacteria is not an easy 
task. Selection of a particular strain from hundreds of isolates is equally difficult. As reviewed in 
Curtis (2002), Grandi (2001) and Bramwell and Perrie (2005), the search for virulence factors is 
currently normally accomplished using genetic techniques, rather than LD50-type experiments. 
The latter leads to limited information, even if the data from surviving animals are extremely 
useful to get insights on protective antigens. In the present study ( Chapter 4), the same 
approach was taken by trying to identify the level of virulence of V. anguillarum in vitro; but with 
the difference that the physiological response to the pathogenic bacteria was observed in 
Atlantic cod leukocytes, instead of molecular markers. This was achieved by measuring the 
resistance of different isolates against components of the immune response of Atlantic cod in 
vitro using flow cytometry. 
The selection of vaccine candidates from several bacterial isolates within each serotype was 
performed by determining which strains were more virulent than others. For this, the relative 
degree of resistance of the killing by complement, phagocytosis and the respiratory burst 
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activity was investigated. The presence of such virulence mechanisms would enable the 
pathogen to have a higher chance of surviving in the fish (Wilson et al., 2002). Thus, if strains 
could be identified that were better at resisting the immune defences, the chances of these 
having virulence factors that could be protective, as well as immunogenic, would be higher than 
in less immunogenic/virulent strains (Curtis, 2002). 
All the isolates tested in  Chapter 4 were found to be resistant to complement-mediated serum 
killing; therefore it was not possible to select isolates on the basis of this characteristic. 
Regarding phagocytosis activity and respiratory burst of the cod leukocytes, a contradiction 
was encountered while taking the decision of which isolates to include in the vaccine; a strain 
resisting phagocytosis would have an advantage and so could be considered more virulent. In 
this instance, this strain should be selected on this basis to be included in the vaccine. On the 
other hand, from a vaccine efficacy point of view, a bacterium that would be more easily 
phagocytosed appears to be a better option since the antigens would be more easily expressed 
by APC, and so the chances of stimulating a higher immune response would follow (Section 
 5.1). Thus, the most highly phagocytosed isolates from each selected serotype were included 
in the vaccine, in order to elicit the highest possible response in Atlantic cod, since this animal 
is known to display a poor (if existing) specific antibody response to vaccination with V. 
anguillarum. 
The vaccine formulation used in  Chapter 5 was not supplemented with adjuvant but it is 
important to remember that since cod has a poor specific immune response to vaccination with 
V. anguillarum, it might be possible to increase this response, or direct the immune system 
towards a more appropriate pathway in order to increase protection with the use of an adjuvant 
(Section  1.4.1). 
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The vaccine produced was efficient at protecting Atlantic cod against heterologous strains of V. 
anguillarum O2b and O2d with very encouraging values for the RPS (100 and 96%, 
respectively). The challenge procedure used (low dose) did not allow the investigation of the 
protection against V. anguillarum sub-serotype O2c and should be repeated. In addition, the 
formulation should be tested against other strains of all the serotypes included in the vaccine to 
determine the “broadness” of protection elicited. Nevertheless, the vaccine formulation appears 
to be a good combination of bacterial candidates for protecting Atlantic cod against Vibrio 
anguillarum, which allowed the vaccinated fish to clear the pathogen. 
It would have been interesting to test two vaccines to estimate the relationship between the 
choice of the strains and the protection elicited. Together with the vaccine designed in this 
study, the immunisation of Atlantic cod with a vaccine containing the strains from  Chapter 4 
which had the highest resistance to phagocytosis (VIB1 (O1), VIB72T (O2a) and VIB102 
(O2b)), might have shown if this choice was clearly affecting the elicited protection. But due to 
the number of fish available for this study, this double vaccination experiment could not be 
designed. 
No evaluation of the antibody levels elicited has been carried out in this experiment and the 
immunological mechanisms which allow Atlantic cod to stop infection by V. anguillarum after 
vaccination have still not been elucidated. Maybe the protection of the fish is due to a “normal” 
anamnestic response with the activation of B cells to long-lived plasma cells and the secretion 
of specific antibodies but these have not been clearly shown to be detectable at this point. The 
possibility of a T-dependant type response is also to be considered, with the production of 
memory T cells and the subsequent activation of the cellular mediated immunity with the 
activation of phagocytic and cytotoxic cells. An interesting experiment which could give insights 
into the mechanisms of the cod vaccine protection would be the collection of B and T cells after 
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vaccination and passively immunise naïve fish with these. A subsequent challenge with V. 
anguillarum could give indications as to whether the antigen is producing an immune response 
and if either the B or the T cells are involved. Unfortunately, the advances in fish cellular 
immunology have not reached the point where many antibodies are available as markers, 
especially for fish species such as Atlantic cod. This type of experiment, relying on the use of B 
and T cell specific antibodies is not possible at the moment. 
In conclusion, Atlantic cod will certainly become a major fish species for cold-water marine 
aquaculture. Vibrio anguillarum is the main pathogen affecting cod and even though all fish 
produced in captivity are vaccinated, outbreaks of vibriosis are still reported. The problems 
regarding the specific immune response of Atlantic cod to pathogens, especially V. 
anguillarum, still evades researchers and this has hampered vaccine development for this 
species. Nevertheless, the tools developed in this study produced valuable information for the 
development of a suitable vaccine for cod. The identification of the different serotypes affecting 
this species (using the mAbs) as well as the in vitro assays developed for analysis by flow 
cytometry to examine the interaction of cod leukocytes with different serotypes of V. 
anguillarum enabled the investigation of some pathogenic mechanisms of isolates belonging to 
different serotypes. This helped in the decision of which isolates to include in the vaccine, so as 
to provide a broad range protection against different V. anguillarum serotypes. The vaccine 
specifically tailored to protect Atlantic cod against V. anguillarum in this study showed very 
promising results, eliciting high protection and therefore would be a very valuable product for 
the cod farming industry. 
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Appendix 1.  Bacteriology Buffers and Solutions 
All solutions and buffers were stored at 4°C unless otherwise stated. 
Appendix 1.1. Tryptone Soya Agar + 2% NaCl (TSA+NaCl): 
Tryptone Soya Agar (Oxoid)     20 g 
NaCl (Sigma-Aldrich)      7.5 g 
Distilled water       500 mL 
The solution was shaken and autoclaved. After cooling to 50°C in a water bath, 25 mL was 
poured into 90 mm Agar plates (Sterilin) and left to solidify overnight at RT. 
Appendix 1.2. Tryptone Soya Broth + 2% NaCl (TSB+NaCl): 
Tryptone Soya Broth (Oxoid)     15 g 
NaCl        7.5 g 
Distilled water       500 mL 
The solution was mixed and autoclaved. 
Appendix 1.3. Gram Staining Solutions: 
Appendix 1.3.1. Crystal Violet Solution: 
Methyl violet (Fissons)      2 g 
Ethanol (95%, VWR)      20 mL 
Ammonium oxalate (Sigma-Aldrich)    0.5 g 
Distilled water       80 mL 
The solution was left overnight at RT and filtered through a filter paper N°1 (Whatman). 
Appendix 1.3.2. Iodine Solution: 
Iodine (VWR)       1 g 
Potassium Iodine (VWR)     2 g 
Distilled water       300 mL 
The solution was left overnight at RT and filtered through a filter paper N°1 (Whatman). 
Appendix 1.3.3. Safranin Solution: 
Safranin (Sigma-Aldrich)     0.25 g 
Ethanol (95%, VWR)      10 mL 
Distilled water       90 mL 
The solution was left overnight at RT and filtered through a filter paper N°1 (Whatman). 
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Appendix 2.  SDS Gel Electrophoresis Buffers and 
Solutions 
Appendix 2.1. Phosphate Buffered Saline (PBS, 10x): 
NaH2PO4 (VWR)      4.38 g 
Na2HPO4 (VWR)      12.8 g 
NaCl        43.85 g 
Distilled water       500 mL 
For use, the solution was diluted 1:10 in distilled water, the pH adjusted to 7.2 and autoclaved. 
Appendix 2.2. SDS Sample Buffer (2x): 
Trisma HCl (Sigma-Aldrich, 0.5 M, pH 6.8)   2.5 mL 
Glycerol (Sigma-Aldrich)      2 mL 
SDS (10% w/v, Sigma-Aldrich)     4 mL 
DTT (Sigma-Aldrich)      310 mg 
Bromophenol Blue (Sigma-Aldrich)    a few grains 
Distilled water       adjusted to 10 mL 
The solution was vortexed vigorously, aliquoted in 500 µL and frozen at -20°C. 
Appendix 2.3. SDS Separating Buffer: 
Trisma Base (Sigma-Aldrich)     91 g 
SDS (Sigma-Aldrich)      2g 
Distilled water       500 mL 
The pH of the solution was adjusted to 8.7 and kept at 4°C for 1 month. 
Appendix 2.4. SDS Stacking Buffer: 
Trisma Base       6.05 g 
SDS        0.4 g 
Distilled water       100 mL 
The pH was adjusted to 6.8 and the solution kept at 4°C for 6 months.  
Appendix 2.5. SDS Running Buffer (5x): 
Trisma Base       7.5 g 
Glycine (Sigma-Aldrich)      36 g 
SDS        2.5 g 
Distilled water       500 mL 
The solution was kept at 4°C for 6 months. For use, 60 mL of running buffer was diluted with 
240 mL of distilled water and the pH adjusted to 8.3. 
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Appendix 3.  Western blot Buffers and Solutions 
Appendix 3.1. Blotting Buffer: 
Glycine        14.4 g 
Trisma base       3.03 g 
Methanol (Thermo Fisher Scientific)    200 mL 
Distilled water       800 mL 
The pH was adjusted to 8.3, if required. 
Appendix 3.2. Trisma Buffered Saline (TBS, 10x): 
Trisma base       12.1 g 
NaCl        146.2 g 
Distilled water       500 mL 
For use, the solution was diluted 1:10 in distilled water and the pH adjusted to 7.5. 
Appendix 3.3. Tween Trisma Buffered Saline (TTBS): 
TBS solution (1x)      500 mL 
Tween 20 (Sigma-Aldrich)     250 µL 
The pH was adjusted to 7.5. 
Appendix 3.4. Substrate Buffer and Developing Solution: 
Appendix 3.4.1. Substrate Buffer: 
4-chloro-1-naphtol (Sigma-Aldrich)    0.15 g 
Methanol       50 mL 
The solution was aliquoted in 10 mL and kept in the dark at -20°C. 
Appendix 3.4.2. Developing Solution: 
Substrate buffer       2 mL 
TBS (1x)       10 mL 
H2O2 (Sigma-Aldrich)      10 µL 
The H2O2 was added just before use. 
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Appendix 4.  ELISA Buffers and Solutions 
Appendix 4.1. Low Salt Wash Buffer (x10): 
Trisma base       12.1 g 
NaCl        111.1 g 
Tween 20       2.5 mL 
Distilled water       500 mL 
For use, the solution was diluted 1:10 in distilled water and the pH adjusted to 7.3. 
Appendix 4.2. High Salt Wash Buffer (x10): 
Trisma base       12.1 g 
NaCl        146.1 g 
Tween 20       5 mL 
Distilled water       500 mL 
For use, the solution was diluted 1:10 in distilled water and the pH adjusted to 7.7. 
Appendix 4.3. Coating Buffer: 
Carbonate-bicarbonate buffer (Sigma-Aldrich)   1 tablet 
Distilled water       100 mL 
Appendix 4.4. ELISA Developing Solutions 
Appendix 4.4.1. Substrate Buffer: 
Citric acid (VWR)      2.1 g 
Sodium acetate (Sigma-Aldrich)     0.82 g 
Distilled water       100 mL 
The pH was adjusted to 5.4. 
Appendix 4.4.2. TMB Solution: 
3’3’5’5’-Tetramethylbenidine dihydrochloride 
(TMB, Sigma-Aldrich)      79 mg 
Acetic acid (VWR)      2 mL 
Distilled water       4 mL 
The solution was vortexed and kept in the dark at 4°C. 
Appendix 4.4.3. Developing Solution: 
TMB solution       150 µL 
Substrate buffer       15 mL 
H2O2        5 µL 
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Appendix 5.  LPS Silver Staining 
Appendix 5.1. Solution A: 
Ethanol        45 mL 
Acetic acid       5 mL 
Distilled water       50 mL 
Appendix 5.2. Solution B: 
Acetic acid       7 mL 
Iso-propanol (Sigma-Aldrich)     1 mL 
Periodic acid (Sigma-Aldrich)     1.05 g 
Distilled water       92 mL 
Appendix 5.3. Solution C: 
Sodium Hydroxyde (VWR, 0.1M)     28 mL 
Ammonium hydroxide (Concentrated, Sigma-Aldrich)  1.5 m 
Silver nitrate solution (20% w/v, Sigma-Aldrich)   5 mL 
Distilled water       115 mL 
The solution was prepared in the fume hood. 
Appendix 5.4. Solution D: 
Citric acid (Sigma-Aldrich)     25 mg 
Formaldehyde (Sigma-Aldrich)     250 µL 
Distilled water       100 mL 
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Appendix 6.  Respiratory Burst Solutions 
Appendix 6.1. DHR: 
Dihydrorhodamine 123 (Sigma-Aldrich)    10 mg 
Dimethyl sulfoxide (DMSO, Sigma-Aldrich)   1 mL 
The solution was aliquoted in 20 µL and kept at -20°C until use. For use, 20 µL of the solution 
was thawed and diluted with 1.980 mL of sterile PBS (1x). 
Appendix 6.2. PMA: 
Phorbol 12-myristate 13-acetate (Sigma-Aldrich)   100 µg 
Dimethyl sulfoxide      1 mL 
The solution was aliquoted in 20 µL and kept at -20°C until use. For use, 20 µL of the solution 
was thawed and diluted with 1.980 mL of sterile PBS (1x). 
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Appendix 7.  Serum Killing Buffers and Solutions 
Appendix 7.1. Serum Buffer: 
Tris HCl       630 mg 
NaCl        877 mg 
Distilled water       100 mL 
Appendix 7.2. Live Stain Solution: 
Thiazole Orange (Sigma-Aldrich)     200 mg 
Dimethyl sulfoxide      1 mL 
The solution was aliquoted in 20 µL and kept at -20°C until use. For use, 20 µL of the solution 
was thawed and diluted with 1.980 mL of sterile PBS (1x). 
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Appendix 8.  Cell Separation Solutions 
Appendix 8.1. 34% Percoll: 
Percoll (Sigma-Aldrich)      3.4 mL 
PBS (10x)       1 mL 
Distilled water       5.6 mL 
Appendix 8.2. 51% Percoll: 
Percoll        5.1 mL 
PBS (10x)       1 mL 
Distilled water       3.9 mL 
Appendix 8.3. Preparation of the discontinuous gradient: 
To prepare the discontinuous gradient, 5 mL of 34% Percoll solution was poured into a 20 mL 
universal tube (Sterilin) and 10 mL of 51% Percoll solution was layered below the 34% layer by 
placing a 10 mL pipette filled with 51% Percoll solution and very slowly expelled. The tube was 
then kept at 4°C with care not to mix the layers while moving it. 
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Appendix 9.  Cell culture media 
Appendix 9.1. DMEM*: 
DMEM (Sigma-Aldrich)      500 mL 
Sodium pyruvate (Sigma-Aldrich, 100mM)   5 mL 
L-glutamine (Sigma-Aldrich, 200mM)    5 mL 
Penicillin-Streptomycin (Sigma-Aldrich, 200 IU.mL-1/200 µg.mL-1) 2.5 mL 
Appendix 9.2. L15*: 
L15 (Sigma-Aldrich; without glutamine)    500 mL 
L-glutamine (Sigma-Aldrich, 200mM)    5 mL 
Fetal Calf Serum (Sigma-Aldrich)    10 mL 
 
 
 
Companies: 
Sterilin Ltd, Caerphilly, UK 
Whatman, GE Healthcare, Maidstone, UK 
Oxoid, Thermo Fisher Scientific Inc., Loughborough, UK 
Fissons, Thermo Fisher Scientific, UK 
VWR, Lutterworth, UK 
Sigma-Aldrich, Poole, UK 
 
 
 
 
